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Every year there are approximately 300 million new cases of malaria with 2 million deaths.
The majority of deaths occur in African children between the ages of 1 and 4 years and are
caused by the parasite Plasmodium falciparum. Approximately R90-million is spent by the
South African government each year to control malaria. Peripheral blood monocytes are the
first line of defence during infection and they perform many functions, such as phagocytosis,
intracellular and extracellular killing by the generation of reactive oxygen intermediates and
the production of cytokines. During malaria infection some of these functions are suppressed
or elevated by phagocytosis of hemozoin, fever conditions (heat shock) and the presence of
anti-malarial drugs in the bloodstream of the patient. Under normal conditions phospholipase
Az (PLAz) is down regulated by heat shock protein 70 (HSP70) but in severe malaria PLAz is
elevated. Two antigenic peptides were selected from the highly conserved human HSP70 and
HSC70 proteins. Anti-peptide antibodies raised in chickens were affinity purified and were
able to recognize the free peptide in an ELISA and the native proteins in human and canine
heat shocked lymphocyte lysates on western blots. Antibodies against HSP70 detected two
major proteins at 70 kDa and 33 kDa, which are most likely native HSP70 and a possible
breakdown product ofHSP70 respectively. The anti-HSC70 antibodies detected two proteins,
an as yet unidentified 100 kDa protein and the 70 kDa HSC70. Due to the monocytes being
activated during the isolation procedure, HSP70 was expressed at both 37°C and 44°C in this
study. Electron-probe X-ray microanalysis enables determination ofthe elemental composition
of any sample under the electron microscope. When the electron beam interacts with a
specimen, X-rays are generated and can be used to identify and quantify the elements in the
cell. Canine monocytes were analysed using this technique after incubation with
therapeutically relevant concentrations of anti-malarial drugs, ~-hematin and under fever
conditions. The concentrations of the elements in normal canine monocytes were: Na (518.2
mmoles/kg), Mg (199.1 mmoles/kg), P (439.7 mmoles/kg), S (316.3 mmoles/kg), Cl (279.7
mmoles/kg), K (204 mmoles/kg) and Ca (81.3 mmoles/kg). All the drugs (quinine,
chloroquine, primaquine, pyrimethamine, artemisinin, tetracycline, doxycycline, dapsone and
suramin), phagocytosis of latex beads and ~-hematin as well as heat shock, altered the
elemental concentrations of canine monocytes in a unique way. Quinine, artemisinin and
IV
suramin were the most influential drugs in altering the concentrations of elements in the cells.
Suramin substantially increased the concentration of Ca (356%) after 18 h and decreased K
concentration (64%) after 18 h. Quinine decreased the concentrations ofNa (47%), Cl (70%),
and K (67%). The concentrations ofP (52%) and Ca (72%) were increased by quinine after 10
min. Artemisinin induced small increases in Mg (21 %) and K (38%) concentrations within 10
min and large increases in the concentrations of Na (291%) and Cl (389%) after 18 h.
Chloroquine induced a large increase in S (212%). Quinine induced major changes after 10
min whereas artemisinin, suramin chloroquine induced huge changes after 18 h. Although
artemisinin did increase the concentrations certain elements after 10 min, it was by much
smaller amounts than after 18 h. Quinine, suramin and pyrimethamine altered the P/K ratios
by the greatest margins whereas artemisinin had no significant effect. The P/K ratio was
increased by quinine (348%) after 10 min and suramin (261%) after 18 h. Pyrimethamine
decreased the P/K ratio after 18 h by 49%. The findings suggest that further investigations into
the alterations in the elemental concentrations of monocytes by anti-malarial drugs, fever and
hemozoin may lead to a greater understanding of the influence of these conditions in a patient
during a malaria infection and its treatment.
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Every year there are approximately 300 -500 million new cases of malaria with between 1.5
and 2.7 million deaths (Carosi and Castelli, 1997); to put this value into perspective a person
dies of malaria every 12 seconds (Butler et al., 1997; Philips, 2001). The majority of deaths
occur in African children between the ages of 1 and 4 years. Approximately R90-million is
spent by the South African government each year to control malaria, this includes treatment of
people who have contracted the disease as well as buying DDT to spray infected areas (Health
Systems Trust news article, 2001).
Protozoal parasites of the Plasmodium genus are responsible for the disease in a wide range of
vertebrates, but four morphologically distinct species (P. jalciparum, P. vivax, P. ovale and P.
malariae) infect humans (Collins and Paskewitz, 1995). The most morbidity and mortality is
caused by P. falciparum.
Female mosquitoes of the genus Anopheles are the vectors of the malaria parasites, with nearly
20% of the 500 plus described species implicated in transmission of the parasites (Collins and
Paskewitz, 1995). The transmission of malaria is dependent on climate and geography and
coincides with the rainy season (Coetzee et al., 2000; Petney, 2001).
1.1.1 Life cycle of malaria parasites
The life cycle of the malaria parasite comprises of stages in invertebrate and vertebrate host's,
as well as intracellular and extracellular developmental stages. The intricacy of the host
response to infection by these parasites is not surprising considering the complexity of the
organism's life cycle (Figure 1.1).
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The bite of an infected anopheline mosquito initiates the infection, with motile sporozoites
being injected into the bloodstream (Deans and Cohen, 1983). The sporozoites remain in the
bloodstream for 30 min prior to entering hepatic parenchyma cells (Wemsdorfer, 1980). Here
they become multinucleated hepatic schizonts, wherein many thousands of tiny invasive
merozoites develop. After approximately one week after infection, the liver cells rupture and
release more than 30,000 merozoites, in a P. falciparum infection, into the hepatic capillaries
(Knell, 1991). The merozoites invade erythrocytes within a few minutes of their release,
where they appear as a ring shape (Wemsdorfer, 1980). The merozoite now becomes an
erythrocytic trophozoite that ingests and digests hemog10bin. The trophozoite accumulates
hemozoin as it grows and divides into a schizont (Knell, 1991). During P. falciparum.
malaria, the trophozoites and schizonts are usually absent from the peripheral blood as they are
sequestered within the deep vascular beds (Newton et al., 2000). Erythrocytic schizonts
rupture periodically, with the periodicity depending on the species; each blood cell releases 10
- 20 merozoites and these invade new erythrocytes (Noble and Noble, 1982; Deans and
Cohen, 1983). At the same time hemozoin is also released. The clinical manifestations of
malaria, such as the shivering and sweating stages coincide, with the erythrocytic cycle of the
parasite (Sherry et al., 1995). A number of merozoites, after invading a new erythrocyte
differentiate into gametocytes.
Sexual reproduction occurs when the gametocytes are ingested into the gut of the mosquito
and are transformed into gametes (Wemsdorfer, 1980; Noble and Noble, 1982). The zygote
elongates and becomes an actively mobile ookinete, which enters the invertebrates' gut
epithelium. It comes to rest under the basal lamina, forming an oocyst. The oocyst's
cytoplasm divides to form sporozoites. When these emerge they migrate to the host's salivary
glands, where they penetrate the cells until they reach the lumina of the salivary duct








.. Invasive asexual form
~ Invasive sexual form
~ Trophic (growth) form
leading to asexual
multiplication
Figure 1.1 The life cycle ofPlasmodium malaria parasites. Adapted from Knell (1991).
3
4
1.1.2 The malaria problem
On August 16, 1897 the Surgeon-Major Rona1d Ross dissected an Anopheles mosquito, that
had previously fed on a malaria patient (Schmidt and Roberts, 1989). He found the malaria
parasites in the stomach lining of the insects. That day he wrote in his notebook:
This day designing God
Hath put into my hand
A wondrous thing. And God
Be praised. At this command
I have found they secret deeds
Oh million-murdering Death
I know that this little thing
A myriad men will save -
Oh death where is they sting?
Thy victory oh Grave?
Ross thought that they had conquered malaria by finding the mosquito stages of the infection.
But that was 106 years ago, and we are still no closer to conquering malaria. Of great concern
today is the resurgence of malaria, when in the early 60s it was nearly completely eradicated.
Some of the reasons are mentioned in Table 1. However, the technological age and the
increase in the gap between poverty stricken and 'wealthy' nations can be seen as some of the
most important man-made factors. The increase in resistance of the malarial parasites to the
drugs used in treatment of malaria (Rosenblatt, 1999) and the resistance of vectors to
insecticides are also other contributors.
Average global temperatures are predicted to rise by 1.5 - 6°C by 2100, which will ultimately
impact the geographical distribution of malaria (patz and Reisen, 2001). The minimum
temperature required for Plasmodium falciparum and vector development is between 15 and
18°C.
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Table 1.1 Reasons for the resurgence of malaria.














Global warming - increased breeding and life span of the insect
vector
Unusual El Nino type weather conditions
Shrinking world _.spread of malaria from endemic areas to all other
parts ofthe world
1.2 ANTI-MALARIAL DRUGS
A relatively small number of drugs against malaria are available today. Drugs are used in two
capacities, for prophylaxis and for treatment of the disease. Some may be used for both.
There are different classes of drug activity (Figure 1.2). Drugs in current use are either based
on natural products, such as quinine (Figure 1.3A), artemisinin (Figure 1.3H) and its
derivatives, or drugs introduced as a result of research during the 1940s and 1950', such as
chloroquine (Figure 1.3B), primaquine (Figure 1.3C) and pyrimethamine (Figure 1.3d)
(Breckenridge and Winstanely, 1997). However, since then there have been no really

















Figure 1.2 Anti-malarial drug activity in relation to the plasmodial life cycle. Drug
activity is indicated in black and the plasmodial life cycle is indicated in blue. Adapted from
Wemsdorfer (1997).
Briefly, blood schizonticides interfere with erythrocyte schizogony. Since this part of the cycle
is when the clinical manifestations appear, they are important in treatment. Gametocytocides
affect the gametocytes at any stage in their development; thus far there are none against P.
falciparum (Wemsdorfer, 1997). The drugs acting against any form within the invertebrate
host and thus preventing transmission are known as sporonticides. Hypnozoitocides are anti-
relapse drugs as they act against the "latent" hypnozoites. Lastly, the tissue schizontocides
affect the schizonts within the hepatocytes (Wemsdorfer, 1997). A number of these activities
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Figure 1.3 Structures of the anti-malarial drugs utilized in this study: A. quinine; B.
chloroquine; C. primaquine; D. pyrimethamine; E. dapsone; F. doxycycline; G.
.tetracycline; H. artemisinin. Adapted from Wemsdorfer (1997).
In the last decade, drug resistance has been developing worldwide. Resistance has been
defined as the 'ability of a parasite strain to survive and / or multiply despite the administration
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and absorption of a drug given in doses equal to or higher that those usually recommended but
within tolerance ofthe subject' (Bloland and Ettling, 1999).
To put the treatment ofmalaria into perspective here is a quote from White (1996):
"Mother Nature gave us cinchona alkaloids and qinghaosu. World War IT led to the
introduction of chloroquine, chloroguanide (proguanil), and eventually amodiaquine and
pyrimethamine. The war in Vietnam brought mefloquine and halofantrine. These drugs are all
we have available now to treat malaria. It is difficult to see where the next generation of anti-
malarial drugs will come from ...there is little pharmaceutical industry interest in developing
new anti-malarial drugs; the risks are great, but the returns on investment are low... If drug
resistance in P. falciparum continues to increase at the current rate, malaria may become
untreatable in parts of Southeast Asia by the beginning of the next Millennium,"
1.2.1 4-Quinolines and related drugs - quinine
The chemical name of quinine is 6-methoxy-a-(5-vinyl-2-quinuclidyl)-4-quinolinemethanol
(Figure l.3A), and it is the main alkaloid extracted from the bark of the Cinchona tree
(Wemsdorfer, 1997). In the 1650s Jesuit priests used it as an anti-pyretic (Van Beek and
Piette,2001). It was only in 1820, that the alkaloid quinine was isolated from the bark (Crum
and Gable, 2000). Its mode of action is blood schizonticidal and it has a very high activity
against all human malaria parasites. Parasite protein metabolism is where the drug is thought
to exert an effect. Quinine is also a K-channel blocker and this may be another mechanism of
action (Maruyama et al., 1994). Quinine is used today intravenously to treat severe and
complicated malaria, particularly multi-drug resistant P. falciparum (Wemsdorfer, 1997;
Raynes, 1999; Skinner-Adams and Davis, 1999). Resistance to quinine has been reported in
Southeast Asia, South America and Africa, despite this clinical failure is unusual outside of
Southeast Asia (Winstanley, 2000).
Some of the major side effects of quinine treatment include rash, thrombocytopaenia,
hemolytic-uremic syndrome or disseminated intravascular coagulation (Crum and Gable,
2000).
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1.2.2 4-Aminoquinolines - chloroquine
Chloroquine (Figure 1.3B) is the most widely used of all the anti-malarial drugs (Winstanley,
2000). It is a man-made drug with the chemical formula of 7-ch10ro-4-(4'-diethylamino-1 '-
methylbutylamino)quinoline (Wernsdorfer, 1997). It is a blood schizonticidal drug that
appears to inhibit the enzymes within the food vacuole of the parasite, as well as hemozoin
formation. How it does this is a matter of debate and there are numerous hypotheses, some of
which will be discussed. Thus far the proposed mechanisms of chloroquine action include: 1.
intercalation with parasite DNA, 2. inhibition of heme-dependent parasite protein synthesis
and, 3. inhibition ofheme-polymerization (Padmanaban and Ranarajan, 2000).
Electron microscopy studies revealed that there are morphological changes within the food
vacuole of P. jalciparum after treatment with quinoline drugs. These include swelling of the
vacuole, vesiculation, pigment clumping (Pandey and Chauhan, 1998; Sullivan, 2002) and
accumulation of undigested hemoglobin; these changes indicate inhibition of the normal
functioning of the food vacuole (Sullivan Jr et al., 1996b; Raynes, 1999).
Chloroquine is a diprotic weak base that has a pKal of 8.1 and a pKaz of 10.2 (Raynes, 1999).
It moves down the pH gradient between the acidic digestive vacuole of the parasite and the
extracellular matrix (Figure 1.4). Chloroquine is able to diffuse across membranes and
accumulate in the food vacuole in its unprotonated form. When the drug enters the acidic
milieu of the food vacuole it is protonated and becomes membrane impermeable and hence
trapped inside the organelle (Ginsburg et aI., 1999; Weber et al., 2000). Due to being a weak
base, chloroquine is able to achieve a concentration in the food vacuole 1000 - 5000 times that
of the external concentration of 10 - 100 nM (Foley and Tilley, 1997; Sullivan, 2002).
Evidence from the laboratory of Hawley et al. (1998) suggests that a regulator of anti-malarial
activity is the extent of drug accumulation in the food vacuole. It has been suggested that
within resistant strains of P. jalciparum, there is an impaired membrane bound proton pump
that increases the pH of the food vacuole, resulting in a decrease in the accumulation of
chloroquine (Figure 1.4) (Raynes, 1999).
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A Na+/H+ exchanger has also been implicated in the uptake of chloroquine by infected
erythrocytes (Figure 1.4). Using an inhibitor that binds to the Na+ binding site of the
exchanger, the accumulation of chloroquine was decreased. This evidence suggested that
chloroquine is transported by the Na+ binding domain of the exchanger into the parasite, in
exchange for protons (Raynes, 1999). However, Bray et al. (1998) showed with Na+-free
medium that chloroquine is not directly exchanged for protons by the plasmodial Na+~
exchanger (Bray et al., 1999).








Figure 1.4 Movement of chloroquine and other quinolines in and out of the food
vacuole. A mechanism proposed by Raynes (1999).
In chloroquine resistant malaria the drug may be pumped directly out of the food vacuole by a
drug efflux protein or more specifically an ATP-dependent P-glycoprotein (Raynes, 1999).
This idea was supported by the finding of a gene in P. jalciparum (pfmdr 1), which is
homologous to the mammalian multi-drug resistant (MDR) gene that encodes for this protein
(Winstanley, 2000). Resistant parasites have also been found to accumulate chloroquine less
avidly than non-resistant strains (Winstanley, 2000; Sullivan, 2002). Dua et at. (2000) found
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evidence to support the hypothesis that resistance to chloroquine comes about from a reduction












Figure 1.5 Proposed mechanism of chloroquine action on malarial parasites. A. After
hemoglobin digestion, ferriprotoporphyrin IX (FpIX) is released. This is detoxified by
polymerization into hemozoin, a reaction proposed to be catalyzed by a "heme polymerase".
B. Chloroquine accumulates in the food vacuole, where it is thought to inhibit the
polymerization of heme and thus lead to a build up of the toxic molecule (Foley and Tilley,
1997).
Independent of the way chloroquine enters the food vacuole, it will still have the same
mechanism of action. It is believed by some that it is an inhibitor of hemoglobin uptake and
digestion (Raynes, 1999).
Chloroquine treatment irreversibly impairs the uptake of lysosomal acid hydrolases as well as
affecting the recycling of receptors necessary for this function. Since chloroquine is a base,
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when it accumulates in the vacuole it increases the pH, which decreases the activity of the
enzymes present. Ultimately, digestion of hemoglobin is inhibited. Alternatively, the
sequestration of heme may be inhibited by chloroquine terminating hemozoin polymers
prematurely, thus leading to a build up of unpolymerized heme (Figure 1.5) (Sullivan Jr et al.,
1996b; Raynes, 1999; Egan et aI., 2000). This is probably due to the drug binding to the heme
with a l«J as low as 10-8 (Egan et al., 1994; Meshnick, 1996; Sullivan Jr et al., 1996b). Zhang
et al. (1999) found that chloroquine caused a dose-dependent accumulation ofhemozoin in the
membrane fraction of infected cells, which may correlate with parasite killing via the
production of ions that permeabilize the membrane. Egan et al. (2000) proposed that the 4-
aminoquinoline nucleus of chloroquine is required to bind to ferriprotoporphyrin IX; the 7-.
chloro group inhibits the formation of p-hematin and the basic amino acid side chain is
involved in the drug's accumulation in the parasite's food vacuole.
Chloroquine intercalates with DNA and many groups believe that this explains its anti-
malarial activity (Foley and Tilley, 1998). The drug also inhibits DNA replication and RNA
synthesis at high concentrations. However, the ability of chloroquine to kill the malaria
parasite by this means has been questioned, since it interacts more strongly with GC-rich DNA
and the malarial genome is AT-rich (Foley and Tilley, 1998).
Chloroquine has been the most widely used anti-malarial drug for clinical treatment of
malaria. However, in recent years it has lost its efficacy due to resistance caused by
indiscriminate use as an over-the-counter drug in many countries (Pandey and Chauhan, 1998).
Malaria parasites that are chloroquine resistant are killed only by very high levels of the drug.
However, it was noted by OIjih and Fitch (1993) that with an increase in drug concentration
there is an increase in the amount of hemozoin produced even when the parasitemia is
reduced.
1.2.3 8-Aminoquinolines - primaquine
This compound is known as 6-methoxy-8-(4' -amino-1 'methylbutylamino) quinoline (Figure
1.3C) that has tissue and blood schizonticidal activity (Wernsdorfer, 1997) and gametocidal
activity. Primaquine is not used routinely for P. falciparum malaria (Winstanely, 2000). The
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drug interacts with hemozoin but does not inhibit hemozoin polymerization (Ridley et al.,
1997). Primaquine undergoes extensive but rapid metabolism by oxidative deamination, with a
carboxylic acid (carboxyprimaquine) being formed (Na Bangchang et al., 1992). Like
chloroquine, primaquine has weak lysosomotrophic base properties (Schwartz et al., 1985).
Primaquine has been found to inhibit the mitochondrial respiration of the malaria parasite via
oxidation reduction of ubiquinones and to disrupt the synthesis of pyrimidines (L6pez-
Antunano, 1999). Due to its toxicity and the fact that it can cause methemeaglobinaemia, it is
used only in treatment, not as a prophylactic.
1.2.4 Dihydrofolate reductase inhibitors - pyrimethamine
Pyrimethamine (Figure 1.3D) has blood schizonticidal activity. It inhibits the enzyme
dihydrofolate reductase (DHFR) (EC 1.5.1.4) by competing with higher affinity than the
enzyme's substrate for binding to the active site. Chemically, the drug is known as 2,4-
diamino-5-p-chlorophenyl-6-ethylpyrimidine (Wernsdorfer, 1997). During normal DNA
synthesis, 2' -deoxyribosyluracil monophosphate is converted to 2'-deoxyribosylthymine
monophosphate, which is accomplished by methylene-tetrahydrofolate (mTHF) donating a
methyl group. The resulting oxidized dihydrofolate is reduced to replenish the pool of mTHF
with the rate limiting step in the reduction being catalyzed by DHFR (Winstanley, 2000). The
antifolate drugs bind into the hydrophobic active site pocket of DHFR by hydrophobic
interactions and hydrogen bonding (Warhurst, 1998).
Resistance to this drug is very high unless it is used in conjunction with the dihydropterate
synthase inhibitor sulfadoxine, but resistance to this combination therapy is already
widespread (Basco et al., 1994; Juckett, 1999). Unlike the resistance to the quinoline anti-
malarials, the resistance to DHFR inhibitors arises when a spontaneous single point mutation
in the genes encoding these enzymes (dhfr) occurs (Warhurst, 1998; Newton and White,
1999). In Africa these point mutations can be found on dhfr at positions 108, 51 and 59,
whereas in Southeast Asia a mutation often occurs at position 164 (Macreadie et aI., 2000;
Winstanley, 2000). Some P. falciparum lines in culture have developed an alternate way to
bypass the blockage in the folate pathway by these drugs (Macreadie et al., 2000), by making
use of external folates, either as folic acid or folininc acid.
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1.2.5 Sulfones - dapsone
Dapsone (4,4' -diaminodipheny1su1fone) (Figure 1.3E) was initially used to treat streptococcal
infections but due to the large doses required and the subsequent side effects, its use was
reduced. In the 1940s it was shown to exert antimycobacterial activity and it became the
mainstay of leprosy treatment for many years (Wolf et al., 2000a). It was found to have anti-
malarial activity when dapsone-treated leprosy patients were observed to be notably more
resistant to malarial infections (Paniker and Levine, 2001). Dapsone is an inhibitor of
dihydropteroate synthase and enhances the activity of dihydrofolate reductase inhibitors. It
impairs folate synthesis by competing with para-aminobenzoic acid (PABA) for the active site
of dihydropteroate synthetase (Wolf et al., 2000a; Paniker and Levine, 2001).
Polymorphonuclear phagocyte adherence is inhibited by dapsone (Tingle et al., 1998).
Dapsone is a blood schizonticide with moderate activity against P. falciparum.
1.2.6 Antibiotics - tetracycline and doxycycline
These include the teracyclines, which are broad spectrum antibiotics that are active against
gram-positive and gram-negative bacteria, as well as Chlamydia, Mycoplasma, rikettsia,
spirochetes and some protozoa (Klein and CUnha, 2001). Both tetracycline and doxycycline
are used as prophylactics for mefloquine-resistant Plasmodium falciparum malaria (Smilack,
1999; Klein and CUnha, 2001).
Tetracycline (4-dimethylamino-1, 4, 4a, 5, 5a, 6, 11, l2a-octahydro- 3, 6, 10, 12, l2a
pentahydroxy-6-methyl-1, ll-dioxo-2-naphthacenecarboxamide) (Figure 1.3G) is used to treat
malaria resistant to 4-aminoquinolines (Wemsdorfer, 1997). It acts on mitochondria by
depressing the activity of dihydroroate dehydrogenase from the pyrimidine pathway, probably
by inhibiting synthesis of the enzyme (Pradines et al., 2000).
Doxycycline (4-dimethylamino-l, 4, 4a, 5, 5a, 6, 11, l2a,-octahydro-3, 5, 10, 12, l2a
pentahydroxyl-6-methyl-1, ll-dioxo-2-naphthacenecarboxamide) (Figure 1.3F) is a broad-
spectrum antibacterial agent that has blood and tissue schizonticidal activity against P.
falciparum. It is a member of the tetracycline group that is thought to inhibit chelation of Ca2+
15
and protein synthesis (Wemsdorfer, 1997). Juckett (1999) mentions that doxycycline attacks
both the preerythrocytic and erythrocytic phase of the Plasmodium life cycle through
ribosomal inhibition. It also depletes the levels of deoxynucleoside and nucleoside 5'-
triphosphates (pradines et al., 2000).
1.2.7 Artemisinin and derivatives
Artemisinin or qinghaosu is an endoperoxide sesquiterpene trioxane lactone found in
Artemisia annua (sweet wormwood) (Basco and Le Bras, 1993; Bradley, 2000). It has a
unique structure (Figure 1.3H) and lacks the nitrogen containing heterocyclic ring, found in
most anti-malarials used today (Dhingra et a!., 2000). The peroxide moiety appears to be
responsible for artemisinin's potent anti-malarial activity (Jung, 1994). Its medicinal use was
first described in the "52 Prescriptions" unearthed in 168 BC (Hien and White, 1993). Several
derivatives have been developed because artemisinin itself is very insoluble; these include
arteether, artemether, sodium (Na) artesunate and dihydro-artemisinin (Skinner et aI, 1996,
Edwards et al., 1997; Wemsdorfer, 1997). Artemether is a methyl ether of the parent
compound and Na-artesunate is its Na-hemisuccinyl ester. These derivatives are 20 - 100
times more active than the parent compound (Hien and White, 1993).
These all exert potent blood schizonticidal activity although they have different stage
specificity within erythrocytic schizogony (Skinner et al., 1996), exerting their anti-malarial
effects during the ring and early trophozoite stages (Van Agtmael et al., 1999). These drugs
also significantly reduce the number of gametocytocytes in the blood (Philips, 2001). Parasite
clearance from the blood is more rapid by these drugs than any other anti-malarial drugs, even
at nanomolar concentrations (Dhingra et al., 2000). Artemisinin-type drugs are so potent that
the parasite load can be reduced by a factor of 104 in a single dose (philips, 2001).
Artemisinin and its derivatives are effective against multi-drug resistant strains of P.
falciparum (Lloyd, 1999). The only disadvantage currently known is the appearance of
recrudescence when these drugs are given in short course monotherapy which is used since
they clear parasites within 48 hours (Van Agtmael et al., 1999).
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Figure 1.6 Proposed mechanism of action of artemisinin and related drug compounds.
Adapted from Pandey et al. (1999).
There are three stages to the mechanism of action of artemisinin (Figure 1.6). These involve
the generation of free oxygen radicals and an unstable radical of the drug, when the
endoperoxide bridge is cleaved by intra-parasitic iron (Basco and Le Bras, 1993; Pandey et al.,
1999; Dhingra et al., 2000; Olliaro et al., 2001). This causes selective alkylation and bonding
to parasite proteins and ultimately hemolysis (Wemsdorfer, 1997). Antioxidants or free
radical scavengers such as catalase, dithiothreitol (DTT), ascorbate and a-tocopherol block the
anti-malarial activity of artemisinin and its derivatives (Dhingra et al., 2000). The catabolism
of hemoglobin may also be inhibited as well as heme polymerization (Pandey et al., 1999).
Meshnick et al. (1991) noticed that hemozoin reacted with artemisinin to form an adduct of
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approximate molecular weight 914 Da. Hong et al. (1994) also showed that artemisinin
concentrated in hemozoin by covalently binding to the heme.
Brewer et al. (1994) found that intravenous injection of high doses ofarteether and artemether
into dogs and rats resulted in progressive cardio-respiratory collapse and fatal neurotoxicity
(price et al., 1999). A study performed using human subjects taking oral doses of artemisinin,
showed that absorption and elimination are both rapid, and at therapeutic concentrations there
was little evidence ofneurotoxicity (Duc et al., 1994). Price et al. (1999) found that artesunate
and artemether are well tolerated by human subjects with no attributable neurotoxicity,
cardiotoxicity or allergic reactions, even when used in combination with mefloquine.
1.2.8 Combination therapy
The logic behind combination therapy is that the probability of resistance developing
simultaneously to two anti-malarial drugs, with different mechanisms of action, is very low;
approximately 1 in 1012 treatments (Bloland et al., 2000). The effect of any combination
therapy is enhanced by the inclusion of artemisinin or one of its derivatives, since these drugs
reduce parasite load more rapidly than any other anti-malarial. Combination therapy may be a
very promising treatment for treating malaria, as it may reduce the selection and transmission
of resistant parasites. A major problem is that resistance may not be inhibited, since the
malaria parasite and its lifecycle are so complex.
Chloroquine/doxycycline combination therapy was found to be effective against chloroquine
resistant P. falciparum malaria in patients in northeastern Irian Jaya, Indonesia (Taylor et al.,
2001).
1.2.9 Suramin - a trypanocidal drug
Suramin or Germanin® was synthesized in 1916 by Bayer AG (Leverkusen, Germany) for the
treatment of trypanosomiasis (Schiller et al., 1994). It is the hexasodium salt of 8,8'-
[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-
1,3,5-naphthalenetrisulfonic acid (Figure 1.7). Suramin has been found to inhibit reverse
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transcriptase in vitro as well as other cellular enzymes such as DNA polymerase, tennina1
deoxynuc1eotidy1 transferase, protein kinase C and ATPase (Schiller et al., 1994). Suramin
induces multiple effects on Ca homeostasis in cells (Emmick et al., 1994).
Figure 1.7 Structure of the trypanocidal drug, suramin.
1.3 THE MALARIAL PIGMENT, HEMOZOIN
1.3.1 Formation of hemozoin
Malaria parasites digest 60 - 80% of the host hemog10bin while they are growing inside
erythrocytes (Go1die et al., 1990; Dom et al., 1995; Francis et al., 1997). Nonnally
hemoglobin comprises 95% of the cytoso1ic protein of the red blood cell. The amino acids
derived from hemoglobin degradation are incorporated into parasite proteins. The proteolysis
of hemog10bin may be essential for parasite survival, since Plasmodium has limited de novo
amino acid synthesis (Francis et al., 1997).
Hemoglobin is converted from a ferrous (Fe2+) to a ferric (Fe3+ or methemeoglobin) fonn in
erythrocytes, and hemozoin is in the ferric state (Akompong et al., 2000). Thus hemoglobin
may be oxidized upon entering the favorable conditions of the acidic food vacuole. Digestion
occurs in the acidic vacuole, by two aspartic (p1asmepsins I and IT) and one cysteine (falcipain)
proteases (Haw1ey et al., 1998) (Figure 1.8). The intravacuolar pH is estimated to be pH 4.5 -
5.2 (Francis et al., 1997; Kirk, 2001; Ziegler et al., 2001). The three vacuolar enzymes which
have been isolated, all have sharp pH optima close to the nonnal physiological pH of the food
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vacuole (Olliaro and Go1dberg, 1995). A metallopeptidase, falcilysin, was discovered by
Eggleson et a!. (1999), which is active after the plasmepsins and falcipain.
Endocytosis ofhost cell
cytosol into food vacuole
Hemoglobin
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Figure 1.8 The pathways of hemoglobin digestion and hemozoin formation in the food
vacuole of Plasmodium falciparum parasites. Adapted from Raynes (1999).
The toxic heme [Fe(III)protohemeatoporphyrin-IX] released during digestion is sequestered
into hemozoin, an insoluble crystalline heme coordination polymer (Bohle et a!., 1997). This
is an insoluble pigment (Goldie et a!., 1990) that consists of polymerized Fe (III)
protohemeatoporphyrin-IX subunits (Dom et al., 1995) (Figure 1.9). The estimated
concentration of heme in the parasite food vacuole can reach as high as 400 mM. At these
levels, if the heme was still free, metabolic functioning would be disrupted via peroxidation of
membranes, inhibition of enzymes and the generation of oxidative free radicals (Ziegler et a!.,
2001).
The catabolism of hemoglobin and the formation of hemozoin are highly organized processes
that are designed to produce amino acids for de novo protein synthesis, as well as to prevent
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the build up and release of toxic heme (Figure 1.8). Free heme has a number of biochemical
consequences that include membrane lysis and protease inhibition (Berger et al., 1995; Bohle
et al., 1997). Malaria parasites do not have heme oxygenases so they are unable to cleave the
heme into an open chain tetrapyrrole (Slater et al., 1991; Berger et al., 1995; Bohle et al.,
1997). Hemozoin formation was initially believed to be an enzyme-mediated process with
heme polymerase being the mediator. However, when Dom et al. (1995) treated parasite
lysates with extreme heat, low temperatures for long periods of time and proteinase digestion,
there was no significant decrease in the polymerization of heme, indicating that this is likely
to be an autocatalytic chemical process and not enzyme catalysis (Dom et al., 1995; Ridleyet
al., 1997; Sullivan, 2002). Other evidence exists in that J3-hematin which is similar in
structure to hemozoin, can form spontaneously under the conditions prevailing in the food
vacuole (Egan et al., 1994; Sullivan et al., 1996; Egan et aI., 2001; Sullivan, 2002). Hemozoin
itself is capable of supporting heme polymerization. But there must be another mechanism as
prior to hemoglobin digestion there is no hemozoin.
Phospholipids have been found to promote the polymerization of heme and could thus play a
role in hemozoin formation in the malarial parasite (Bendrat et al., 1995). Sullivan Jr. et al.
(1996a) hypothesized that histidine-rich protein IT (HRP IT) could bind heme in the digestive
vacuole. It has a repetitive sequence, that is similar to the heme binding motif of human
histidine-rich glycoprotein (HRG), and thus may play a role in hemozoin formation (Pandey et
al., 1999).
1.3.2 Structure of hemozoin
Hemozoin has been found to be composed of 65% protein, 16% ferriprotoporphyrin-IX
(hematin), 6% carbohydrate and trace amounts ofnucleic acids and lipids (Goldie et al., 1990).
J3-Hematin [Fe(ill)-protoporphyrin-IXh, a synthetic product, is chemically, spectroscopically
and chrystallographically identical to hemozoin (Pagola et al., 2000; Egan et al., 2001).
Hemozoin is thought to consist of polymeric heme units (Figure 1.9) linked by a bond between
the ferric iron of one heme and a proprionate carboxylate side chains (Fe3+-0) (Slater et al.,
1991; Berger et aI., 1995; Ridley et al., 1995).
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Hemozoin may play a significant role in the physiology ofmalaria infection by interfering with
phagocyte function once ingested and thus ultimately suppressing the host immunological
response (Schwarzer et al., 1998). It has also been implicated in the action of a number of anti-
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Figure 1.9 Structure of heme and hemozoin (ferriprotoporphyrin IX).
Ferriprotoporphyrin IX (FP) is represented by an oval ring in the second hemozoin polymer.
The dashed line shows the chelation of the iron atom with the proprionic acid side chain. The
dimeric structure is thought to be fonned by hydrogen bonds fanning between the remaining
proprionic functional groups (Raynes, 1999).
1.3.3 Targets for·anti-malarial drugs
The sequestration of heme derived from hemoglobin may be critical to the survival and
maturation of the parasites, hence this may represent an important target for anti-malarial
drugs (Bendrat et al., 1995). Drugs such as methylene blue, artemisinin and the quinolines are
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thought to exert their pharmacological effects on the heme released during hemoglobin
degradation (padmanaban and Rangarajan, 2000). However, their mechanisms of action are
open to a great deal of debate as many have been proposed.
Falcipain and plasmepsin inhibitors are also potential anti-malarials (Francis et al., 1997). It
has been shown that blocking the cathepsin-L like cysteine proteinase, plasmepsin I, is lethal
. to the parasite (Rosenthal et al., 1991; Ziegler et al., 2001). PlasmepsinII cannot compensate
for the loss of plasmepsin I (Ziegler et al., 2001). Inhibition of falcipain with a variety of
cysteine proteinase inhibitors results in a marked swelling of the digestive vacuole,
accumulation of undigested hemoglobin and parasite death.
Before new drugs can be developed we need to have an understanding of the mechanisms of
action of the drugs that are used today, as well as the mechanisms employed by the parasites to
resist these drugs.
1.4 MONONUCLEAR PHAGOCYTES
The mononuclear phagocyte system (MPS) compnses monoblasts in the bone marrow,
promonocytes, peripheral blood monocytes and tissue macrophages (Auger and Ross, 1992).
Mononuclear phagocytes are primitive cells, which are phylogenetically related to cells found
in primitive life forms.
1.4.1 Morphology
Macrophages are large cells with a diameter measuring 25 - 50 nm. They have an irregular
shape with either a round or kidney-shaped nucleus. Within the cytoplasm are many fine
granules and azurophilic granules (Beelen et al., 1989; Auger and Ross, 1992). Monocytes are
smaller cells (12 - 15 ~m diameter) but they have a large nucleus which is kidney-shaped.
The cytoplasmic components are similar to those of macrophages (Auger and Ross, 1992).
1.4.2 Metabolism and organization
During differentiation the composition and metabolism of mononuclear phagocytes is altered.
Changes may be increases in the number of mitochondria, the activity of mitochondrial
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enzymes and cellular respiration and an increase in the respiratory burst in response to
receptor-ligand interactions (Auger and Ross, 1992). The respiratory burst involves increased
oxygen consumption and metabolism of glucose via the hexose monophosphate shunt. The
activity of a membrane bound oxidase complex is altered by the respiratory burst, and
molecular oxygen (02) is reduced to the superoxide (Ol} The superoxide is converted to
hydrogen peroxide (H202) and hydroxyl (OB-) radicals, which are referred to as reactive
oxygen intermediates (ROI) (Auger and Ross, 1992). Interferon-y (IFN-y) and migration
inhibitory factor (MIF) can induce an increased respiratory burst in vitro. The respiratory burst
is decreased markedly when monocytes mature into macrophages. There are a number of
hydrolytic enzymes found within these cells, such as lysozyme, acid phosphatase, p-
glucuronidase, N-acetyl-glucosamines, a-napthyl butyrate esterase and peroxidase (Auger and
Ross, 1992).
1.4.3 Functions
Phagocytes provide the first defense against invading microbes. Mononuclear phagocytes are
more efficient than neutrophils when the pathogen is large or the burden is large. They thus
play a major role in thedefense against microorganisms such as viruses, bacteria, fungi and
protozoa (Auger and Ross, 1992). Microbicidal functions are mediated by reactive oxygen
intermediates. The phagocytes kill microorganisms by both oxygen-dependent and
independent mechanisms.
Secretions contain not only enzymes but other biologically active molecules, such as enzyme
and cytokine inhibitors; complement components; reactive oxygen intermediates, arachidonic
acid intermediates; coagulation factors, cytokines and many others (Rook, 1989; Segal, 1989;
Auger and Ross, 1992). The cytokines that are secreted include tumor necrosis factor (TNF),
interleukin-1 (IL-1) and interleukin-6 (IL-6).
Antigens are processed within these cells after uptake to generate peptides that are expressed
on one of two glycoproteins, class I or n, of the major histo-compatibility complex (MBC).
CDS+ and CD4+ T cells are activated once they recognize the presented peptides. When
activated, the CDS+ T cells secrete IFN-y, which subsequently activates inducible nitric oxide
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synthase (iNOS) and this induces the L-arginine dependent nitric oxide pathway (Good and
Doolan, 1999). During malaria infection, T cell responses are generally suppressed (Plebanski
and Hill, 2000). Intracellular parasites such as Plasmodia have evolved a mechanism to avoid
the host immune response, by living within the host's cells, where the immune products such
as antibodies and complement are unable to reach them (Sadick, 1992).
1.4.4 Effect of malaria on mononuclear phagocytes
1.4.4.1 Phagocytosis
The first line of defense in malaria is provided by phagocytic cells. Monocytes recognize
parasite-infected red blood cells as non-self cells and attack them by phagocytosis and by
intracellular and extracellular killing with reactive oxygen intermediates (Schwarzer et al.,
1992; Fiori et al., 1993). Phagocytic activity is maximal at the beginning of infection but
thereafter it declines with repeated malarial episodes (Schwarzer et al., 1992). Phagocytosis is
mediated by Fc and complement receptors and by phosphatidylserine-dependent ingestion.
Malaria pigment (hemozoin) and infected red blood cells are avidly phagocytosed by host
monocytes and tissue macrophages, where the pigment has been found to suppress the ability
of these cells to elicit respiratory burst and to block the further phagocytosis of
microorganisms and damaged erythrocytes (Francis et al., 1997; Scorza et al.,1999). The
acidic conditions in the lysosomes of the monocyte induces the release of free iron from
hemozoin, and this interferes with the phagocytic capacity of the cells (Leitner and Krzych,
1997). The most highly active of phagocytes are inhibited to a greater extent than less effective
phagocytes, since they would have phagocytosed more hemozoin. Thus hemozoin has been
implicated as the major depressor of cell induced immunity that is commonly seen in malarial
infections (Sherry et al., 1995; Scorza et al.,1999). Monocytes that have previously
phagocytosed trophozoite infected red blood cells, are unable to neutralize bacteria, fungi and
tumor cells (Schwarzer et al., 1992). Incapacitation of monocytes is only one aspect of
immune suppression in malaria (Fiori et al., 1993).
. The amount of phagocytosed hemozoin in monocytes may reflect the sequestered pathogenic
parasite burden during Plasmodium falciparum infection and ultimately disease severity
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(Metzger et aI., 1995; Phu et al., 1995). The presence ofhemozoin in monocytes is also be a
marker ofrecent malaria in patients with negative blood films.
1.4.4.2 Cytokine production
The response of the host immune system to infection with malarial parasites involves both
humoral and cellular mechanisms that include the actions of a large number of cytokines.
Thuma et al. (1996) mention that the ability of macrophages to be stimulated by interferon-
gamma (IFN-y), secreted by TH-1 cells is reduced under the prolonged stimulation of the
immune system by malaria. The phagocytesability to destroy the malarial parasites by nitric
oxide generation is concomitantly reduced.
During malarial infections, hemozoin is not only found within the parasites but also in many
tissues throughout the host, but predominantly in monocytes (Sullivan et aI., 1996).
Erythrocytes that have been parasitized and thus contain hemozoin are either phagocytosed by
leucocytes or at schizogony crystals of hemozoin are released into the bloodstream. As much
as 200 !J,mol of hemozoin may be liberated into the bloodstream of a P. jalciparum infected
patient at schizogony with an underlying synchronous parasitemia of 1% (Sherry et aI., 1995).
Hemozoin has also been shown to induce the production and secretion of pyrogenic cytokines,
namely TNF-a (Kwaitkowski, 1993), and two macrophage-derived inflammatory mediators
(MIP-la and MIP-1B) in human peripheral blood monocytes and murine macrophages (Sherry
et al., 1995). These may mediate the recurrent bouts of fever that are characteristic of a
malarial infection. The increased levels of TNF-a and interleukin-1B (IL-1B) secreted by
monocytes and macrophages, may be responsible for the anemia seen in many patients, since
they are powerful inhibitors of erythroid differentiation (Mohan et aI., 1995; Arese and
Schwarzer, 1997; Wickramasinghe and Abdalla, 2000). IL-2 production is actively inhibited
in monocytes that have phagocytosed hemozoin (Scorza et aI., 1999).
Macrophage migration inhibitory factor (MIF) is released by macrophages after phagocytosis
of infected red blood cells or hemozoin (Martiney et al., 2000). MIF acts as a counter
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regulator of glucocorticoid activity, induces TNF-a secretions in macrophages and works with
IFN-y to promote nitric oxide formation. This factor may also be involved in malarial anaemia
as it inhibits erythropoiesis.
IL-6 and interleukin la (IL-1a) levels are also increased in malaria, although their plasma
levels follow the rise and fall of parasitemia in the blood (Picot et al., 1993; Turrini et al.,
1993).
1.4.4.3 Surface receptors of endothelial cells and parasite sequestration.
Major histo-compatibility complex class IT (MBC class IT), intracellular adhesion molecule 1
(ICAM-l/ CD54) and p150,95 integrin (CDllc) expression is impaired in hemozoin loaded
monocytes (Schwarzer et al., 1998). Hemozoin loading does not affect the expression ofMHC
class I, the IgG receptors (CD16, CD32, CD64), the complement CR3 receptor (CDllb), the
complement C3b/C4b receptor (CD35) and a vascular adhesion molecule 1 (VCAM-l/CD36)
on monocytes (Schwarzer et aI., 1998). In diseases such as malaria, upregulation of MBC
class IT for antigen processing is important to ensure adequate helper T-cell development, as is
the upregulation of ICAM-1 which contributes to the capacity of monocytes to adhere and
stimulate T-cell proliferation by reinforcing the signal from the T-cell receptor. Hemozoin
downregulation of ICAM-1 may explain the defective T-cell response in malaria (Schwarzer et
aI., 1998).
Increased TNF and IL-1 secretions have been implicated in the upregulation of endothetilial
cell surface receptors such as ICAM-l (McGilvray et al., 2000). This leads to the
sequestration of circulating cells, such as monocytes and infected erythrocytes, expressing the
leukocyte function antigen 1 (LFA-11 CDlla/ CD18) (Senaldi et aI., 1994; Warrell, 1997;
Newton et aI., 2000). LFA-1 is also upregulated after exposure of the leukocytes to hemozoin
(Pichyangkul et al., 1997). Ultimately, the sequestration of monocytes along with other
leukocytes will lead to capillary clogging which may lead to pathological conditions. This has
been noted in cerebral malaria where TNF levels are extremely high (Patnaik et al., 1994).
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Parasite glycosylphosphatidylinositol toxin (GPI) when released into the blood leads to the
upregulation of ICAM-l, VCAM-l, E-selectin as well as cytokines and nitric oxide synthase
(NOX) (Schofield et al., 1996; Tachado et al., 1996).
1.4.4.4 Reactive oxygen intermediate production and the enzymes involved.
Hemozoin may be inert but once it enters the phagocytes phagolysosome it may become
harmful since it is a powerful generator of radicals. Free radicals are generated by aggregated
ferric heme; unsaturated fatty acids and small amounts of free heme liberated by the acidic
conditions and hydrogen peroxide (HzOz) (Arese and Schwarzer, 1997). Elemental iron
catalyzes the formation of highly reactive hydroxyl radical (eOH) or oxidants of similar
reactivity from hydrogen peroxide via the Fenton reaction (HzOz + Fez+ ~ Fe3+ + OH- +
eOH). The hydroxyl radical initiates a range of toxic reactions including peroxidation of
biological membranes, damage to DNA (Wilson and Britigan, 1998), functional impairment
(Schwarzer et al., 1992) and the derangement of antigen processing and presentation
(Schwarzer et al., 1998). Lipid peroxidation is associated with a variety of pathological
events, including changes in the bilayer properties, reduction of membrane fluidity and
inactivation ofmembrane bound enzymes (Omodeo-Sale et al., 1998).
Elevated concentrations of lipoperoxides have been located within hemozoin loaded cells;
these are short lived, labile compounds that produce short chain aldehydes upon degradation of
fatty acids. Unsaturated fatty acids, such as arachidonic and linolenic acid, yield an open chain
hydroxyaldehyde degradation product named 4-hydroxy-trans-nonenal (RNE) (Arese and
Schwarzer, 1997). The levels of this compound are elevated markedly in the hemozoin
containing cells. liNE is an e1ectrophylic alkylating agent that reacts with thiols and amino
groups and thus inhibits a number of enzymes by blocking the reactive sites or other essential
groups (Schwarzer et al., 1996; Arese and Schwarzer, 1997). Protein kinase C (PKC), which
is involved in phagocytosis and the oxidative burst (Turrini et al., 1993), is inhibited by
concentrations of RNE between 10 - 100 /-lm. The inhibition is due to the numerous thiol
groups present on the enzyme, which have to be in the reduced state before it can function
normally (Schwarzer et al., 1996). Schwarzer et al. (1993) found that membrane-associated
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PKC is irreversibly inactivated, after a brief activation, in human monocytes that had
phagocytosed hemozoin. Low micromolar concentrations of hemozoin inhibited IFN-y-
mediated MHC class IT expression (Schwarzer et al., 1998).
One of the major phagocyte functions inhibited by hemozoin loading is the respiratory burst,
that is controlled by the activity of NADPH oxidase (NOX) (Schwarzer and Arese, 1996;
Arese and Schwarzer, 1997). NOX is under the control of PKC but it appears that it is
inhibited by damage inflicted to the cytosolic subunits by free radicals.
Arese and Schwarzer (1997) posed two important yet unanswered questions. Why is
hemozoin not toxic while in the parasite's food vacuoles? Why is the heme oxygenase from
monocytes and macrophages not able to destroy the hemozoin heme?
1.4.4.5 Redox status of monocytes
The cell redox state may be modified by the phagocytosis of hemozoin or by the inevitable
iron overload via the accumulation of iron-rich molecules. Transcription factors such as AP-1
and NF-kB/NF-IL6, that are involved in the regulation of the expression of the genes which
control cytokines and adhesion molecules, are influenced by the redox status of the cell
(Taramelli et al., 1998).
1.4.5 Immunomodulatory action of anti-malarial drugs
1.4.5.1 Phagocytosis
Therapeutic concentrations of tetracycline, chloroquine, qmmne and dapsone inhibited
phagocytic activity in rhesus monkey (Macaca mulatta) monocytes (Prasad et al., 1984).
Opsonization and phagocytosis of infected red blood cells is inhibited by therapeutically
relevant concentrations of quinine, chloroquine and artemether (Shalmiev et al., 1996). When
the infected red blood cells were opsonized prior to treatment with the drugs, phagocytosis was
not inhibited. Shalmiev et al. (1996) concluded that the anti-malarial drugs affected the
affinity of the IgG for infected red blood cells. Quinine did not noticeably affect phagocytosis
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of latex beads by macrophages or their viability, even at concentrations as high as 200 IlM
(Maruyama et a!., 1994).
1.4.5.2 Intracellular organelles
The 4-aminoquinolines, 8-aminoquinolines and derivatives accumulate within the acidic focid
vacuole of the malaria parasite where they may increase the pH. Leukocytes have an acidic
lysosomal system and these drugs also become trapped in millimolar concentrations in these
organelles (Schwartz et al., 1985; Gabay et al., 1994). The pH of the lysosome is increased
from pH 4.8 to pH 6.5, and this results in the swelling of the organelle as well as the inhibition
of the lysosomal acid hydrolases and ultimately of degradation of proteins and
glycosaminoglycans (Riches et al., 1981; Wolf et al., 2000b). Also, during treatment with
chloroquine the number of lysosomes increases and their density decreases (Mackenzie, 1983).
Vesicle fusion and exocytosis of cell products is diminished by chloroquine, probably through
the modification of clathrin.
Chloroquine, primaquine and quinine inhibit esterase activity in leucocytes (Markovic et al.,
1988). However, these drugs had no inhibitory effect on the activity of peroxidase, alkaline
phosphatase, acid phosphatase and ~-glucuronidase. An accumulation of myeloid bodies also
occurs, which results in decreased phagocytosis, chemotaxis and overall cell functioning (Van
Beek and Piette, 2001). The majority of these effects have been observed at concentrations far
exceeding those found in the blood ofpatients during treatment.
Primaquine potently inhibits membrane transport from the endosome to the plasma membrane
(Van Weert et aI., 2000). Transferrin receptor recycling is inhibited by 1 mM primaquine.
The secretory pathway from the trans-Golgi network (TGN) is inhibited with by primaquine.
The drug may alter the physical properties of the membranes, thus interfering with the budding
and fusion process.
Artemisinin concentrates ill the acidic food vacuole. Morphological changes in the
mitochondria, ribosomes and the endoplasmic reticulum and, much later in treatment the
destruction of the digestive vacuole membrane has been observed at high concentrations
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(Olliaro and Goldberg, 1995; Van Agtmael et aI., 1999). Artemisinin rapidly decomposes in
medium containing peroxidase activity, thus indicating its instability in the presence of these
enzymes and may likely contribute to changes seen in cells containing these enzymes (Dhingra
et aI., 2000).
Dapsone has been found to inhibit lysosomal enzymes in polymorphonuclear leucocytes and it
also stabilizes lysosomes by its potent antioxidant activity (Wolf et al., 2000b). However,
there have been numerous reports of dapsone inducing agranulocytosis, with a reduction in the
number ofperipheral granulocytes from 2 -7.7 x 109 to 0.5 X 109 (Coleman, 2001).
Suramin accumulates in the secondary lysosomes of monocytes and inhibits the fusion of the
phagosome with the lysosome (Schiller et al., 1994).
1.4.5.3 Cytokine production
Macrophages treated with quinine, chloroquine, proguanil, mefloquine or halofantrine prior to
stimulation were used by Picot et al. (1993). It was found that the secretions ofTNF and IL-6
were suppressed by chloroquine in a dose-dependent manner (Kremsner et aI., 1993; Van den
Borne, et aI., 1997; Karres et al., 1998; Seth et al., 1999), but the other drugs had no effect.
Chloroquine also suppresses the production of interferon-y (IFN-y) in stimulated peripheral
blood monocytes (Van den Borne, et al., 1997). It is believed that TNF secretion is dependent
on intracellular iron metabolism and that chloroquine inhibits its secretion by interfering with
iron homeostasis (Picot et al., 1993).
Chloroquine has been shown to inhibit the secretion of IL-l and IL-2 and antigen presentation
by helper cells and to depress the cytotoxicity of natural killer cells as well as displaying anti-
inflammatory properties (Karres et aI., 1998; Wolf et al., 2000b). The inhibition of pro-
inflammatory cytokines is most likely at the transcription level (Karres et al., 1998) and may
be related to chloroquine intercalating with DNA.
Seth et al. (1999) observed that chloroquine upregulated the production of a number of
inflammatory cytokine genes such as those for interleukin-l receptor agonist (IL-IRa), IL-la,
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IL-1~, IL-6, IL-12p40 and interferon-y (IFN-y). IL-1Ra levels are also enhanced during viral
infections, but it's role during infection has yet to be ascertained. It has been shown that
chloroquine enhances the severity of the symptoms and mortality observed during infection
with the Semliki forest virus and encephalomycordartis virus (Seth et al., 1999). Chloroquine
also increases the viral titres in various organs.
Quinine, at concentrations capable of blocking the K-channels, inhibits cell proliferation and
protein synthesis in human T-Iymphocytes (Maruyama et al., 1994). K-channels may be
involved in cytokine production, which will thus be blocked by quinine.
Dapsone suppresses the expression of TNF-a mRNA as well as levels of TNF-a secreted by
monocytes stimulated with lipopolysaccharide (LPS) (Miyachi, 2000).
Suramin has been found to inhibit the activity of TNF-a through a direct action on the
cytokine rather than its receptors (Grazioli et al., 1992). Alzani et al. (1993) demonstrated that
the drug dissociates the quaternary structure ofTNF-a.
1.4.5.4 Reactive oxygen intermediates
Chloroquine induces the activity of iNOS and thus increases the amount of nitric oxide
produced. DNA and RNA biosynthesis is blocked, as is DNA replication and RNA
transcription as chloroquine intercalates with DNA between adjacent base pairs (Van Beek and
Piette, 2001). Kremsner et al. (1993) found that chloroquine significantly inhibited the
production of reactive nitrogen intermediates (RNI) by murine macrophages, without affecting·
the production of reactive oxygen intermediates (ROI). However, these experiments were
conducted at concentrations of chloroquine that greatly exceeded those normally found in
patient blood. Quinine, at concentrations within the therapeutic range, significantly reduced
the synthesis of reactive nitrogen intermediates without having any effects on reactive oxygen
intermediate production (Kremsner et al., 1993). Artemisinin was also found to effect a
significant decrease in the production of reactive nitrogen intermediates, but this occurred at
concentrations higher than therapeutic levels.
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Endogenous H202 is produced by liver microsomes during the oxidation of NADPH. This
process is enhanced by a number of drugs, including arteether and artelinic acid, but
dihydroartemisinin had no effect (Leskovac and Peggins, 1992).
Dapsone has anti-inflammatory effects on PMNs. In normal PMNs activation leads to a
cascade of reactions which ultimately releases reactive oxygen intermediates. However,
dapsone directly inhibits the myeloperoxidase-peroxide-halide system of the PMNs by
promoting the formation of an inactive form of myeloperoxidase (Wolf et al., 2000a). Thus
the conversion of H20 2 to hypochlorous acid is prevented. The extracellular xanthine oxidase
system is also disrupted by dapsone (paniker and Levine, 2001).
Tetracyc1ines inhibit reactive oxygen intermediate generation by PMNs and they also reduce
PMN chemotaxis (Miyachi, 2000).
1.4.5.5 Surface receptors
Anti-malarial drugs at therapeutic concentrations have been found to reduce expression of
monocyte receptors that ultimately affect the immune response and cytoadherence of the cells
(Goldring and Nemaorani, 1999). Monocyte surface receptor expression as well as cytokine
secretion, is also altered by anti-inflammatory and anti-oxidant drugs such as dexamethasone,
cortisol, probucol, ambroxol, danazol and staurosporine (Goldring and Ramoshebi, 1999).
During P. jalciparum malaria, trophozoite infected red blood cells adhere to non-infected red
blood cells in a phenomenon known as 'rosetting' (David et al., 1988). This is thought to
enhance the ability of the parasites to invade the surrounding red cells when the schizonts
rupture. Therapeutic concentrations of artemisinin, chloroquine, primaquine, pyrimethamine
and quinine disrupt the rosettes (Goldring et al., 1999), with artemisinin and quinine being the
.most effective and chloroquine being the least effective.
The expression of various surface receptors on monocytes and the phagocytic capacity of
monocytes were found to be inhibited by suramin (Schiller et al., 1994). However, Goldring
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and Nemoarani (1999) found that suramin had minimal inhibition «10%) on the expression of
monocyte surface receptors.
1.4.5.6 Other effects
Quinine is used as a blocker of K+ channels and has been found to modify phospholipid
metabolism, by increasing phosphatidylserine and phosphatidylinositol synthesis, but
decreasing the synthesis of phosphatidylcholine and phosphatidylethanolamine (Pelassy et al.,
1992). Primaquine inhibits liver microsomal cytochrome P450-dependent enzymes (Na
Bangchang et al., 1992). Chloroquine is used in laboratory technique for typing red blood
cells since it has the ability to split antigen-antibody complexes (Wolf et aI., 2000b).
1.5 HEAT SHOCK RESPONSE IN MONOCYTES
1.5.1 The heat shock response
All organisms from bacteria to man when exposed to elevated temperatures or fever exhibit
the phenomenon known as the "heat shock response" (Polla, 1988; Donati et al., 1991).
Various other stresses such as oxidative injury, heavy metals, ethanol, amino acid analogues,
uncouplers of oxidative phosphorylation, steroid hormones and proinflammatory cytokines
also induce the heat shock response (Maresca and Kobayashi, 1994; Polla et al., 1995). The
heat shock response can be characterized by three specific events: the specific and transient
induction of heat shock gene expression; preferential expression of the heat shock proteip
(HSP)-coding mRNAs, and a blockade of normal protein translation and the induction of
thermotolerance (Donati et a!., 1991).
The HSPs are classified according to molecular weight, with the HSP70 family consisting of
both constitutive (HSC70) and inducible (HSP70) proteins (Polla et al., 1995). The proteins in
the HSP70 family are a highly conserved ubiquitous group of proteins (Miao et al., 1997).
When the HSP70 sequences from 24 divergent eukaryotic and prokaryotic species were
compared, the most distantly related species were at least 45% identical in sequence (Miao et
al., 1997). They are able to bind short stretches ofpolypeptides and prevent the aggregation of
unfolded proteins. Heat shock proteins are more commonly known as chaperones because of
34
their roles III protein translation, folding and proteolysis under nonnal physiological
conditions.
1.5.2 Heat shock cognate protein - 70 (HSC70)
The majority of the HSP70s are abundantly and constitutively expressed under nonnal growth
conditions (Miao et al., 1997). However, their expression may be increased by fever (elevation
of temperature) or other stresses. HSC70 is part of a large chaperonin complex, which
facilitates protein renaturation, and it chaperones proteins for membrane translocation
(Hightower and Leung, 1997). In unstressed cells HSC70 is distributed in the cytoplasm and
nucleus but, in cells that are heat shocked, both HSC70 and the newly expressed HSP70·
increase in the nucleus (Hightower and Leung, 1997) close to the chromosomes (Velazquez et
al., 1980). During the recovery stage after heat shock, both HSC70 and HSP70 redistribute in
the cytoplasm. The HSC70 sequences are more conserved in the C-tenninal region than those
ofHSP70, which is most likely due to evolutionary constraints due to their different functions.
1.5.3 Heat shock protein - 70 (HSP70)
HSP70 has been implicated in a number of cellular functions, such as DNA replication,
binding of proteins in the endoplasmic reticulum, translocating proteins across intracellular
organelle membranes and clathrin-uncoating ATPase (Donati et al., 1991). These functions
require HSP70 to bind to unfolded proteins in an ATP-dependent manner. However, the actual
role of HSP70 in stressed cells is not clearly defined but it has been implicated in
thennotolerance (Hightower and Leung, 1997). The structure of HSP70 consists of two
domains: an N-tenninal ATPase domain and a C-tenninal peptide binding domain (Feige and
Polla, 1994).
1.5.4 Heat shock protein expression in monocytes
vVhen monocytes phagocytose a particle they generate large amounts of reactive oxygen
intennediates (Polla et aI., 1991). It is believed that the increased production of reactive
oxygen intennediates is detrimental to phagocytic cells and thus these cells are protected from
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oxidative injury by the heat shock response (Clerget and Polla, 1990; Donati et al., 1991;
Fincato et al., 1991; Jacquier-Sarlin et al. 1994). Oxygen free radicals generated in the
presence of hemoglobin-derived iron are involved in the induction of the heat shock response
during erythrophagocytosis (Clerget and Polla, 1990). The generation of hydroxyl radicals
(-OH) in the presence of iron released from oxidized hemoglobin by the Haber-Weiss metal
catalyzed reaction may induce the expression ofheat shock proteins in monocytes (Clerget and
Polla, 1990; Jacquier-Sarlin et al. 1995). However, phagocytosis oflatex beads did not induce
O2- production or detectable alterations in the synthesis of proteins. Heat shock proteins may
also be induced by the presence of abnormal proteins as a result of the reactive oxygen
intermediates altering protein structure and inducing breaks in the DNA strand (Polla and.
Kantengwa, 1991). Heat shock in monocytes was found by Polla et al. (1995) to selectively
modulate the activity of enzymes without altering phagocytosis and microbial killing. NADPH
oxidase activity was decreased and superoxide dismutase (SOD) activity was increased by heat
shock. HSP70 expression in monocytes inhibits the production of IL-1Band TNF-a in the
cells (Njemini et al., 2002; Njeminiet al., 2003). Heat shock proteins have been found to
protect monocytes from TNF-a induced lysis (Polla and Kantengwa, 1991; Jacquier-Sarlin et
al., 1994).
1.5.5 Heat shock protein 70, phospholipase A2 and malaria
The inflammatory reaction is characterized by phospholipase A2 (PLA2) activity induced by
pro-inflammatory cytokines (11-1 and TNFa) (Pruzanski and Vadas, 1991; Vadas et al., 1991)
(Figure 1.9). PLA2 is part of a calcium-dependent family of enzymes that cleave the sn-2 bond
of diacylphospholipids, freeing fatty acids and monoacylphospholipids (Diccianni et al.,
1990). TNF-a activated PLA2 (Clark et al., 1988) induces the release of arachidonic acid from
membrane phospholipids (JaatteHi, 1993). However, HSP70 has been found to inhibit the
TNF-a induced activation of PLA2 without interfering with the signal transduction pathways
or receptor binding (Figure 1.9). PLA2 activity can also be altered by local anesthetics, anti-
malarial drugs, antibiotics, polyamines, anti-psychotics (Diccianni et aI., 1990) and anti-

















Figure 1.9 Schematic representation of the role of heat shock protein 70 in terminating
the inflammatory response. TNF-a (tumor necrosis factor-a); IL-1 (interleukin-1); ROS
(reactive oxygen intermediates); HSP70 (heat shock protein 70) and PLA2 (phospholipase A2).
Stimulation of the inflammatory response is indicated by - and inhibition by - - - .
In patients with P. jalciparum malaria, serum levels of TNF-a and PLA2were elevated (Vadas
et al., 1992; Vadas et al., 1993). Elevated levels of secretory PLA2 have been implicated in the
pathogenesis of numerous diseases such as collagen vascular disease, acute pancreatitis,
Crohn's disease, septic shock, adult respiratory distress syndrome (ARDS) and multiple
sclerosis (Vadas and Pruzanski, 1986). Since HSP70 has been implicated in inhibiting TNF-a
induced activation ofPLA2in cells, why does HSP70 not inhibit the activation ofPLA2 during
malaria? HSPs are generally regarded as intracellular molecules but they can be released into
the extracellular compartments and serum (pockley, 2001). HSP70 binds to human monocytes
and CD14 with high affInity and subsequent activation of the monocyte. Pro-inflammatory
cytokines (IL-1~, IL-6 and TNF-a) are induced by the CD14-dependent interaction (Asea et
aI., 2000; Kuppner et aI., 2001; Pockley, 2001). Thus the increased levels ofTNF-a in serum
would most likely lead to elevated levels of serum PLA2. Polla (1991) suggests that host HSP




1.6.1 What is X-ray microanalysis?
Literally, microanalysis is the analysis of "very small' samples by any technique available but
the term actually has a much narrower meaning. Electron-probe X-ray microanalysis
(EPXMA) enables one to determine the elemental composition of any sample under either the
scanning electron microscope (SEM) or the transmission electron microsoope (TEM) (Warley,
1997). This technique is able to detect low concentrations with its minimum detection limits
(MDLs) below 1% and in the very best cases 0.1 %. This technique enables one to correlate
the elemental content with specific structural features using qualitative or quantitative digital
mapping (Warley, 1997).
1.6.2 Principles of the technique
When the electron beam enters the sample, a number of interactions occur, but the only one of
interest in X-ray microanalysis is the generation of X-rays. These X-rays contain information
about the elemental content of a specific region that is being irradiated. There are two
mechanisms in which X-rays are produced (Figure 1.11).
X-rays are generally produced as a result of the rearrangement of the orbiting electrons, after
an incident electron from the electron beam has ejected an inner shell electron from an atom
(Warley, 1997). This results in an ionized but unstable state and an electron from an outer
shell will move to the inner shell to stabilize the atom. Since this electron has moved from a
high-energy state to a low energy state it loses the excess energy as an X-ray photon (Warley,
1997). The energy of this emitted photon is equivalent to the difference between the energy of
the two shells. X-rays may also be producedwhen the incident electrons pass the nucleus and
are slowed down and thus lose energy. The X-rays emitted by the atom are distinct and
characteristic of the element emitting it: ultimately a number of peaks are produced, each







Figure 1.11 Model of an atom showing the production of X-rays. An electron in the
incident beam may have sufficient energy to eject an inner electron: another electron in an
outer orbital with higher energy moves to fill the vacated position. The excess energy is
emitted as an X-ray (Warley, 1997).
The major difficulties associated with the preparation of biological samples, apart from the
development of appropriate standards (Warley, 1990), is the preservation of the chemical
composition of the cell without altering ultrastructural details (Fishman et al., 1985). In an
ideal situation, studies should be made on fresh, hydrated specimens but due to the vacuum
present in the microscopes as well as the interaction of the electron beam, severe mass loss
occurs (Warley and Skepper, 2000). The composition of standards should generally resemble
the specimen closely, i.e. they are based on proteins as the organic matrix and are, either cryo-
frozen or embedded in resin before sectioning.
1.6.3 X-ray microanalysis and monocytes
Fishman et al. (1985) determined the elemental composition of normal blood cells, namely
monocytes, neutrophils, lymphocytes and platelets. They found that nucleus-containing cells
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had a high phosphorous content, and platelelets, monocytes and neutrophils had elevated
levels of sulfur. This is thought to be due to the cytoplasmic granules that contain sulfated
glycosamines. Monocytes and neutrophils yield similar high peaks for phosphorous and suIfur
(Fishman et al., 1985). Monocytes yield higher peaks for sodium, chlorine and calcium.
Since it is possible to distinguish types of cells by their different elemental content or spectra,
it should be possible to distinguish activated, drug treated, hemozoin- or infected erythrocyte-
fed monocytes from normal monocytes. Monocytes occur naturally and are easily isolated,
and easily prepared for EM by cryofixation and cryosectioning (Warley et al., 1994). Cells
may even be cultured on gold grids covered with a pioloform film and laminin, especially
since monocytes are known for their ability to adhere to surfaces (Warley et aI., 1994; Skepper
et al., 1999).
1.6.4 X-ray microanalysis and malaria
To date only one X-ray microanalysis study has been done on malarial parasites and drugs.
The normal erythrocyte maintains a high intracellular K and a low intracellular Na
concentration, with the [Na] / [K] being ~ 0.12 (Kirk, 2001). In infected red blood cells the
[Na] / [K] was greatly altered to ~ 11.6, a 100 fold change indicating that the normal Na and K
gradients may be lost (Lee et al., 1988).
The only related approach to have been used is soft X-ray microscopy, which involves the
bombardment of the specimens with X-rays (Magowan et al., 1997). This technique does
offer high spatial resolution, as well as being a novel way to approach the intraerythrocytic
development of Plasmodium. Utilizing this technique gave new insight into the complex
relationship between the host and the parasite, similarly the use of X-ray microanylsis may
offer new insights in a number of areas including the interaction and effects of Plasmodial by-
products and parasite-infected erythrocytes on monocytes, as well as the immunomodulatory
effects of anti-malarial drugs on monocytes. The detection of alterations in elemental contents
and distributions in parasites brought about by anti-malarial drugs, may also provide new
insights.
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1.7 OBJECTIVES OF THE PRESENT STUDY
• The initial aims of this study were to isolate monocytes from either human or canine
blood and assess their yield, viability and functional integrity.
• Trypan blue exclusion was used to determine the viability and number of the cells.
• Phagocytosis of latex beads and the staining for peroxidase and alkaline phosphatase
activity, would give a clear indication of the functional integrity of the isolated
monocytes.
• Due to the difficulty of isolating hemozoin from malaria parasites, ~-hematin was
synthesized from hematin. The synthesized ~-hematin structure was confirmed by
scanning electron microscopy and EPXMA.
• The phagocytic ability of the isolated monocytes will be further investigated using
unopsonized ~-hematin.
• Prior to examining the monocytes usmg EPXMA on the transmission electron
microscope, the grid, film and elemental correction factors were determined.
• The cells were analysed and individual elemental concentrations ofNa, Mg, P, S, Cl, K
and Ca were calculated and statistically evaluated using the Mann-Whitney U-test.
• The major focus of the study will be to examine the effects of anti-malarial drugs
(quinine, chloroquine, primaquine, pyrimethamine, dapsone, doxycycline, tetracycline
and artemisinin); the trypanocidal drug, suramin; fever and ~-hematin phagocytosis on
the elemental concentrations of monocytes.
• It was hypothesized that the elemental concentrations within monocytes, would be
altered by the experimental conditions applied.
• Monocytes express heat shock proteins in response to malarial fever. Peptides from
two heat shock proteins, HSP70 and HSC70 that were most likely to elicit an immune
response in immunized chickens were identified and synthesized.
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• The antibody production was evaluated using an ELISA coated with the peptide and
western blot with the native protein. If the antibodies detected and differentiated
between HSP70 and HSC70, the effects of anti-malarial drugs on the expression of




GENERAL MATERIALS AND METHODS
2.1 MATERIALS
The majority of the chemicals utilized in this study were from BDH (Poole, England), Merck
(Darmstadt, Germany), Roche Diagnostics GmbH (Mannheim, Germany) or Sigma (St. Louis,
USA), and were of analytical grade. The low molecular weight markers and nitrocellulose
Hybond-C were from Amersham Phannacia Biotech (USA). Bovine serum albumin (BSA),
2,2' -azino-di-(3-ethyl)-benzthiozoline sulfonic acid (ABTS), nitroblue tetrazolium (NET), 5- .
bromo-4-chloro-3-indolylphosphate (BCIP) were from Roche Diagnostics GmbH (Mannheim,
Germany). Giemsa stain, Histopaque®-1077, RPMI-1640, IM HEPES buffer (N-2-
hydroxyethylpiperazine-N'-2-ethanesulphonic acid), cell culture filtration units (0.45 J.!m),
latex beads (polystyrene 0.760 J.!m), 3,3'-diaminobenzidine (DAB), m-maleimidobenzoyl-N-
hydroxysuccinimide ester (MBS) and 5,5'-dithiobis-(-2-nitrobenzoic acid) (Ellman's reagent)
were from Sigma (St. Louis, USA). Other chemicals from Sigma were hematin, artemisinin,
chloroquine, quinine, pyrimethamine, primaquine, dapsone, trypan blue, ponsceau S, pepstatin
A, 1,1O-phenanthroline, iodoacetic acid and N-[(L-3-trans-carboxyoxiran-2-carbonyl)-L-
leucyl]-amido(4-guanidino)butane (E64). Pefabloc [4-(2-aminoethyl)benzenesulfonylfluoride
(AEBSF)] and phenylmethylsulfonyl fluoride (PMSF) were from Boehringer Mannheim,
GmbH, Germany. Tetracycline HCI and doxycycline HCI were from ICN Biomedicals Inc.
(Ohio, USA). Jackson Immunoresearch Laboratories Inc. (Westgrove, P. A., USA) supplied
the horseradish peroxidase linked rabbit anti-chicken IgY. Fetal calf serum was from Delta
Bioproducts (Kempton Park, South Africa). Sigma Genosys (St. Louis, USA) synthesized the
synthetic peptides, HSP and HSC. MaxisorplM surface 96 well ELISA plates were from
Nunc-Immuno™ (Denmark). The Sulfolink® affinity matrix was from Pierce (Rockford,
USA). The gold grids (lOO square mesh) and LR white resin were from Agar Scientific LTD
(Essex, UK). Dimethylsulfoxide was from Fluka Chemie (GmbH, Switzerland). Heparinized
vacutainers, sleeves and needles were from BD vacutainer systems (Plymouth, UK). Petri
dishes were from Sterilin (Biddy Sterilin LTD, Staffs, UK) and Coming Incorporated (USA).
Canine blood was obtained through Dr Tanya HUghes of the Pietermaritzburg SPCA and
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human blood was donated by a healthy male volunteer. Distilled water (dH20) was from a
Milli-Ro® 15 water purification system (Millipore, Marlboro, USA) and deionised water
(ddH20) was from a Milli-Q Plus ultra-pure water system (Millipore, Marlboro, USA) with a
minimum resistivity of 18MQ.cm. Scanning of images was performed using the Scanmaker
8700 (Microtek) scanner. All scanned images and digital pictures of cells under the light
microscope were captured using analySIS® Version 3.0 (Soft Imaging Systems, GmbH,
Germany). X-ray spectra were collected using the EDAX® DX-4 bDX Biological Thin System
Version 2.30 (EDAX International, Mahwah, USA).
2.1.1 Ethical approval
Ethical approval was obtained from the University of Natal Ethics. Committee to inject
chickens with peptide rabbit albumin conjugates. The ethics reference number was
U.NATAL.AE/GoldringlOl/07.
2.2 ISOLATION OF MONOCYTES
In 1968, Boyum described methods for the isolation of mononuclear cells from circulating
blood. These cells are one of the easiest blood cells to isolate since they adhere to plastics and
glass, whereas the remaining non-adherent blood cells are washed off. Blood was collected in
heparinized vacutainers, since monocytes isolated from EDTA and citrate-phosphate-dextrose
(CPD) anti-coagulated blood showed very poor adhesion as well as loss of phagocytic activity
(Bussolino et al., 1987). Wynne and Moore (1982) mention that one of the disadvantages of
isolating monocytes using heparin as an anticoagulant is that platelets become "stickier" and
large numbers of platelets may contaminate the monocyte preparations. This can be avoided
by washing the cover slips thoroughly. The procedure utilizes Histopaque®-1077 which is a
solution of polysucrose and sodium diatroate, adjusted to a density of 1.077±0.00l glm!. This
. solution facilitates the rapid recovery of viable mononuclear cells from small volumes of
blood. The anti-coagulated blood is layered on to the Histopaque®-1077. During
centrifugation the erythrocytes and granulocytes are aggregated by polysucrose and rapidly
sediment while the monocytes and other mononuclear cells remain at the plasma interface
(Figure 2.1). RPMI-1640 medium was developed by Moore et al. (1967) at Roswell Park
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Memorial Institute. This medium is used for the culturing of normal and neoplastic leukocytes.
The isolation procedure outlined here is adapted from Goldring et al. (1992).
2.2.1 Materials
Phosphate buffered saline (PBS), pH 7.2. NaCI (8 g), KCI (0.2 g), Na2HP04.2H20 (1.15 g)
and KH2P04 (0.2 g) were dissolved in 900 ml ddH20, the pH was adjusted to 7.2 with NaOH
and made up to 1 1. The solution was aliquoted into smaller volumes, sterilized by autoclaving .
and kept refrigerated at 4°C.
Heat inactivated fetal calf serum (PCS). Fetal calf serum was aliquoted into 10 ml sterile tubes.
and heated to 60°C for 30 min.
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid CHEPES) buffer (l M), pH 7.5.
Purchased from Sigma (St. Louis, USA)
Complete RPMI 1640 medium C25 mM HEPES; 5% FCS). RPMI 1640 medium powder
(10.64 g) was dissolved in 900 m1 sterile ddH20 by stirring. If required, the pH was adjusted
to pH 4 with HCI to aid in dissolving the powder. Once dissolved, the pH is increased to pH
7.2 with NaOH and Na2C03 (2 g) is added and stirred until dissolved. The pH was adjusted to
within 0.1 - 0.3 pH units of pH 7.2, the volume was adjusted to 11. HEPES buffer (25 ml) and
heat inactivated fetal calf serum (50 ml) was added. This solution was filter sterilized through
0.451lm acetate filters into sterilized bottles.
2.2.2 Procedure
Canine or human blood was drawn using heparinized vacutainers or sterile tubes containing
heparin (25 V/ml). The blood was inverted a number of times to ensure complete mixing of
the anticoagulant heparin. The tubes were kept·on ice. The blood was diluted 1: 1 with sterile
cold PBS.For a 13 m1 polyallomer ultracentrifuge tube, 10 ml of the blood:PBS solution was
carefully layered onto 3 m1 of Histopaque®-1077 (d = 1.077). The tubes were centrifuged in
the Beckman preparative ultracentrifuge with a SW 40 Ti swinging bucket rotor (2000 g 25
min, 8°C). The buffy coat that contains the lymphocytes (2nd layer) was removed and diluted
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with cold PBS (Figure 2.1). The tubes were centrifuged (250 g, 10 min, 8°C). The pellet was
resuspended in PBS and recentrifuged (250 g, 10 min, 8°C). These steps remove any excess
Histopaque that may have a negative impact on any further experiments. The fmal pellet was
resuspended in complete RPM! 1640 medium (2 ml). The cell suspension (1 mllcoverslip ~
lxl06 cells) was placed on 22x22 mm cover slips previously sterilized at 120°C overnight or
sterile 35 mm petri dishes. The cover slips in petri dishes or the petri dishes were incubated at
37°C for 2 h in a humidified atmosphere with 5% CO2• Non-adherent cells were removed by












Figure 2.1 Diagrammatic representation of the separation of blood into its components
before and after centrifugation through the Histopaque®-1077 density gradient. (A) Prior
to centrifugation the blood/PBS mixture was layered on to the Histopaque®-1077. (B) After
completion of centrifugation four layers are visible: the plasma layer, monocyte layer, the
histopaque layer and the red blood cell layer.
2.3 VIABILITY AND COUNTING ASSAYS
Trypan blue has been used in viability assays since 1956 (Martel et al., 1974). It is an acid dye
of the dis-azo group (Gurr, 1960) that is actively excluded from viable cells due to its negative
charge, but it readily enters and stains dead cells because the outer membrane is no longer
intact. Thus dead cells are stained blue. This allows an estimation of the number of viable
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cells present. A haemocytometer is an etched glass chamber with raised sides that will hold
the cover slip exactly O.lmm above the chamber floor. The volume under the cover slip will
always be the same and is known.
2.3.1 Materials
Trypan blue stock solution [0.4% (w/v) in 0.81 % (w/v) NaC1 and 0.06% (w/v) K2HP041
Trypan blue (0.04 g), NaC1 (0.081 g) and K2HP04 (0.006 g) were dissolved in ddH20 in a
final volume of 100 ml. The solution was sterilized through an acetate filter (0.22 Ilm pore
size) into a bottle sterilized by autoclaving and stored at 4°C.
2.3.2 Procedure
An aliquot of the cell suspension (50 Ill) obtained as described in Section 2.2 was diluted with
PBS (450 Ill), mixed with trypan blue stock solution (500111) in a 1.5 ml Eppendorfmicrofuge
tube and incubated for 15 min at RT. A small volume was aspirated using a clean Pasteur
pipette and dispensed into a haemocytometer by capillary action until both chambers were full
but not overflowing. The cell numbers and the percentage of viable cells were estimated using
the following calculations.
Dilution factor (DF) = 20
Total no. viable cells = [average no. viable cells x DF x 104]x volume ofresuspended pellet
Total no. cells = [average no. cells x DF x 104] x volume ofresuspended pellet
Viability = [Total no. viable cells / Total no. cells] x 100
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2.4 GENERAL STAINING OF MONOCYTES
Monocytes can be identified by their morphology, their ability to phagocytose and their
surface molecules (Stachura, 1989). In order to visualize and identify monocytes or any cells
they must be stained. There are many stains to choose from. Giemsa is one of the most
widely used of the blood cell stains. The nucleus is stains dark purple with the cytoplasm
stained lightly. Different types of blood cells are stained differently by giemsa and thus one is
able to differentiate between them. Methyl green is a counter stain, which stains the whole cell
a light green. This is useful when in enzyme cytochemistry where the cells' enzymes, such as
alkaline phosphatase or peroxidase, cleave a substrate into a precipitating product and thus
visualize where the enzyme is localized.
2.4.1 Giemsa and methyl green staining of monocytes
Giemsa stain is a mixture ofmethylene blue and the azurs in different combinations with eosin
Y (Gurr, 1960). Thus different brands may vary in the combinations of the component dyes
present. Giemsa is traditionally used for staining blood smears for cells and parasites,
particularly malaria. The nuclei of stained leucocytes are a reddish purple with the cytoplasms
being a pale pink.
Methyl green is a bluish-green basic dye of the triphenylmethane group (GUrr, 1960). It is a
widely used nuclear stain for both plant and animal material, and occasionally as a cytoplasmic
stain. Methyl green stains DNA as it occurs in the nuclei, but it will not stain depolymerised
DNA or RNA. In the present study it was used as a general stain where both the nuclei and
cytoplasm were stained a light green.
2.4.1.1 Materials
Giemsa staining solution. Dilute stock stain solution (1 ml) in ddH20 (20 ml).
2% Methyl green. Methyl green (2 g) was dissolved in dH20 (100 m1).
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2.4.1.2 Procedure
Monocytes on glass cover slips (Section 2.2) were air dried and immediately fixed in methanol
(100%) for 30 s and air-dried. They were stained, with the cell side of the cover slip on the
stain solution, either for 15 min at RT for the giemsa stain or 5 min for 2% methyl green. The
cover slips were rinsed in three changes of distilled water and air-dried, followed by mounting
onto slides with DPX (distrene dibutyl phthalate xylene) mountant.
2.4.2 Detecting alkaline phosphatase and peroxidase activity in monocytes
Alkaline phosphatase is a zinc-containing metalloenzyme that catalyses the hydrolysis of an
ortho-phosphoric monoester to yield an alcohol and an orthophosphate.. Phosphatase has been
localized in the primary lysosomes ofpromonocytes and mature monocytes (Van Noorden and
Frederiks, 1992). The detection of this enzyme involves the indoxyl-tetrazolium salt method.
In the case of substrates containing an indoxyl or indolylamine group, such as 5-bromo-4-
chloro-3-indolyl phosphate (BCIP), a colourless dehydro-indigo is generated instead of blue
indigo. The electrons liberated during the dehydro-indigo formation reduce a tetrazolium salt
such as nitroblue tetrazolium (NBT) to form formazan (reduced NBT dye), which in this case
is a purple precipitate (Van Noorden and Frederiks, 1992). According to Absolom (1986)
neutrophils are positive for the histochemical reaction for alkaline phosphatase while
monocytes are negative. On the other hand Van Noorden and Frederiks (1992), as mentioned
before state that alkaline phosphatase is present in monocytes.
Peroxidases are heme-containing enzymes that oxidize a variety of xenobiotics by hydrogen
peroxide (O'Brien, 2000). Plant peroxidases consist of 300 amino acids (aa) and the heme is
non-covalently bound, whereas mammalian peroxidases are much larger (576 - 738 aa) and
the heme is covalently bound. The peroxidase of interest in neutrophils and other leukocytes
is myeloperoxidase (MP0), which is localized in the lysosomes (O'Brien, 2000). MPO
functions by oxidising chloride to produce strong oxidants (e.g. hypochlorous acid) that kill
microorganisms. Promonocytes contain peroxidase in primary lysosomes and the more mature
promonocytes develop a second population of granules, which are peroxidase negative. As
monocytes mature the peroxidase activity is decreased (Stachura, 1989). Several chromogens
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have been used to localize peroxidase activity, the most common being 3,3'-diaminobenzidine
(DAB). The light-brown water soluble DAB acts as a hydrogen and electron donor and
becomes oxidized to form a water insoluble precipitate (Van Noorden and Frederiks, 1992).
The use of 4-chloro-1-naphthol was explored in the present study but it was found not to stain
monocytes.
2.4.2.1 Materials
50 mM Tris-HCL, pH 9.5. Tris base (3.03 g) was dissolved in 450 ml dH20, the pH was
adjusted with HCI and made up to a final volume of 500 ml with dH20.
50 mM Tris-HCL, 5 mM MgCh, pH 9.5. MgCh (25 fll of a 1 M solution) was made up to
500 rol with 50 mM Tris-HCL (pH 9.5).
70% (v/v) Dimethylformamide (DMF). DMF (700 fll) was made up to 1 ml with dH20.
Alkaline phosphatase substrate solution. 5-Bromo-4-chloro-3-indolyl phosphate (BCIP)
(0.003 g) was dissolved in 1 ml DMF and nitroblue tetrazolium (NBT) (0.006 g) was dissolved
in 70% (v/v) DMF (1 ml). These two solutions were mixed and made up to 20 ml with 50 mM
Tris-HCL, 5 mM MgCh (pH 9.5).
50 mM Tris-HCL, pH 7.3. Tris base (0.6 g) was dissolved in 90 ml dH20, the pH was
adjusted to 7.3 with HCI, and the solution was made up to a final volume of 100 ml with
dH20.
Peroxidase substrate solution [39 mM 3,3'-diaminobenzidine (DAB), in 50 mM Tris-HCI (pH
7.3) with H2ili (0.01%)]. DAB (0.011 g) was dissolved in 20 ml 50 mM Tris-HCI (pH 7.3)
and H20 2 (2 Ill). Immediately prior to use.
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2.4.2.2 Procedure
Monocytes were isolated according to the procedure outlined in Section 2.2. After removal of
the non-adherent cells the cover slips were incubated with either the alkaline phosphatase or
the peroxidase substrate solutions for 30 min. The cover slips were rinsed in dH20 and stained
as described in Section 2.4.1.2.
2.5 MONOCYTE PHAGOCYTOSIS OF UNOPSONIZED LATEX BEADS AND ~­
HEMATIN
Phagocytosis is the most important defence mechanism in all species in the animal kingdom·
and today it still remains the principal way of disposing of invading pathogens CVan Oss,
1986; Oppenheim and Leonard, 1989). Monocytes are the second line of defence after
neutrophils but both are highly phagocytic cells. Phagocytosis may be halted by lowering the
temperature to O°C (Wright, 1986). The binding of particles occurs, but pseudopods cannot be
extended and invagination of the plasma membrane does not occur. When measuring
phagocytosis in vitro, it is important to distinguish between adhering particles and those that
have been ingested.
Heme is detoxified by the malaria parasite in a unique process to hemozoin. Hemozoin is not
identical to ~-hematin, as hemozoin is hematin associated with a protein (Goldie et al., 1990).
When comparing the two compounds using elemental composition, extended X-ray absorption
fine structure (EXAFS) and the infra-red spectrum (IR) they were very similar (Slater et al.,
1991). The X-ray powder diffraction pattern obtained for hemozoin and ~-hematin were
almost indistinguishable. Since the molecules are very similar, ~-hematin is a good substitute
for the study of cell interactions with hemozoin. ~-Hematin was synthesized according to the
method used by Slater et al. (1991) and Taramelli et al. (1995), with minor modifications.
Monocytes are activated when incubated with the supernatants of parasite cultures, which
contain malarial pigment or hemozoin (Abdalla and Wickramasinge, 1985). Taramelli et al.
(1995) found that certain functions in monocytes are inhibited by the phagocytosis of
hemozoin. Hemozoin phagocytosis has also been found to inhibit the expression of MHC
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Class IT antigen, CD54, CDllc and LAM-1 and increases the expreSSIOn of CDllb
(Pichyangkul et al., 1997; Schwarzer et al., 1998). Malarial pigment was later found to be a
hematin derivative hemozoin. It was noted that hematin was responsible for inhibiting the
production of nitric oxide and TNF-a (Taramelli et al., 1995). Sherry et al. (1995) estimated
that approximately 200 Ilmol hemozoin could be released into the blood stream of a malaria
patient at schizogony, that is with a 1% underlying synchronous parasitemia. Pichyangkul et
al. (1994) used p-hematin as a substitute for hemozoin in phagocytosis experiments. Latex
beads are also phagocytosed by monocytes but they do not appear to alter the functioning of
the cells. Latex beads were used as a control for phagocytosis (Schwarzer et al., 2001).
2.5.1 Materials
0.1 M NaOH. NaOH (0.4 g) was dissolved in dH20 (100 ml).
49 mM acetic acid. Acetic acid (1.4 ml) was added to dH20 (490 ml) and made up to 500 ml
with dH20.
0.2 M sodium carbonate (Solution A). Na2C03 (4.24 g) was made up to 200 ml with dH20.
0.2 M sodium hydrogen carbonate (Solution B). NaHC03 (3.36 g) was made up to 200 ml with
dH20.
0.1 M sodium bicarbonate buffer, pH 9.1. Solution A (10 ml) was titrated with solution B to
pH 9.1 and made up to 200 ml with dH20.
200 UM p-hematin solution. p-hematin (1 mg) was suspended in ddH20 (1 ml). This mixture
(126 Ill) was made up to 1 ml with RPMI complete medium (Section 2.2.1).
Phosphate buffer [lOO mM sodium phosphate, 0.02% NaN3, pH 7.61. NaH2P04.H20 (13.8 g)
and NaN3 (0.2 g) were dissolved in ddH20. The pH was adjusted to 7.6 with NaOH and made
up to 1 1with ddH20.
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Latex beads Cl blm). Purchased from Sigma chemicals as a 10% (w/v) solution in sterile water.
0.1 % Cw/v) Latex bead solution. Latex beads in solution (10 Ill) were made up to 1 ml using
complete RPM! medium (Section 2.2.1).
2.5.2 Procedure
Hematin (600 Ilmol or 0.03 g) was dissolved in 0.1 M NaOH (80 ml). The porphyrin was
precipitated by addition of 49 mM acetic acid. The suspension was heated overnight at 70°C,
and the precipitate was washed four times with dH20. Unreacted hematin was removed by
extracting the precipitate twice for 3 h in 0.1 M sodium bicarbonate buffer. The remaining
insoluble material was recovered by centrifugation (20 000 g, 10 min, RT) (Sigma 3K20) and
washed four times with dH20. The insoluble ~-hematin was recovered by centrifugation (20
000 g, 5 min, RT). After a final wash in 70% ethanol, the ~-hematin was air dried and
weighed. The hematin and the ~-hematin were mounted onto carbon stubs and viewed in a
Philips environmental scanning electron microscope (ESEM) under a large field detector. This
allowed for the comparison of the crystal structure of the compounds. X-ray microanalysis was
also performed on the ESEM at 2000x magnification, accelerating voltage of 20 kV and a spot
size of4.
Monocytes were isolated as per the protocol in Section 2.2. After removal of the nonadherent
cells, the 0.1 % latex bead solution or the 200 IlM ~-hematin solution (1 ml) was placed on
each of the cover slips. The cells were incubated at 37°C for 30 min in a humidified
atmosphere containing 5% CO2. The cover slips were rinsed in dH20 and stained with giemsa
or methyl green as described in Section 2.4.1.
2.6 ELECTRON MICROSCOPY AND ELECTRON PROBE X-RAY
MICROANALYSIS OF MONOCYTES
The transmission microscope is used for viewing particles smaller than a few tenths of a
micrometer in diameter. Resolution in the light microscope is limited by the wavelength ofthe
light being larger than the particle examined. The electron beam gives greater resolving power
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than the light microscope and hence higher magnifications are possible. The electrons are
produced by a tungsten filament operating in a vacuum and the electron beam is focused by
electromagnets. In the TEM the electrons pass through the specimen and then 1 on a
fluorescent screen where the image is visualized (Jones et al., 1994). Electron probe X-ray
microanalysis (EPXMA) is a technique that enables determination of the elemental
composition of a specimen in the TEM (Warley, 1997). When the electron beam interacts
with the specimen, X-rays are generated and carry information about the composition of
elements in the cell.
2.6.1 Preparation of the cell pellet
2.6.1.1 Materials
Phosphate buffered saline (PBS), pH 7.2. See Section 2.2.1 for preparation. .
0.2 M K-phosphate buffer, pH 6.8. Equal volumes of 0.2 M K2HP04 and 0.2 M KH2P04 were
mixed to make 0.2 M phosphate buffer. The pH was 6.8.
2.6.1.2 Procedure
Monocytes were isolated as outlined (Section 2.2). The adherent cells were removed with 1
ml ice cold PBS and scraping of the petri dish with the rubber end of a syringe plunger. The
cell suspension was placed into an Eppendorf tube. This process was repeated three times.
The Eppendorfs were centrifuged in a Heraeus Biofuge Pico desktop centrifuge (400 g, 5 min,
RT). The cell pellets were resuspended in a small volume of 0.2 M phosphate buffer and
combined into one Eppendorftube and recentrifuged (400 g, 5 min, RT). The monocyte pellet
was resuspended in 0.2 M phosphate buffer.
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2.6.2 Fixing and resin embedding of the monocyte cell pellet
Without careful preparation of the cells being studied, the ultrastructural detail is rendered
meaningless. The main purpose of chemical fixation is to preserve the cells in a lifelike state
(Jones et al., 1994). Primary fixation involves the use of paraformaldehyde and glutaraldehyde
and is probably the most important step, in that it fixes and stabilizes proteins. Osmium
tetroxide acts as post fixative and is an excellent lipid stabilizer and contrasting agent. It reacts
with both proteins and lipids, thus the contrast of lipoprotein cell membranes and fatty
inclusions are intensified (Weakley, 1981). Osmium tetroxide fixes by reacting with the
double bonds in lipids and thus crosslinks neighbouring molecules. Thereafter it reacts with
the polar groups of lipids. It appears to crosslink proteins via SS and SH groups. The high .
water content in tissues and cells usually hinders subsequent preparation so the water needs to
be removed. Dehydration involves a series of organic solvents decreasing in water content
(Jones et al., 1994). Embedding involves infiltrating the specimen with a solid medium (resin)
that will support it during sectioning. There are many types of resins available but the current
trend has been to move away from hydrophobic resins to the hydrophilic resins. In the present
study LR-White was utilized. This has been found to give better morphology and, in the case
of immunocytochemistry, retention of antigenicity. The only disadvantage of using a
hydrophilic resin is that scrupulous attention must be paid to the technical procedure in order
to obtain high quality results.
2.6.2.1 Materials
Paraformaldehyde [16% (w/v)]. Paraformaldehyde (16 g) was dissolved in ddH20 (100 ml)
and heated to 60°C. Saturated NaOH was added drop wise to the solution until clearing
occurred.
Paraformaldehyde [8% (w/v)] in 0.1 M phosphate buffer. Paraformaldehyde [50 ml of 16%
(w/v)] was mixed with an equal volume of 0.2 M phosphate buffer (Section 2.6.1.1).
Paraformaldehyde [2% (w/v)] in 0.1 M phosphate buffer. Paraformaldehyde [1 ml of 8%
(w/v)] was diluted with 1 ml ddH20. 0.2 M phosphate buffer (200 J.!l; Section 2.6.1.1) was
diluted with 1.5 ml ddH20. The two solutions were mixed.
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Paraformaldehyde [8% (w/v)] / Glutaraldehyde [0.2% (v/v)] in 0.1 M phosphate buffer.
Paraformaldehyde [50 ml of 16% (w/v)] and glutaraldehyde [600 fll of25% (v/v)] was mixed
with 0.2 M phosphate buffer (50.6 ml; Section 2.6.1.1).
0.2 M Glycine. Glycine (0.113 g) was dissolved in 100 ml PBS (Section 2.2.1), aliquoted into
Eppendorftubes and stored at -20°C.
Gelatin solution [10% (w/v)]. Gelatin (l g) was dissolved in 1 ml ddH20, with heating until
clear and stored at 37°C until required.
Osmium tetroxide stock solution [4% (w/v)]. For safety reasons, this was prepared by the
electron microscopy unit staff.
Osmium tetroxide working solution [2% (w/v)]. 0.2 M Phosphate buffer (1 ml; Section
2.6.1.1),4% osmium tetroxide stock solution (2 ml) and ddH20 (1 ml) were mixed together to
prepare a working solution, which was used immediately.
2.6.2.2 Procedure
The monocyte suspension (500 fll from Section 2.6.1.2) was mixed with an equal volume of
8% paraformaldehyde / 0.2% glutaraldehyde in 0.1 M phosphate buffer for 2 h at RT. The
cells were gently pelleted by centrifugation in a Heraeus Biofuge Pico desktop centrifuge at
(400 g, 5 min, RT). The supematant was removed and replaced with 8% paraformaldehyde in
phosphate buffer and incubated ovemight at 4°C. The cells were pelleted and the supematant
removed. The cells were resuspended in 0.2 M glycine (1 m1), incubated for 15 min at RT,
repelleted and the supematant discarded. A further 1 m1 0.2 M glycine was added and the
pellet was resuspended and allowed to quench for 30 min. The cells were recentrifuged and
the supematant removed. The warmed gelatin solution (l ml) was added and the pellet
resuspended and incubated for 1 h at 37°C. The cells were spun down and the gelatin
supematant aspirated. Fresh gelatin solution (lOO fll) was added and allowed to solidify on ice
for 20 min. The gelatin pellet was removed from the Eppendorf using a needle and cut into
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cubes. The cubes were osmicated using 2% osmium tetroxide for approximately 30 min or
until they appeared brown. The osmium tetroxide was removed and the cubes washed twice in
0.2 M phosphate buffer for 15 min. The cubes were taken through a dehydration series of:
30% ethanol (5 min); 50% ethanol (5 min); 70% ethanol (5 min); 90% ethanol (5 min) and
100% ethanol (2 x 5 min). LR white resin (1 part) was mixed with 100% ethanol (1 part) and
incubated with the pellet for 30 min. This solution was removed and replaced with 2 parts LR
white resin, 1 part 100% ethanol and incubated for 30 min. LR white resin was added and
incubated for 30 min: the resin was changed and left overnight. The cubes and fresh resin
were added to the gelatin capsules and were allowed to polymerise at 45 - 50°C for 24 h. The
polymerised resin was removed from the capsule and prepared for sectioning by cutting the tip
off and mounting it on a perspex stub. The stub was then trimmed and ultra thin sections (100
nm) cut on a LKB Ultratome III using a glass knife.
2.6.3 Heavy metal staining of ultra thin sections
Many factors affect contrast within the electron microscope and of these the four most
important are the thickness of the specimen, accelerating voltage, aperture size and the
presence of heavy metal atoms in the specimen (Weakley, 1981). The atoms present in
biological material are mainly of low atomic number: hydrogen (1); carbon (6); nitrogen (7);
oxygen (8); phosphorous (15) and sulfur (16). Thus the electron scattering ability of these
light elements is very small. Heavy metal salts are useful as contrast-increasing stains.
Generally heavy metal cations form complexes with negatively charged groups in the cells
while the ions of lead and uranium bind to oxygen. Uranyl acetate has strong affinities for
nucleic acids, but also acts as a general stain for proteins (Weakley, 1981). It is thought that
the uranium ions attach to the P04
2
- groups of nucleic acids and some proteins. Lead citrate
adds contrast to nucleic acids, membranes and glycogen. Lead also attaches to osmium
compounds bound to the cellular components during fixing. The lead attaches to the OH
groups of carbohydrates and RNA phosphate groups. These two stains give contrast and
details on the ultrastructure of the sectioned cells.
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2.6.3.1 Materials
Uranyl acetate [2% (w/v)). Uranyl acetate (1 g) was dissolved in ddH20. A drop of 95%
ethanol was added to lower the surface tension. The solution was kept in the dark and
refrigerated.
Lead citrate. Pb(N03) (1.33 g) and Na3(C6Hs07).2H20 (1.76 g) were dissolved in 30 ml CO2
free ddH20 (freshly boiled or vacuum degassed) by shaking vigorously for 1 min then
intermittently every 30 min, to give a milky white solution. 1 N NaOH (8 ml) (1 g NaOH
made up to 25 ml with C02 free ddH20) was added to the solution, which turns. The solution
was made up to 50 ml with CO2 free ddH20. Lead citrate is CO2 sensitive and should be.
stored in the dark and in a sealed bottle. For safety reasons this reagent was made up by the
staff of the electron microscopy unit.
2.6.3.2 Procedure
Drops of 2% uranyl acetate solution were placed on a clean waxed petri dish. Grids were
inverted with the section side down on the surface of the drop. The specimens were allowed to
stain for 10 min. The grid was removed and washed with a stream of dH20. The excess water
was removed by touching the grid on a piece of filter paper. A teaspoon of pure sodium
hydroxide pellets was placed in a second clean, waxed petri dish. Drops of the lead citrate
solution were placed in the petri dish and the staining was carried out as for the 2% uranyl
acetate. The grids were washed with dH20 and dried as above.
2.6.4 Preparation of grids for EPXMA
TEM grids are made from a wide variety of materials and come in many patterns depending on
the application. Typically the grids are 3.05 mm in diameter, made of copper and contain
holes, which are very precisely calibrated with between 100 and 1000 holes per 25 mm. Due
to copper being toxic to cells, gold was used in the present study as it is a neutral metal which
has little to no effect on the viability of growing cells (Warley et a!., 1994). The cells are far
too small to fit on the grid without falling through so the grid must be coated. The coating
process involves placing a very thin film of a plastic compound (formvar) over the entire grid.
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2.6.4.1 Materials
Acetic acid [20% (v/v)]. Acetic acid (20 ml) was added to dH20 (80 ml).
Formvar solution [0.2% (w/v)]. Formvar (0.2 g) was dissolved ill 100 ml dehydrated
chloroform.
2.6.4.2 Procedure
The gold grids were cleaned by sequentially sonicating in chloroform, 100% ethanol, dH20
(x2), 20% acetic acid, dH20 (x2), 100% ethanol and dH20 (x2). The grids were allowed to
dry before being used. Clean microscope slides were dipped into the formvar solution and the
excess solution was drained off onto tissue paper. The slides were allowed to dry and, using a
sharp blade, the edges of the slide were cleared of formvar. The slide was carefully dipped
into distilled water at an angle of+ 45°, allowing the formvar to float off. The gold grids were
placed on the floating formvar. Using another clean slide the grids and the formvar were
picked up and allowed to dry. Once dry, three formvar-coated gold grids were placed in
alternate wells of an ELISA plate lid (Figure 2.2). The grids on the lid were sterilized under









Figure 2.2 Schematic representation of the ELISA plate lid and the placement of the
formvar coated grids for the culture of monocytes in preparation for EPXMA.
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2.6.5 Preparation of monocytes for EPXMA
Cells such as monocytes can be cultured on grids since they adhere to plastic (formvar) and
they grow in monolayers. Even though a small number of cells may be present per grid, this is
all that is required for EPXMA. According to Warley et al. (1994) this is an ideal method for
measuring elemental concentrations, Duxes and for studying the effects of drugs on a given
cell type. The cells were washed in sterile ultra pure water to remove the medium as this was
found by Warley et al. (1994) to be better than 0.3 M sucrose or 0.15 M sodium acetate.
Liquid nitrogen is suitable and convenient to use for rapid freezing of cell monolayers. In the
present study a freeze dryer capable of handling electron microscope grids was not available,
so resort was made to air-drying. Air-drying is the simplest method for the preparation of cells, .
but the specimens shrink and their structure is disrupted. This technique is not suitable if
ultrastructural details are required but when the total elemental content of the cell is of interest
it is very successful (Chandler, 1977; Warley, 1997). Therapeutic concentrations for all the
drugs used were from Goldring and Nemaorani (1999) and Goldring et al. (1999).
2.6.5.1 Materials
Phosphate buffered saline (PBS), pH 7.2. See Section 2.2.2 for preparation.
Complete RPMI 1640 medium [25 mM HEPES; 5% FCS]. See Section 2.2.2 for preparation
Quinine stock solution (200 blg!ml). Quinine (1 mg) was dissolved in 1 ml dimethylsulfoxide
(DMSO) and made up to 5 ml with sterile ddH20.
Therapeutic quinine working solution 05 btg!ml). Quinine stock solution (375 Jll) was made
up to 5 ml with complete RPM! medium.
Chloroquine stock solution 000 blg!ml). Chloroquine (1 mg) was dissolved in 1 ml DMSO
and made up to lO ml with sterile ddH20.
Therapeutic chloroquine working solution (0.2 blg!ml). Chloroquine stock solution (20 Jll) was
made up to 10 ml with complete RPMI medium.
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Artemisinin stock solution (lOO f-Lg/ml). Artemisinin (l mg) was dissolved in 1 ml DMSO and
made up to 10 ml with sterile ddH20.
Therapeutic artemisinin working solution (0.4 f-Lg/ml). Artemisinin stock solution (40 Ill) was
made up to 10 ml with complete RPM! medium.
Primaquine stock solution (lOO f-Lg/ml). Primaquine (l mg) was dissolved in 1 ml DMSO and
made up to 10 ml with sterile ddH20.
Therapeutic primaquine working solution CO.15 f-Lg/ml). Primaquine stock solution (31 Ill) was
made up to 20 ml with complete RPMI medium.
Pyrimethamine stock solution (lOO f-Lg/ml). Pyrimethamine (1 mg) was dissolved in 1 ml
DMSO and made up to 10 ml with sterile ddH20.
Therapeutic pyrimethamine working solution CO.15 f-Lg/ml). Pyrimethamine stock solution (31
Ill) was made up to 20 ml with complete RPMI medium.
Dapsone stock solution (l mg/ml). Dapsone (1 mg) was dissolved in 1 ml with sterile ddH20.
Therapeutic dapsone working solution C3 f-Lg/ml). Dapsone stock solution (30 Ill) was made up
to 10 ml with complete RPMI medium.
Doxycycline stock solution (l mg/ml). Doxycycline HCI (l mg) was dissolved in 1 ml with
sterile ddH20.
Therapeutic doxycycline working solution C3 f-Lg/ml). Doxycycline stock solution (30 Ill) was
made up to 10 ml with complete RPMI medium.
Tetracycline stock solution (l mg/ml). Tetracycline HCI (1 mg) was dissolved in 1 ml with
sterile ddH20.
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Therapeutic tetracycline working solution (3 ug/ml). Tetracycline stock solution (30 Jll) was
made up to 10 ml with complete RPMI medium.
Suramin stock solution Cl mg/ml). Suramin (1 mg) was dissolved in 1 ml with sterile ddH20.
Therapeutic suramin working solution (20 blg/ml). Suramin stock solution (100 Jll) was made
up to 5 ml with complete RPMI medium.
DMSO working solution. DMSO was made up to 5 ml with sterile ddH20, and 1.86 ml of this
solution was made up to 5 ml with complete RPMI medium.
200 blM [3-hematin solution. See Section 2.5 for preparation
0.1 % Latex bead solution. See Section 2..5 for preparation
2.6.5.2 Procedure
Monocytes were isolated as described in Section 2.2. The adherent cells were removed with 1
ml ice cold PBS and scraping the petri dish with the rubber end of a syringe. The cell
suspension was placed into an Eppendorf tube. This process was repeated three times. The
Eppendorfs were centrifuged in a Heraeus Biofuge Pico desktop centrifuge (400 g, 5 min, RT).
The cell pellets were resuspended in a small volume of cold PBS and combined into one
Eppendorf tube and recentrifuged. The monocyte pellet was resuspended in warm complete
RPMI medium, the volume corresponding to 100 Jll for every three formvar coated gold grids
in the ELISA plate lid (Figure 2.2). The cells were allowed to adhere to the grids at 37°C for 2
h in a humidified atmosphere with 5% CO2. The medium was removed and the experimental
conditions were applied to canine monocytes (Table 2.1). The grids were gently washed in
sterile ddH20 and air-dried or frozen in liquid nitrogen.
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Table 2.1 Experimental conditions applied to monocytes adhering to gold grids.
Drug or conditions Concentration Biologically Time
relevant levels omin 10 min 30 min 2h 18 h
Control (No drug) Medium only ~ ~ ~
Quinine 151lg/ml Therapeutic ~ ~ ~
Chloroquine 0.21lg/ml Therapeutic ~ ~ ~
Artemisinin 400 ng/ml Therapeutic ~ ~ ~
Primaquine 153 ng/ml Therapeutic ~ ~ ~
Pyrimethamine 155 ng/ml Therapeutic ~ ~ ~
Dapsone 31lg/ml Therapeutic ~ ~ ~
Doxycycline 31lg/ml Therapeutic ~ ~ ~
Tetracycline 3llg/ml Therapeutic ~ ~ ~
Suramin 2OIlg/ml Therapeutic ~ ~ ~
DMSO 20% (v/v) Max Dilution ~ ~ ~
Hemozoin 200llM 'Normal level' ~ ~ ~
Latex beads 0.1% (v/v)
~ ~ ~
Incubated 37°C Medium only No Heat Shock ~ ~ ~ ~
Incubated 44°C Medium only Heat Shock ~ ~ ~ ~
2.6.6 Grid and film correction for quantitative EPXMA
For quantitative analysis of specimens using the peak to continuum method, the contribution
of the grid and the film to the continuum must be taken into account and corrected for. If this
is not done concentrations will be grossly over estimated. An uncoated gold grid was analysed
by X-ray microanalysis in a Philips CM120 transmission electron microscope equipped with
an EDAX detector fitted with a 10 J.!m beryllium window. Ten spectra (Figure 2.3) were
obtained at 80 kV, spot size 200 nm, specimen tilted to + 200 and a live time of 100 s. The








Figure 2.3 X-rays produced by irradiation of a gold (Au) grid either coated with formvar
or uncoated. The spectrum collected between 0 and 18 keY, shows the L and M families of
peaks. The M family occurs at 2.123 and 2.205 keY and the L family consists of La (9.71
keY), Lp (11.44 key), Ly (13.38 keY), which are clearly defined peaks.
Using the following fonnulas the grid correction factors for the microscope were calculated
and an average taken.
Cx = Concentration ofx
Px = Net peak intensity
W = Continuum (4.2 - 6.2)
kx = Calibration constant
Thus Grid correction factor = WIPAu
PAu = Net peak intensity Au
W = Continuum (4.2 - 6.2)
The average of all the grid correction factors was 0.38. The actual grid correction was
calculated from the specimens being analysed and again an average taken. The fonnula for the
grid correction is:
Grid correction for sample = 0.38 x PAu
PAu = Net peak intensity Au
in sample
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The film correction was carried out on the each sample, with an area devoid of cells being
measured three times on each grid. The film correction was calculated using the following
formula:
Film correction = WFilm - Grid correction
WFilm = Continuum of
specimen film
For most of the grids analysed the film correction corresponded to approximately 564.
2.6.7 Efficiency of sodium with respect to potassium for quantitative EPXMA
Sodium and potassium occur in the compound sodium potassium tartrate in a 1:1 ratio, thus
the concentration is the same, and thus so should the peaks and calculated concentrations. This
is not the case, however, as the detector's efficiency decreases with atomic number. This
chemical enables us to correct for sodium.
2.6.7.1 Materials
Sodium potassium tartrate solution. A few crystals of NaKC40 6!L+.4H20 were dissolved in
sterile ddH20.
2.6.7.2 Procedure
A drop of the sodium potassium tartrate solution was placed on a formvar coated gold grid and
allowed to dry. The grid was analysed and spectra (Figure 2.4) obtained using X-ray
microanalysis in the TEM and the number of counts under each peak determined. The Na peak
is much smaller than the K even though they are in a 1:1 ratio, due to the efficiency of the
detector diminishing with decreasing atomic number. The efficiency was calculated using the
following formula:
% efficiency ofNa = (PNaIPK) X 100
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Figure 2.4 X-rays produced by irradiation of sodium potassium tartrate on a formvar
coated gold grid. The spectrum collected between 0 and 10.5 keY, shows the Na, K and Au
peaks, which are of different intensities.
2.6.8 Relative detector efficiency for quantitative EPXMA
The relative detector efficiency can be determined in a similar way to Section 2.6.7 but using
an isoatomic solution containing the elements Na, Mg, P, S, Cl, K and Ca. The number of
counts increase with increasing atomic number, with the exception of chlorine that is labile
under the electron beam in this preparation. Thus the detectors efficiency for all the elements
Na, Mg, P, S, Cl, and Ca can be determined with respect to K, these efficiencies are
determined as a percentage and using K's correction factor the remaining correction factors
can be determined. The isoatomic solution was sprayed onto the plastic film-covered grid.
There are two main problems that may be encountered in preparing and analysing the fluids.
One is the formation of large crystals of solute in the droplets as they dry and the second is the
loss of elements during analysis. Ideally, the dried crystals should be small and have a
homogenous appearance (Warley, 1997)
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2.6.8.1 Materials
Isoatomic Solution. MgS04.7H20 (0.5 g), NaCl (0.12 g), KH2P04 (0.28 g) and
Ca(N03)z.4H20 (0.48 g) were dissolved in sterile ddH20 (250 ml).
2.6.8.2 Procedure
The isoatomic solution was sprayed onto the formvar coated gold grids using an atomizer.
The grids were allowed to dry in a clean atmosphere. Once dry, they were coated with a thin
layer of carbon. Spectra were collected from each whole droplet (Figure 2.5) and the number
of counts under each peak determined. The counts for each element were normalized against
K to give the relative detector efficiency with respect to K. The number of counts increases
with increasing atomic number. The correction factors for each element were calculated using
the known correction factor for K (Kk = 298). Cl was calculated by extrapolation from the
curve (Figure 2.6) as it is extremely labile in this preparation and the correction factor would





















Figure 2.5 A typical spectrum produced by irradiation of isoatomic droplets containing
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Figure 2.6 Relative efficiency of the EDAX detector system, with respect to the element
potassium, plotted against atomic number as determined by the analysis of isoatomic
droplets. The analyses were carried out at 80 kV, spot size 200 nm, specimen tilted to + 20°
and with a live time of 100 s. Each point is the mean of ten analyses and each bar represents
standard deviation of the mean.

























2.6.9 EPXMA analysis of monocytes
The handling of the specimen prior to analysis and the operation of the microscope during
analysis will affect the results obtained. The specimen can become contaminated with
elements from the environment during preparation and analysis, thus it is important to work in
a clean environment and handle specimens as little as possible. Sources of contamination from
the environment include dust; dirty glassware (various elements); sweat (Na, Cl); vacuum oils
(Si, Cl, S); desiccants (Si, P, Ca, Cl, Cu, S); talcum powders (AI, Ca, Mg, Si, Zn) and adhesive
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tape (Cl) (Warley, 1997). The optimal conditions of accelerating voltage, apertures, probe
current, probe size, duration of analysis and magnification are determined and adhered to
throughout analysis of the specimens.
2.6.9.1 Procedure
Monocytes on grids prepared in Section 2.6.5.2 were analysed in a Philips CM120
transmission electron microscope equipped with an EDAX detector fitted with a 10 !lm
beryllium window. Ten spectra per grid were obtained at 80kV, spot size 200 nm, specimen
tilted to + 20° and a live time of 100 s. The number of counts under each peak were
determined and using the correction factors for each element (Table 2.2) and the continuum for
each reading, the concentration in mmole/kg dry weight was calculated.
r------------,
Cx= Concentration ofx
Cx= kx.Px/W Px= Net peak intensity
W = Continuum (4.2 - 6.2)
kx= Calibration constant
The P:K ratios were also calculated as these are a useful indicator of fluxes in the cell. The
results were subjected to statistical analysis to determine any significant differences in the
concentrations of elements (Na, Mg, P, S, Cl, K and Ca) in the monocytes. Statistical
significance was determined using a Mann~Whitney U-test; a value ofp < 0.05 was considered
statistically significant.
2.7 HEAT SHOCK PROTEIN PEPTIDE SELECTION AND ANTIBODY
PRODUCTION
2.7.1 Selection of peptides
The antigenic properties of synthetic peptides are interesting as they are able to mimic the
antigenic sites of proteins (Van Regenmortel et al., 1988). By breaking a protein down into
smaller parts, knowledge about that specific protein can be gained using antibodies which the
corresponding synthetic peptides can elicit. The anti-peptide antibodies generally react with
the native protein from which the peptides were originally developed. Synthetic peptides are
usually sequential or continuous epitopes since they are a defined sequence of amino acid
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residues linked by peptide bonds (Van Regenmortel et al., 1988). Confonnational epitopes
consist of a group of amino acid residues that are brought together by the folding of the protein
and are not adjacent. A prerequisite for the development of peptides is knowledge of the DNA
sequence or the amino acid sequence. This infonnation enables prediction of the location of
sequential epitopes in the protein.
Predict7 is a programme, which incorporates four prediction factors: hydrophilicity, flexibility,
surface probability and antigenicity (Carmenes et al., 1989). Hydrophilicity is considered an
important factor since hydrophilic amino acid residues are generally on the exterior of the
folded protein where they can interact with water (Van Regenmortel et al., 1988). Hopp and
Woods (1981; 1983) showed that hydrophilic segments correspond to sequential epitopes.
Hydrophilic peptides are also more likely to be soluble for coupling reactions (Harlow and
Lane, 1988). Thus, for the purpose of prediction, only the highest peaks on the hydrophilicity
peaks were considered. Flexibility of the peptides is an important factor, as this allows
different confonnations to fonn and ultimately one will form that is the same as that in the
protein. Flexible peptides will also be easier to couple to a carrier protein without disrupting
the folding. Surface probability is related to hydrophilicity, as antibodies can only access the
external surface of the protein (Van Regenrnortel et al., 1988).
Another selection criterion is the sequence variability, i.e. where the protein of interest is not
similar in sequence to any known protein. It has been found in families with homologous
proteins with highly conserved sequences, such as heat shock protein 70 (HSP70) and heat
shock cognate protein 70 (HSC70), that regions of sequence variability correspond to the
location of antigenic epitopes (Van Regenrnortel et al., 1988). Peptides consisting of 10 - 15
amino acid residues are easy to synthesize, and purify and yield satisfactory anti-sera.
Peptide fragments can be conjugated to a carrier protein and immunized, and the antibodies
produced can be tested against the native protein. A positive result is indicative that the
peptide approximated to an epitope on the target protein (Van Regenmortel et al., 1988).
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2.7.1.1 Predict7
The amino acid sequences of human heat shock protein 70 (HSP) and heat shock cognate
protein 70 (HSC) were obtained from Swiss Prot (http://www.expasy.ch). The accession
number for human HSP is P08107 and human HSC is P11142. The sequences were entered
into the Predict7 programme. The programme was utilized to find regions where all the
prediction factors had high probabilities and 7 suitable regions were found for HSP and 10 for
HSC.
2.7.1.2 Similarity searches
All the suitable peptide regions were run through a similarity search programme, BLAST2.0,.
on the Swiss Prot website. The number of suitable peptide regions was narrowed down to one
for HSC and six for HSP. Sequences were also compared with those of chicken (Gal/us
gal/us) proteins to determine percentage similarity since these proteins are highly conserved
between species and this was the animal of choice for immunisation of the peptides. The
HSP70 and HSC70 sequences were aligned, to determine where areas of non-similarity were.
These were found in the C-terminal 110 amino acids and those peptides that were similar
between these two proteins were not considered. Stressgen makes monoclonal antibodies
against both the proteins of interest and in their catalogue they use a region between amino
acids 436 and 503 for HSP only and for antibodies that recognized both HSP and HSC they
use between amino acids 503 and 640. These regions were found to have high similarity
between human and mouse proteins. The selected peptides are indicated in Table 2.3. The HSP
peptide (1761.99 Da) and the HSC peptide (1689.96 Da) were synthesized by Sigma Genosys
(St. Louis, USA).
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Table 2.3 Peptide sequences selected to elicit anti-heat shock protein antibodies. Selected
peptide sequences, with the corresponding amino acid number in the parent protein and the
similarities between human and chicken heat shock and heat shock cognate proteins.
Peptide Sequence Protein AA No. Similarity between sequences
(Human) Human Chicken
HSP70 HSC70 HSP70 HSC70
KINDEDKQKIlPKC HSC 561-574 66% 100% ND 82%
CLAEKDEFEHKRKE HSP 586-598 100% 73% 73% ND
2.7.2 Conjugation of peptides to rabbit albumin with MBS
To produce antibodies against small peptides, it is important to intensify their immunogenicity
by coupling them to protein carriers (Van Regenmortel et al., 1988). The peptides chosen in
Section 2.7.1 have many lysine residues (K), thus glutaraldehyde cannot be used to conjugate
the peptide to the carrier protein. Neither can carbodiimide be used, as there are many
aspartic- (D) and glutamic acids (E). The HSC peptide has a cysteine on its C-terminus and
the HSP peptide has had a cys residue added to its N-terminus, enabling conjugation with m-
maleimidobenzoy1-N-hydroxysuccinimide ester (MBS). MBS is a heterobifunctional reagent
that crosslinks peptides to carrier proteins through cysteines and free amino groups (Harlow
and Lane, 1988). MBS reacts with the carrier protein first, by acylating the amino groups via
the active N-succinimide ester, followed by the formation of a thioester bond through addition
of a thiol group to the double bond of the maleimide (Van Regenmortel et al., 1988;
Hermanson, 1996). The peptide thiol groups are reduced by dithiothreito1 (DTT). Ellman's
reagent (5,5' -dithio-bis-(2-nitrobenzoic acid) is a compound used for the qualitative
determination of su1fhydryls in solution. The disulfide in Ellman's reagent undergoes
disulfide exchange with free sulfhydryls, such as those on the reduced peptides, to form a
mixed disu1fide and release one molecule of the chromogenic substance 5-sulfido-2-
nitrobenzoate, which has an intense yellow colour (Hermanson, 1996).
The carrier was chosen with the following criteria in mind: availability of reactive sites, size,
solubility, immunogenicity, commercial availability and cost. The conjugates of choice were
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bovine serum albumin (BSA), ovalbumin and rabbit albumin. BSA is used routinely in the
blocking steps for ELISAs and western blots and so would be unsuitable as the carrier, and
ovalbumin is also unsuitable as the animal of choice for immunization is the chicken. Thus the
carrier of choice was rabbit albumin. The MBS and rabbit albumin, and the peptides and DTT
were separated from each other, respectively, on a gel exclusion column, which separates
particles according to their size.
2.7.2.1 Materials
MEC buffer [lOO mM phosphate buffer, 0.02% Cm/v) NaN3, pH 71. NaH2P04.2H20 (13.8 g)
was dissolved in 900 ml dH20, the pH was adjusted to 7 with NaOH, NaN3 (0.1 g) was then·
added and the solution made up to 1 I with dH20.
Reducing buffer [100 mM Tris-HCI, 1 mM Na2EDTA, 0.02% Cm/v) NaN3, pH 8]. Tris base
(1.21 g) and Na2EDTA (0.037 g) were dissolved in 90 ml dH20, the pH was adjusted to 8 with
HCI and made up to 100 ml with dH20.
Ellman's reagent buffer [100 mM Tris-HCI, 10 mM Na2EDTA, 0.1% SDS, pH 8]. Tris base
(1.21 g), Na2EDTA (0.37 g) and SDS (0.1 g) were dissolved in 90 ml dH20, the pH was
adjusted to 8 with HCI and made up to 100 ml with dH20.
10 mM dithiothreitol CDTT). DTT (7.71 mg) was dissolved in reducing buffer (5 ml).
Ellman's reagent. Ellman's reagent [5,5' -dithiobis-(2-nitrobenzoic acid)] (10 mg) was
dissolved in Ellman's reagent buffer (2.5 ml).
Phosphate buffered saline CPBS), pH 7.2. See Section 2.2.1 for preparation
2.7.2.2 Procedure
Each peptide (4 mg) was dissolved in 100 III DMSO and made up to 1 ml with reducing
buffer. 10 mM DTT (1 ml) was added and allowed to incubate for 1.5 h at 37°C. The reduced
peptide was separated from the DTT on a Sephadex-G10 column. To test for the reduced
73
peptide 10 III eluant was added to 10 III Ellman's reagent. The yellow samples indicated tubes
containing the reduced peptide which were pooled. The amount of rabbit albumin carrier, was
calculated for each peptide with HSC requiring 4 mg and HSP requiring 3.9 mg, thus a total of
7.9 mg of rabbit albumin was used and dissolved in 1.25 ml PBS. m-Maleimidobenzoyl-N-
hydroxysuccinimide ester (MBS) (1.5 mg) was dissolved in 300 III DMF and 450 III PBS.
The carrier protein and the MBS were combined and incubated at RT for 30 min with stirring.
Unreacted MBS was separated from the carrier on a Sephadex G-25 column; the A280 of the
eluant indicated where the carrier eluted. The reduced peptides were combined with the
appropriate volume of the MBS-activated carrier (HSC - 2.04 ml; HSP - 1.96 ml) and
incubated for 3 h at RT. The peptide-carrier conjugates were separately aliquoted into 4 equal
volumes and stored in the freezer.
2.7.3 Immunization of chickens
Antibody production normally requires the use of laboratory animals (rabbits, mice, rats or
guinea pigs) or larger animals (horses, sheep or goats). The procedure involves two steps,
both of which causes distress or pain to the animals: the immunization itself and the bleeding,
which is a prerequisite for antibody production (Schade et al., 1999). The use of chickens for
antibody production, as opposed to mammals, represents a refmement in that there is no longer
the necessity to bleed the chickens, as the antibodies are packaged in the eggs. Chickens also
produce much larger amounts of antibodies [50 - 100 mg IgY per egg (5-7 eggs/week)] than
laboratory rodents (200 mg IgG per 40 ml bleed), so the number of animals used can also be
reduced. Another advantage of using chickens to make antibodies against mammalian proteins
or peptides is that birds are evolutionary distant from mammals, thus a good response will be
elicited.
Classical immunization procedures can be used for synthetic peptides since there is usually no
problem in raising antibodies as they are good immunogens. The adjuvant most commonly
used to enhance the humoral response is Freund's complete adjuvant (PCA), which contains
heat-killed Mycobacterium tuberculosis cells and mineral oil. Further inoculations use
Freund's incomplete adjuvant (FIA), which consists only of mineral oil. It is essential to
immunize more than one animal, as it has been commonly observed that animals receiving the
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same immunogen and immunization regimen produce antisera with completely different
characteristics (Van Regenmortel et al., 1988).
2.7.3.1 Materials
Phosphate buffered saline (PBS), pH 7.2. See Section 2.2.1 for preparation
Freund's complete adjuvant. Purchased from Sigma (St. Louis, USA).
Freund's incomplete adjuvant. Purchased from Sigma (St. Louis, USA).
2.7.3.2 Procedure
An equal amount of Freund's complete adjuvant was added to the peptide-rabbit albumin
conjugate and triturated. Trituration was considered complete when a small drop of the
mixture, placed in dH20, remained a tight 'ball'. Using half the syringe volume per chicken,
i.e. 1 ml and 1.2 ml for the chickens immunized with the HSP conjugate and the HSC
conjugate, respectively, the chickens were immunized in both sides of the breast muscle.
Boosters were administered on weeks 2, 4 and 6 used Freund's incomplete adjuvant. Prior to
immunization, non-immune eggs were collected and after immunization all eggs until week 16
were collected for the isolation of IgY.
2.7.4 Chicken antibody (IgY) isolation
Several methods can be utilized for the extraction of IgY from egg yolk, but the method of
choice involves the precipitation of the protein using polyethylene glycol (PEG) (PoIson et al.,
1985). PEG is a non-ionic polymer available in a number of molecular weights from 400 to 20
000 (Boyer, 1993). PEG 6 000 was originally used by PoIson et al. (1964). It is a mild
precipitating agent that fractionally precipitates proteins by exclusion from water. The method
involves successive precipitations at 3.5% PEG, to remove the vitellins and lipids, and 12%
PEG to precipitate the IgY (PoIson et al., 1980). An advantage of using PEG is that, because it
does not alter the ionic strength, there is no need to dialyse the antibodies. One of the greatest
advantages of PEG over other precipitation techniques is its ability to fractionate proteins
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according to size (Boyer, 1993). The procedure is also very mild and results in very little
denaturation of the antibodies (page and Thorpe, 1998).
2.7.4.1 Materials
100 mM Na-phosphate buffer, 0.02% Cm/v) NaN3, pH 7.6. NaH2P04.H20 (13.8 g) was
dissolved in 950 ml dH20, the pH was adjusted to 7.6 with NaOH, NaN3 (0.2 g) was added
and the solution was made up to 11 with dH20.
2.7.4.2 Procedure
Egg yolks were separated from egg whites and carefully washed under running water. The
yolk sac was broken and the volume of the yolk determined in a measuring cylinder. Two
volumes of 100 mM Na-phosphate buffer (pH 7.6) were added and mixed in. Polyethylene
glycol (pEG) was added to 3.5% (m/v) and dissolved gently. The vitellin precipitate was
removed by centrifugation (4 420 g, 30 min, RT), and the supematant filtered through
absorbent cotton wool to remove the lipid fraction. The PEG concentration was increased by
8.5% to 12%, and mixed in thoroughly and the solution was centrifuged (12 000 g, 10 min,
RT). The pellet was dissolved in a volume of 100 mM Na-phosphate buffer (pH 7.6) equal to
that of the yolk volume. The PEG concentration was increased to 12%, mixed and centrifuged
(12 000 g, 10 min, RT). The final IgY pellet was dissolved in 1/6 the original yolk volume of
100 mM Na-phosphate buffer (pH 7.6). The concentration of IgY was determined by
measuring the A280 of a 1/50 dilution and using the extinction coefficient for IgY (E 280 Imglml =
1.25) and the following formula:
[IgY] = [(A28o / 1.25) x 50] mg/ml
The efficiency of the IgY isolation was determined by SDS-PAGE (Section 2.7.7).
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2.7.5 Enzyme-linked immunosorbent assay (ELISA) to determine anti-peptide antibody
titre
ELISAs are the most widely used immunoassays and are usually carried out in 96 well
microtitre plates (Thorpe and Kerr, 1994). These assays are simple, robust, versatile, accurate
and sensitive. They combine the specificity of antibodies with the sensitivity of a simple
spectrophotometric enzyme assay by using antibodies coupled to enzymes that are easily
assayed (Burrin, 1994). This technique may be used to measure the ability ofpeptides to elicit
an immune response (Van Regenmortel et al., 1988). As the outcome of immunizations is
often unpredictable, it is important to frequently monitor the titre of antibodies to establish
when it peaks. This is, however, more important when the animal that has been immunized
has to be bled, but in the case of chicken IgY it is done solely to determine when the antibody
titre peaks.
The antigens or, as in this case, the peptides were adsorbed directly onto the plastic wells of
the microtitre plate. The coating concentration of the peptide are very important. At a higher
concentration the binding is more rapid but when too much has bound it can lead to weak
binding (Thorpe and Kerr, 1994). Commonly concentrations used are 1- 5J.lg/ml. Peptides of
15 residues or more adsorb to the plastic of a microtitre plate, although smaller peptides have
been shown to bind (Van Regenmortel et aI., 1988). The temperature should also remain
constant to avoid edge effects. The majority of antigens bound to the plate retain their
immunological and biological activity. The antigens are effectively aggregated and thus lower
affinity interactions may be favoured more than in solution. Due to this lower affinity,
antibodies may be detected (Thorpe and Kerr, 1994).
The plates are blocked with fat free milk to eliminate 'non-specific' binding of proteins later in
the assay. This step is very important, as antibodies used in the detection steps are particularly
prone to 'non-specific' binding. If the plates are washed before the blocking step there should
be no detergent in the wash buffer (Thorpe and Kerr, 1994), whereas after the blocking step
detergent should be present. Washing the plates is important to remove free peptides. The
detergent (Tween 20) blocks hydrophobic interactions and acts as a wetting agent. After
washing, the bound antigen is detected with the addition of a specific enzyme linked antibody,
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such as horseradish peroxidase (HRPO)-linked rabbit anti-chicken IgY. Upon addition of a
substrate, the enzyme produces a coloured product that can be quantified
spectrophotometrically. When using HRPO, the buffers, with the exception of the stopping
buffer, should not contain azide as this inhibits the enzyme.
A positive control should always be used to ensure that all the reagents are working. Negative
controls such as a non-immune primary antibody are also important to check for non-specific
binding (Kemenyand Chant1er, 1988; Thorpe and Kerr, 1994).
2.7.5.1 Materials
Phosphate buffered saline (PBS), pH 7.2. See Section 2.2.1 for preparation
Bovine serum albumin - PBS (BSA-PBS) [0.5% (m/v)]. BSA (0.5 g) was dissolved in 100 m1
PBS.
PBS-Tween [0.1 % (v/v)]. Tween 20 Cl m1) was made up to a litre in PBS.
0.15 M citrate-phosphate buffer, pH 5.0. A solution of citric acid.H20 (21.0 g/1) was titrated
with a solution of Na2HP04.2H20 (35.6 g/1) to pH 5.0.
Substrate solution [0.05% (m/v) ABTS and 0.0015% (v/v) H2lli in citrate phosphate buffer].
2,2' -azino-di-(3-ethy1)-benzthiozo1ine su1fonic acid (ABTS; 7.5 mg) and H20 2 (7.5 ~1) were
dissolved in citrate-phosphate buffer, pH 5.0 (15 m1) per ELISA plate.
Stopping buffer [citrate-phosphate-0.1 % (m/v) NaN31 NaN3 (0.1 g) was made up to 100 m1 in
citrate-phosphate buffer.
2.7.5.2 Procedure
Peptides or rabbit albumin were coated at a concentration of 1 ~g/m1 in PBS (150 Jl1, 16 h,
4°C). The wells were blocked with 0.5% BSA-PBS (200 Jl1, 1 h, 37°C) to prevent non-
specific binding of proteins. The plates were washed three times with 0.1 % PBS-Tween.
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Serial two-fold dilutions starting from 100 J.lg/ml anti-peptide antibody were prepared on the
plate in 0.5% BSA-PBS and incubated (100 J.lI, 2 h, 37°C). The plates were washed three
times with 0.1% PBS-Tween. Horseradish peroxidase linked rabbit anti-chicken IgY
secondary antibody, at a dilution of 1:30 000 in 0.5% BSA-PBS was added to the wells and
incubated (120 J.lI, 1 h, 37°C). The plates were washed with 0.1% PBS-Tween three times.
Substrate solution (150 J.lI) was added to each well and the green colour was developed in the
dark against the background of the controls for approximately 15 min. Adding the stopping
buffer (50 J.lI) stopped the reaction and the ~05 of each well was measured on a Titretek
ELISA plate reader.
2.7.6 Affinity purification of anti-peptide antibodies
Affinity chromatography is a powerful procedure that is commonly used to purify antibodies
present in sera or polyclonal antibody preparations (Page and Thorpe, 1998). Pure antigen,
which in this case are the peptides HSP and HSC, are linked covalently to a solid support
matrix. The polyclonal antibodies pass through the matrix and the anti-peptide antibodies bind
to the peptides. The unbound antibodies are removed with washing and the specific antibodies
are eluted using a low pH buffer, which in some cases may lead to the loss of the antibodies
activity. High affinity antibodies may also remain bound to the column even under those
conditions and this may ultimately lead to the column losing its antigen binding capacity
(Harlow and Lane, 1988). The advantage of this technique is that specific antibodies can be
isolated from a polyclonal antibody mixture. The large amount of antigen required and the
harsh eluting conditions are the major disadvantages (Harlow and Lane, 1988).
The peptides HSC and HSP were activated using DTT and then coupled to a sulfolink®
affinity column. Free cysteine was used to block the unbound sites on the column, which
would otherwise interfere with the purification of the antibodies.
The anti-peptide antibodies in a polyclonal antibody solution were cycled through the peptide
affinity matrix. The peptide specific antibodies bind to the matrix and the remaining antibodies
pass straight through the column or are washed out during the washing step. The specific anti-
peptide antibodies are eluted with a low pH buffer, which interferes with the bonds between
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the peptide and antibody and hence elute the specific antibody. The only disadvantage with
this technique is some of the highly specific antibodies may remain bound to the column
(Harlow and Lane, 1988).
2.7.6.1 Materials
Tris buffer [50 mM Tris-HCI, 5 mM Na2EDTA, pH 8.5]. Tris base (0.6 g) and Na2EDTA
(0.185 g) was dissolved in dH20 (90 ml), the pH was adjusted to 8.5 with HCI and made up to
100 ml with dH20.
10 mM Dithiothreitol (DTT). See Section 2.7.2 for preparation
Sulfolink® affinity column. Purchased from Pierce (Rockford, USA)
50 mM Cysteine, 50 mM Tris-HeI, 5 mM Na2EDTA, pH 8.5. Cysteine (8.78 mg) was
dissolved in Tris buffer (1 ml).
1 M NaCl, 0.05% Cw/v) NaN3, pH 7.6. NaCI (5.84 g) was dissolved in 90 ml dH20, the pH
was adjusted to 7.6 with HCI, NaN3 (0.05 g) was added and the solution was made up to 100
ml with dH20.
100 mM Na-phosphate buffer, 0.02% Cm/v) NaN3, pH 7.6. See Section 2.7.4.1 for preparation
100 mM Na-phosphate buffer, 0.02% Cm/v) NaN3, pH 6.5. NaH2P04.H20 (13.8 g) was
dissolved in 950 ml dH20, the pH was adjusted to 7.6 with NaOH, NaN3 (0.2 g) was added
and the solution was made up to 1 1with dH20.
0.1 M Glycine-HeI, 0.02% Cm/v) NaN3, pH 2.8. Glycine (7.5 g) was dissolved in 950 ml
dH20, the pH was adjusted to 2.8 with HCI, NaN3 (0.2 g) was added and the solution was
made up to 1 1with dH20.
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1 M Na-phosphate buffer. 0.02% Cm/v) NaN3, pH 8.5. NaH2P04.H10 (13.8 g) was dissolved in
90 ml dH20, the pH was adjusted to 8.5 with NaOH, NaN3 (0.02 g) was added and the solution
was made up to 100 ml with dH20.
2.7.6.2 Procedure
The peptide (10 mg) was dissolved in DMSO (100 Ill) and Tris buffer, pH 8.5 (400 Ill), to this
was a~ded 10 mM DTT (500 Ill). The peptide-DTT mixture was incubated for 1.5 h at 37°C.
The DTT and the peptide were separated on a Sephadex G-10 column. To test for the reduced
peptide 10 J-ll eluant was added to 10 J-ll Ellman's reagent and the yellow samples indicated the
tubes containing the peptide: these were pooled. Sulfolink® (4 ml of 50% slurry) was washed.
with six column volumes ofTris buffer (pH 8.5) and the reduced peptide was added to the gel.
The gel was mixed for 15 min at RT and incubated for 30 min at RT without mixing. The
buffer was drained and the column washed with three column volumes of Tris buffer (pH 8.5).
50 mM cysteine (2 ml) was added to the gel, mixed for 15 min at RT and incubated for 30 min
with out mixing. The column was drained and washed with 16 column volumes of 1 M NaCl,
0.5% NaN3 (pH 7.6) followed by 2 column volumes of 100 mM Na-phosphate buffer (pH 7.6).
The column was packed and washed with 100 mM Na-phosphate buffer (pH 6.5). The
antibody solution (max 70 ml) was circulated through the column overnight. The column was
washed with several column volumes of the 100 mM Na-phosphate buffer (pH 6.5). The
bound antibodies were eluted with 0.1 M glycine-HCl (pH 2.8). Fractions of 900 J-ll were
collected and neutralized with 100 J-ll of the 1 M Na-phosphate buffer (pH 8.5). The A2so of all
fractions was read and those with absorbance values above 0.2 were retained. The column was
washed with 100 mM Na-phosphate buffer (pH 6.5) for several hours. The affinity-purified
antibodies were tested using an ELISA (Section 2.7.5) and compared to those prior to
purification.
2.7.7 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
Electrophoresis is defined as the separation of charged particles through a molecular sieving
gel towards an electrode of opposite charge, under the influence of an externally applied
electric field. Laemmli (1970) developed sodium dodecyl sulfate gel electrophoresis or SDS-
PAGE, since native PAGE could not distinguish between the effects of size, shape and charge
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on electrophoretic mobility. The gel is formed by the free radical polymerisation of
acrylamide and the cross linking agent N,N'-methylene-bis-acrylamide. The polymerisation is
controlled by an initiator - catalyst system of ammonium persulfate and N,N,N' ,N'-
tetramethylethylenediamine (TEMED) (Boyer, 1993). The molecular weights of proteins can
be determined if an anionic detergent, sodium dodecyl sulfate (SDS) and 2-mercaptoethanol, a
disulfide reducing agent is present. SDS disrupts the proteins secondary, tertiary and
quaternary structure to produce a negatively charged linear polypeptide and the 2-
mercaptoethanol reduces any disulfide bridges in a protein (Boyer, 1993). Thus proteins can
be separated according to size, as they are all linear and negatively charged. The smaller
proteins move through the SDS-PAGE gel faster than the larger proteins.
For the protein bands to be well resolved, the starting band of the sample needs to be as narrow
as possible. The protein band diffusion must also be minimized. These two criteria are
fulfilled in a discontinuous system. This system has two gel layers, a stacking gel and a
resolving or running gel where the buffers used to prepare the two gels are of different pH.
The stacking gel has a lower acrylamide concentration and hence larger pores. The sample
and stacking gel buffers contain Tris-HCl at a pH of 6.8, whereas the Tris-HCl running gel
buffer and the Tris-glycine electrode buffer are at pH 8.8 and 8.3 respectively. The glycine
ions at pH 6.8 are poorly dissociated with a small negative charge and poor mobility. The
proteins are thus stacked tightly between the highly mobile chloride ions and the glycine ions.
At the resolving gel interface, the increase in pH causes the glycine ions to dissociate further
and hence increase their mobility. The glycine ions pass the proteins and leave them to
unstack at a constant pH in a uniform voltage gradient. The resolving gel thus separates the
proteins according to their size by means ofmolecular sieving.
The most popular general staining procedures are based on the use of non-polar, sulfated
triphenylmethane Coomassie stains developed for the textile industry. Coomassie brilliant
blue is most frequently used and requires an acidic environment for electrostatic reactions
between the dye molecules and the amino groups ofthe proteins (Dunn, 1987).
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SDS-PAGE was used in the present study to determine the purity ofIgY isolated from chicken
eggs (Section 2.7.4), as well as to separate the proteins in monocyte or lymphocyte heat shock
lysates (Section 2.7.9) for western blotting (Section 2.7.8).
2.7.7.1 Materials
Monomer solution [(30% m1v) acrylamide, 2.7% Cm/v) Bis-acrylamide]. Acrylamide (73 g)
and bis-acrylamide (2 g) were dissolved and made up to 250 ml with ddH20. The solution
was filtered through Whatman No.l filter paper and stored in an amber coloured bottle at 4°C.
Running gel buffer [1.5 M Tris-HCl, pH 8.8]. Tris (45.37 g) was dissolved in approximately
200 ml, the pH was adjusted to 8.8 with HCL and made up to 250 ml. The solution was
filtered through Whatman No.1 filter paper.
Stacking gel buffer [500 mM Tris-HCl, pH 6.8]. Tris (3 g) was dissolved in dH20 (40 ml), the
pH was adjusted to 6.8 with HCl and made up to 100 ml. The solution was filtered through
Whatman No.l filter paper.
10% SDS (m/v). Sodium dodecyl sulfate (SDS, 10 g) was made up to 100 ml with dH20.
Initiator [10% (m/v) ammonium persulfate]. Ammonium persulfate (0.2 g) was made up to 2
ml with dH20.
Tank buffer [250 mM Tris-HCl, 192 mM glycine, 0.1% (m/v) SDS, pH 8.3]. Tris (15 g) and
glycine (72 g) were dissolved and made up to 5 1with dH20. Prior to use 2.5 ml of 10% SDS
was added to 250 ml.
Reducing treatment buffer [125 mM Tris-HCl, 4% (m/v) SDS, 20% (v/v) glycerol, 10% (v/v)
2-mercaptoethanol, pH 6.81. Stacking gel buffer (2.5 ml), 10% SDS (4 ml), glycerol (2 ml)
and 2-mercaptoethanol (1 ml) were made up to 10 ml with dH20.
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Non-reducing treatment buffer [125 mM Tris-HCL 4% Crn/v) SDS, 20% Cv/v) glyceroL pH
6.8]. Stacking gel buffer (2.5 ml), 10% SDS (4 ml), glycerol (2 ml) were made up to 10 ml
with dH20.
Molecular mass markers. Standards for molecular mass determination were: phosphorylase b
(94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa),
soybean trypsin inhibitor (20.1 kDa) and a-lactalbumin (14.4 kDa). Lyophilised markers
(Arnersham Pharmacia Biotech, USA) were reconstituted in either the non-reducing buffer or
the reducing buffer (100 Ill) and heated at lOoec for 5 min for Coomassie staining or
immunoblotting. For silver staining, the reconstituted markers were diluted 1:50 in the
appropriate treatment buffer.
Coomassie stain stock solution [1 % Crn/v) Coomassie blue R-250]. Coomassie blue R-250
(1 g) was dissolved in dH20 (100 ml) by stirring for 1 h at RT. The solution was filtered
through Whatman No. 1 filter paper.
Coomassie staining solution [0.125% Crn/v) Coomassie blue R-250, 50% Cv/v) acetic acid].
Coomassie stain stock solution (62.5 ml) was mixed with methanol (250 ml) and acetic acid
(50 ml), and made up to 500 ml with dH20.
Destaining solution I [50% Cv/v) methanoL 10% Cv/v) acetic acid]. Methanol (500 ml) was
mixed with acetic acid (100 ml) and made up to 1 1with dH20.
Destaining solution rr [7% Cv/v) acetic acid, 5% Cv/v) methanol]. Acetic acid (70 ml) was
mixed with methanol (50 ml) and made up to 1 1with dH20
2.7.7.2 Procedure
The Bio-Rad mini-PROTEAN rr® electrophoresis cell was used for SDS-PAGE and was
assembled as described in the manufacturer's manual. This involved cleaning the glass plates,
spacers, combs and casters with soap and ethanol (95%). After cleaning, the equipment was
rinsed in ddH20. The inner glass plates (7.3x10.2 cm) and the outer glass plates (8.3xlO.2 cm)
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were positioned in the caster, separated by 1.5 mm polyethylene spacers. The running gel
solution (Table 2.4) was run into the space between the glass plates to approximately 3 cm
below the top edge of the outer glass plate. Distilled water was overlaid on top of the running
gel to exclude oxygen that inhibits polymerisation. The running gel was allowed to polymerise
at RT. Once the gel had polymerised (this was indicated by an interface between the water and
gel appearing), the water was removed and the stacking gel (Table 2.4) overlaid till the top of
the outer glass plate. A 10 or 15 well comb was inserted to form the sample loading wells, the
stacking gel was allowed to polymerise at RT and, once polymerised, the wells were rinsed out
with dH20. Tank buffer, containing SDS, was poured into the upper and lower electrode
compartments. Samples for reducing gels were combined with an equal volume of reducing
treatment buffer and incubated in a boiling water bath for 90 s before they were placed on ice.
For non-reducing gels the samples were combined with half their volume of non-reducing
treatment buffer before loading. Bromophenol blue (5 Ill), a marker dye that migrates at the
buffer front, was added to each sample prior to loading. Suitable amounts ofprotein (at least 1
Ilg of protein per band for Coomassie staining) were loaded into each well. The gel unit was
connected to a power pack and run at 18 mA per gel until the dye front was 0.5 cm from the
bottom of the gel.
The gels were removed and placed in the appropriate stain for visualisation, either silver or
Coomassie, or the gel was prepared for immunoblotting. When the Coomassie stain was used,
the gel was placed in the Coomassie stain solution for 4 h. The stain was removed and the gel
was rinsed in dH20 before the addition of destain I, overnight. The gel was placed in destain
II to complete destaining.





















Proteins of interest were separated by Laemmli (1970) SDS-PAGE (Section 2.4.7.2), electro-
blotted and immobilized on nitrocellulose. Nitrocellulose is a matrix with high binding
affinity for proteins and can bind as much as 80 - 100 ~g/cm2. The immobilized proteins were
detected by immunological procedures. Thus the native heat shock proteins found in
monocytes or lymphocytes can be immobilized on nitrocellulose and detected with the anti-
peptide antibodies.
The procedure used was that described by Towbin et al. (1979). Methanol was used in the
transfer buffer to enhance the hydrophobic binding of the protein-SDS complexes to the.
nitrocellulose. The nitrocellulose was blocked with non-fat milk to prevent further 'non-
specific' binding of detection reagents. The antibody was allowed to react with the
immobilized antigen or protein of interest; this reaction is detected by an enzyme-linked
secondary antibody (e.g. goat anti-chicken IgY-horse radish peroxidase conjugate), which
catalyses a reaction with a precipitating substrate (4-chloro-1-napthol) to yield a coloured band
on the nitrocellulose membrane.
In the present study, western blotting was used to determine if the anti-peptide antibodies
produced in chickens recognize the native HSC or HSP proteins in human or canine
lymphocytes.
2.7.8.1 Materials
Blotting buffer. Tris (27.23 g) and glycine (64.8 g) were dissolved in 3.5 I of dH20, and 900
ml of methanol was added. The volume was made up to 4.5 I with dH20. Prior to use, 10%
(m/v) SDS (4.5 ml, Section 2.7.7.1) was added.
Ponceau S stain. Ponceau S [0.1 % (m/v)] was prepared in glacial acetic acid [1 % (v/v)].
Tris buffered saline rTBS: 20 mM Tris, 200 mM NaCl, pH 7.4]. Tris (2.42 g) and NaCl
(11.69 g) were dissolved in 950 ml dH20, the pH adjusted to 7.4 with HCI and made up to 1 1.
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Bovine serum albumin - TBS CBSA-TBS) [3% Cm/v)]. BSA (3 g) was dissolved in 100 ml
TBS.
Bovine serum albumin - TBS CBSA-TBS) [0.5% Cm/v)]. BSA (0.5 g) was dissolved in 100 ml
TBS.
.4-Chloro-1-napthol HRPO substrate stock solution. 4-Chloro-1-napthol (0.03 g) was dissolved
in methanol (10 ml).
4-Chloro-1-napthol HRPO substrate working solution. 4-Chloro-1-napthol HRPO substrate
stock solution (2 ml) and H20 2 (4 J.ll) were made up to 10 ml with TBS.
2.7.8.2 Procedure
After SDS-PAGE, one gel was stained to show position of the protein bands while the other
was used for blotting. Nitrocellulose was cut to a similar size to the gel and was carefully
floated onto blotting buffer before being totally immersed. The nitrocellulose was sandwiched
with the gel lying squarely on top of it, between three pieces of Whatman No. 4 filter paper
and two pieces of scotchbrite foam. The entire sandwich was immersed in the blotting buffer
and placed in the blotting apparatus with the nitrocellulose on the anodal side of the gel. The
apparatus was filled with blotting buffer and the cooling system was set up before the power
pack was connected. Blotting was carried out at 200 mA for 16 h. When blotting was
complete, the gel and the nitrocellulose were removed from the sandwich. The nitrocellulose
was stained with Ponceau S to detennine if the transfer was successful, where the molecular
weight markers were positioned and also so that the nitrocellulose may be cut into smaller
pIeces. The nitrocellulose was destained with the addition of NaOH. The blotted
nitrocellulose was air dried for 1.5 h and blocked with 3% BSA-TBS (1 h, RT). It was washed
with TBS (3x5 min, RT) and incubated with the primary antibody in 0.5% BSA-TBS for 2 h at
RT. Following washing in TBS (2x5 min, RT), the blot was incubated with the horseradish
peroxidase linked rabbit anti-chicken IgY secondary antibody, at a dilution of 1:50 000 in
0.5% BSA-PBS for 1 h at RT. Again the blot was washed in TBS (3x5 min, RT) and
immersed in the 4-chloro-1-napthol HRPO substrate working solution and reacted in the dark
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at RT until bands were clearly visible. The strip was washed with dH20 and dried between
filter paper.
2.7.9 Detection of heat shock proteins in lymphocyte celllysates using western blotting
Lymphocytes contain heat shock proteins, both the constitutive heat shock protein 70 (HSC70)
and the inducible heat shock protein 70 (HSP70). These proteins were released from inside
the cell by using an anionic detergent, sodium dodecyl sulfate (SDS), and 2-mercaptoethanol.
An inhibitor cocktail was also incorporated to inhibit any proteolytic enzymes released under
the lysis conditions. The lysate proteins were separated by SDS-PAGE before being electro-
blotted onto nitrocellulose. The specificity of the anti-peptide antibodies was determined by
probing the blot for the heat shock proteins.
Two temperatures were used for the purposes of this study, 37°C and 44°C. In the case of
37°C, this is the normal body temperature and hence is a normal control but constitutive
HSC70 will be expressed in the lymphocytes. At 44°C, HSP70 expression will be induced.
Thus using the anti-peptide antibodies for the respective protein, there should be differences in
the expression of the two proteins at different temperatures.
Lymphocytes also contain proteolytic enzymes such as elastase, cathepsins, collagenase and
myelinase, to name but a few (Auger and Ross, 1992). Cathepsin D has been found to
hydrolyse E. coli DnaK or HSP70 into many smaller peptides, with there being no ATPase N-
terminal domain fragments larger than 20 kDa (Sehom et al., 2002). A number of fragments
greater than 20 kDa were sequenced and were from the C-terminal domain of HSP70, i.e. the
region of interest in this study. Thus in order to detect the protein at 70 kDa protease inhibitors
and specifically cathepsin D inhibitors must be used. However, if no inhibitors are used and
the anti-peptide antibodies detect bands above 20 kDa, the antibodies can be considered
specific for the C-terminal domain ofHSP70.
An inhibitor cocktail was used to ensure a range of different families of proteases were
inhibited. Phenylmethylsulfonyl fluoride (PMSF) is a general, irreversible inhibitor of serine
proteases (Salvesen and Nagase, 1989). A specific irreversible inhibitor of serine proteases is
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AEBSF (4-(2-Aminoethyl)benzenesulfonylfluoride). This compound inhibits chymotrypsin,
kallikrein, plasmin, thrombin, trypsin and related thrombolytic enzymes. It is also a more
stable, non-toxic alternative to PMSF. Benzamidine is a reversible inhibitor of trypsin and
trypsin-like enzymes. E64 (N-(L-3-trans-carboxyoxiran-2-carbonyl)-L-leucyl]-amido(4-
guanidino)butane) is an irreversible cysteine protease inhibitor that has no effect on cysteine
residues of other proteins. It is specific for the active site where the trans epoxide group is
thought to alkylate the active site cysteine. Iodoacetate is a cysteine protease inhibitor that
alkylates the sulfydryl groups of the enzyme (Salvesen and Nagase, 1989).
Metalloproteinases are classified as such because of the presence of a metal ion (usually zinc),
which participates in catalysis (Salvesen and Nagase, 1989). Disodium EDTA is a reversible
metalloprotease inhibitor that chelates with the Zn. 1,10-Phenanthroline is preferred as an
inhibitor of metalloproteinases as it has a much higher stability constant for Zn (Salvesen and
Nagase, 1989). Pepstatin A is an inhibitor of aspartic proteases and reversibly inhibits
cathepsin D, cathepsin E, pepsin and renin. (Salvesen and Nagase, 1989).
If cathepsin D cleaves human and canine HSP70 and pepstatin A is present, there should be no
small protein bands recognized at 30 kDa. However, the other protease inhibitors used are
precautionary in case any other enzymes are capable of degrading HSP70.
2.7.9.1 Materials
Phosphate buffered saline CPBS), pH 7.2. See Section 2.2.1 for preparation
Complete RPMI 1640 medium {25 mM HEPES; 5% FCS}. See Section 2.2.1 for preparation
10% Cm/v) SDS. See Section 2.7.7.1 for preparation
Reducing treatment buffer. See Section 2.7.9.1 for preparation
0.2 M Phenylmethylsulfonyl fluoride (PMSF). PMSF (29 mg) was dissolved in dry propanol
(1 ml).
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0.1 M NarEDTA. Na2-EDTA (37 mg) was dissolved in ddH20 (1 ml).
0.1 M Benzamidine. Benzamidine (16 mg) was dissolved in ddH20 (1 ml).
Pepstatin stock solution (l mg/ml). Pepstatin (1 mg) was dissolved in methanol (1 ml).
1 M l,lO-phenanthroline. 1,10-Phenanthroline (0.198 g) was dissolved in ethanol (1 ml).
50 mM E-64. N-[(L-3-trans-carboxyoxiran-2-carbonyl)-L-leucyl]-amido(4-guanidino)butane
(E64; 1.8 mg) was dissolved in ddH20 (1 00 ~l).
1 M Iodoacetic acid. Iodoacetic acid (0.208 g) dissolved in ddH20 (1 ml).
Pefabloc [AESBF; 4-(2-aminoethyl)benzenesulfonylfluoride stock solution (1 mg/ml)].
Pefabloc (1 mg) was dissolved in dry propanol (1 ml).
Inhibitor cocktail. 0.2 M PMSF (5 ~l), 0.1 M Naz-EDTA (50 ~l), 0.1 M benzamidine (10 ~l),
pepstatin stock solution (10 ~l), 1 M 1,10-phenanthroline (2 ~l), 50 mM E-64 (8 ~l), 1 M
iodoacetic acid (1 0 ~l) and pefabloc stock solution (1 0 ~l) were mixed together and made up
to 1 ml with ddH20.
2.7.9.2 Procedure
The blood was prepared as in Section 2.2 but the finallymphocyte pellet was resuspended in 2
ml warm complete RPMI medium, and divided into two 1 ml samples in Eppendorf tubes.
The first tube was incubated at 37°C and the other at 44°C, both for 2 h. The tubes were
placed on ice for 5 min and the cells were pelleted by centrifugation (400 g, 5 min, RT). The
pellet was resuspended in PBS and centrifuged (400 g, 5 min, RT). This was repeated twice to
remove proteins that may be present in the medium. The final cell pellet was resuspended in
10% SDS (50 ~l) and thereafter reducing treatment buffer (250 ~l). For inhibition of
proteases, the inhibitor cocktail (15 ~l) was added but this was not the case for all samples as a
comparison between uninhibited and inhibited was required. The samples were boiled for 5
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min to reduce the viscosity. Immediately after boiling the samples were put on ice to cool, and
once cool, a further 15 III of the inhibitor cocktail was added. These samples were loaded
directly on to an SDS-PAGE gel (Section 2.7.7) and western blotted (Section 2.7.8), to
determine if the anti-peptide antibodies recognized human lymphocyte expressed heat shock
protein 70 (HSP) or heat shock cognate protein 70 (HSC) and determine the level of reactivity
between the anti-peptide antibodies and canine lymphocyte expressed HSP and HSC.
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CHAPTER 3
ISOLATION AND CHARACTERIZATION OF MONOCYTES
3.1 INTRODUCTION
In this chapter the isolation of monocytes and their characterization using different staining,
histochemical, morphological and functional assays will be detailed. Isolated cells were
stained with methyl green or giemsa stain. Based on the nature of staining, the type of cell
could be identified. The presence of enzymes localized within vesicles in the cytoplasm of
monocytes, such as alkaline phosphatase and peroxidase, were detected with histochemical
techniques. Transmission electron microscopic analysis of monocytes enabled the
determination of the presence of monocytes morphologically. The functional assays involved
the determination of phagocytic activity using latex beads or ~-hematin. . ~-hematin was
synthesized from hematin and the ultrastructural differences between the two compounds were
examined using scanning electron microscopy and X-ray microanalysis.
3.2 ISOLATION AND STAINING OF MONOCYTES
Monocytes were isolated using the Histopaque@-1077 method. The monocyte layer (Figure
2.1) obtained after the initial centrifugation was more clearly defined in human blood
separations than canine blood. The difference in separation maybe due to interspecies
differences ·in monocyte densities. Austin et al. (1985) suggest that some techniques, which
yield good monocyte preparations from human blood, do not work well with dog blood. The
average viability of the cells as determined by the trypan blue exclusion assay was 96% for
both canine and human cells. Thus 96% of all cells counted retained their membrane integrity
through the isolation procedure. Monocytes are characterized by their ability to adhere to
glass and plastics. To confllTIl the identity of adherent cells, the coverslips were stained with
methyl green or giemsa. The methyl green serves as a stain to confirm the presence of cells as
it stains the entire cell, that is the nucleus and cytoplasm, as indicated in Figure 3.1A. Giemsa
is more specific in that it stains the nucleus more darkly than the cytoplasm. The adherent
isolated cells have the distinctive horseshoe shaped nucleus of monocytes (Figure 3.1B). The




Figure 3.1 Staining of canine monocytes with giemsa and methyl green. Monocytes
were fixed with methanol and stained with (A) methyl green for 5 min or (B) giemsa for 15
min. After staining the coverslips were mounted and viewed at 1000x magnification.
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3.3 DETECTION OF ALKALINE PHOSPHATASE ACTIVITY IN MONOCYTES
Alkaline phosphatase was found to be active in the isolated canine monocytes (Figure 3.2),
indicated by dark purple staining in numerous cytoplasmic granules (Figure 3.2A). There is
diffuse enzyme activity in the cytoplasm as indicated by light purple staining. This is clearly
visible in Figure 3.2B. The light general staining of the cytoplasm with methyl green is almost
completely overlaid with the light purple product (Figure 3.2B). Human monocytes showed
similar staining patterns to the canine monocytes (data not shown).
A B
Figure 3.2 Alkaline phosphatase activity in canine monocytes. Peripheral blood
monocytes were incubated with alkaline phosphatase substrate (BCIPINBT) for 30 min before
being washed and fixed with methanol. (A) No counter stain or (B) counterstained with
methyl green for 5 min. After staining the coverslips were mounted and viewed at 1000x
magnification.
3.4 DETECTION OF PEROXIDASE ACTIVITY IN MONOCYTES
Peroxidase activity was detected in isolated canine monocytes (Figure 3.3). The brown
staining in the cells shows the peroxidase activity localized in cytoplasmic granules (Figure
3.3). There are numerous granules that have stained positively (Figure 3.3A) and there is very
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little staining in the cytoplasm outside the granules. However, in Figure 3.3B there is a lysed
cell and in this case there is enzyme activity in the cytoplasm. This suggests that in this
preparation the granules were also lysed. Human cells showed similar staining patterns to
their canine counterparts (data not shown).
A
B
Figure 3.3 Peroxidase activity in canine monocytes. Peripheral blood monocytes were
incubated with peroxidase substrate (DAB), washed and fixed with methanol. (A) Without
counter stain or (B) counterstained with methyl green for 5 min. After staining the coverslips
were mounted and viewed at 1 OOOx magnification.
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3.5 TRANSMISSION ELECTRON MICROSCOPY OF MONOCYTES
A B
Figure 3.4 Transmission electron micrograph of canine monocytes. Peripheral blood
monocytes were fixed, embedded in gelatin, osmicated, dehydrated and embedded in LR
white resin. Ultrathin sections were cut from the embedded cells, and stained with uranyl
acetate and lead citrate. (A) Monocyte sectioned through the nucleus (magnification 13 OOOx;
Bar = 1 ~m) or (B) different perspective of a sectioned monocyte (magnification 9 500x; Bar
= 2 ~m). The arrows indicate each organelle: mitochondria (M), granules (G) and endoplasmic
reticulum (ER). An N indicates the nucleus.
The monocyte in Figure 3.4A is sectioned in the 'traditional view', showing the horseshoe
shaped nucleus which is also visible when the cells have been giemsa stained (Figure 3.1B).
In comparison to the giemsa stained monocytes, this micrograph gives more ultrastructural
details such as the granules, mitochondria and the endoplasmic reticulum. Figure 3.4B does
not show good ultrastructural detail but it illustrates how different a monocyte may look when
the cell is sectioned at a different angle. The cell has been sectioned through the two lobes of
the nucleus and looks like a different type of cell.
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3.6 MONOCYTE PHAGOCYTOSIS OF UNOPSONIZED LATEX BEADS AND ~­
HEMATIN
3.6.1 Monocyte phagocytosis of unopsonized latex beads
A
B
Figure 3.5 Canine monocyte phagocytosis of unopsonized latex beads. Peripheral blood
monocytes were incubated with latex beads (0.1 % w/v) for 30 min before washing, fixing with
methanol and stained with (A) giemsa for 15 min or (B) methyl green for 5 min. After
staining the coverslips were rinsed, dried, mounted and viewed at 400x magnification. The
arrows indicate ingested latex beads.
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The isolated monocytes (72%) were phagocytically active, as indicated by large quantities of
ingested unopsonized latex beads in the monocytes (Figure 3.5). The giemsa stained
monocytes (Figure 3.5A) showed darkly stained nuclei as in Figure 3.1 but the cytoplasm
appears to be filled with latex beads. In the case of the methyl green stained monocytes the
beads appear to be localized in distinct areas but the nucleus cannot be differentiated from the
cytoplasm (Figure 3.5B). The methyl green stain is useful to determine whether the cells had
in fact ingested the beads. In the case of giemsa, which is a much darker stain, it can be
determined where the beads have been localized.
3.6.2 Synthesis and analysis of f3-hematin
Even though f3-hematin was synthesized from hematin, the crystal structures and the X-ray·
spectra are different. Hematin comprises large crystals that at a magnification of 12 OOOx have
a smooth surface (Figure 3.6A). The f3-hematin also has large crystals, but under the same
magnification as the hematin it is evident that they are composed of numerous small crystals
(Figure 3.7A). This confirms that the acid and temperature conditions applied in Section 2.5
altered the chemical and ultrastructure of the hematin. Both compounds contain the common
elements iron, carbon and oxygen as determined by X-ray microanalysis. Hematin contained
trace amounts of chlorine and potassium (Figure 3.6B), whereas f3-hematin contained trace
amounts of aluminum and silicon (Figure 3.7B). As f3-hematin is elementally similar to
hematin the C, 0 and Fe content would be similar between the two compounds, as was found
experimentally. The additional elements such as K and Cl in the hematin may be by-products
from the extraction procedure used to prepare hematin by the supplier. The Al and Si would
most likely be artifacts from the synthesis of f3-hematin. The figures presented here serve to
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Figure 3.6 Scanning electron micrograph of hematin and corresponding X-ray
spectrum. Hematin was mounted on a carbon stub and viewed in a Philips environmental
scanning electron microscope fitted with a large field detector. (A) The crystal structure of
hematin viewed and photographed at a magnification of 12 OOOx under an accelerating voltage









Figure 3.7 Scanning electron micrograph of p-hematin and corresponding X-ray
spectrum. p-Hematin was mounted on a carbon stub and viewed in a ~hilips environmental
scanning electron microscope fitted with a large field detector. (A) The crystal structure of P-
hematin viewed and photographed at a magnification of 12 OOOx under an accelerating voltage
of 20 kV. (B) The X-ray spectrum obtained at a magnification of 2 OOOx with a spot size of 4
for 150 s.
100
3.6.3 Monocyte phagocytosis of ~-hematin
Figure 3.8 Canine monocyte phagocytosis of ~-hematin. Canine peripheral blood
monocytes were incubated with ~-hematin for 30 min before washing, fixing with methanol
and stained with methyl green. After staining, the coverslips were rinsed, dried, mounted and
viewed at 1000x magnification.
The isolated monocytes (70.5%) phagocytosed unopsonized ~-hematin (Figure 3.8). There
were also numerous crystals adhering to the surface membrane of the monocytes. In
comparison to the latex bead phagocytosis (Figure 3.5), there were fewer ~-hematin crystals
present in the monocytes after 30 min than there were beads. The difference in size of the
particles, with unopsonised latex beads being 1 ~m and ~-hematin being between 0.7 and 3.85
~m, as well as the difference in chemical nature and structure between latex beads and ~­
hematin may account for the variance in phagocytosis of the compounds.
3.7 DISCUSSION
Monocytes are part of the first line of cellular defense against invading pathogens and
disease, especially in a disease such as malaria (Asch, 1991; Roitt, 1997). These very
important cells of the immune system were isolated from human and canine peripheral blood
using a density gradient of Histopaque®-1077 as well as adherence to glass cover slips. A
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series of experiments were performed to confIrm the identity, viability and functionality of the
isolated monocytes. It was noticed that during the density gradient centrifugation of the blood,
the human monocyte layer was more clearly defIned than the canine monocytes. This is most
likely due to interspecies differences in the density of the respective cells, with the human
cells having a density closer to that of the Histopaque®-1077 gradient, which averages 1.077
glml. Thiem et al. (1988) isolated canine monocytes using two techniques. The fIrst using the
method described by Boyum (1968) and the second employing hypertonic conditioning
followed by Percoll density gradient centrifugation. The gradient was adjusted to 390 - 410
mosmlkg with the addition of crystalline sodium chloride. Using the second technique they
obtained a greater yield and purity than obtained using the fIrst method. De Almeida et al.
(2000) also found that a hyperosmolar Percoll density gradient (d = 1.064 glml) improved the
purity of isolated human monocytes. Austin et al. (1985) found that techniques utilized to
isolate monocytes from human blood do not always work well with dog blood, especially
Percoll gradients. They also suggest that Histopaque®-1077 type gradients, which yield mixed
leukocyte populations, have been used successfully in dogs, but methods for further separation
are not well established. In the present study, adherence rather than a Percoll density gradient
was used as a second step to improve the purity of the monocytes isolated using a
Histopaque®-1077 gradient.
The presence of cells adherent to glass cover slips was confIrmed using methyl green staining
(Figure 3.1A). The adherence of the cells served to confIrm that they were monocytes (Miller
and Stevenson, 1986). De Almeida et al. (2000) suggest that monocyte adherence is the most
common purification method for monocytes but it does have a few disadvantages. There is
high lymphocyte contamination within the first hour of adherence. Another disadvantage is
the possible transient activation of the cells by the glass or by the methods used to detach the
monocytes (Austin et al., 1985).
The identity of the cells as monocytes was established using giemsa stain, which shows an
easily-identifiable purple horseshoe shaped nucleus (Figure 3.1B) (Auger and Ross, 1992).
Transmission electron microscopy yielded a similar result to the gie~sa stain identifying an
isolated cell nucleus with the shape of a horseshoe (Figure 3.4A). If, however, the cell is cut
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at a different angle, then the cell can appear to have a different shaped nucleus (Figure 3.4B).
This technique is very good for the identification of the ultrastructure of cells, but for the
identification of cells it is often laborious and time consuming. The giemsa staining technique
is much quicker and easier.
Monocytes act by phagocytosing pathogens and destroying them with enzymes and reactive
oxygen intermediates (Roitt, 1997). Alkaline phosphatase and peroxidase activities were
detected in the granules and, to a lesser extent, in the cytoplasm of the isolated canine
monocytes (Figure 3.2; Figure 3.3). Peroxidase is present in monocytes (Krakowka and
Wallace, 1983), but the activity of the enzymes decreases with the maturation of the cells
(Stachura, 1989; Cribb et al., 1990). There are many contradictory findings with regard to the
presence of alkaline phosphatase in monocytes; Van Noorden and Frederiks (1992) state that it
is present whereas Absolom (1986) and Murata et al. (1993) state that it is not present. Of
interest, however, Murata et al. (1993) studied canine monocytes and neutrophils infected with
Hepatozoon canis and they examined infected and uninfected cells for alkaline phosphatase,
peroxidase and esterases. They found uninfected canine monocytes had no alkaline
phosphatase or peroxidase activity; the only enzyme they found active was the alpha naphthol
acetate esterase. Initially in the present study, when examining peroxidase activity in the
monocytes, 4-chloro-1-naphthol substrate solution was utilized and no enzyme activity was
noted (data not shown). However, when using a different substrate solution, DAB, enzyme
activity was visualized (Figure 3.3). This shows that the substrate used can affect the apparent
presence or absence of a particular enzyme. Unfortunately, Murata et al. (1993) did not
describe the methods or substrates they used, they only refer to other investigators work,
which is written in Japanese. In the case of alkaline phosphatase, Absolom (1986) used
naphthol AS-BI phosphate as a substrate to detect alkaline phosphatase, which yielded a
negative result. In light of these discrepancies in the literature a more conclusive enzyme to
examine would have been the monocyte specific, nonspecific a-naphthyl acetate esterase
(Stachura, 1989).
Monocytes are phagocytic cells (Auger and Ross, 1992), and the phagocytosis of latex beads
is a functional way to confirm monocyte identity. Phagocytosis has to be selective to avoid
103
ingesting 'self cells. The occurrence is dependent on two criteria. Firstly, the surface of the
particle should be rough. Secondly, natural substances generally have an electronegative
surface charge, as do the phagocytes, thus they will repel each other (Guyton, 1982). Dead
tissue and foreign materials generally have an electropositive charge and hence can be
ingested. In the natural system, phagocytosis is enhanced by opsonization, i.e. coating of an
antigen with an opsonin which can be an antibody or C3b (Roitt, 1997). In this case
unopsonized latex beads were used, as the p-hematin was also unopsonized, thus unopsonized
latex beads were an appropriate control. The latex beads and the p-hematin also carry an
electropositive charge, which would be expected to aid in ingestion. The isolated cells
phagocytosed a number ofunopsonized latex beads in 30 min (Figure 3.5).
The role of monocytes in malaria is the major focus of this study. The malaria parasite
produces hemozoin as a result of the breakdown of hemoglobin from infected red blood cells.
Monocytes have been shown to avidly phagocytose hemozoin in vivo (phu et al., 1995) and in
vitro (Schwarzer et al., 1999). The cells are unable to digest hemozoin and thus the
phagocytosed hemozoin remains in the monocyte for a long time. It has been shown that
phagocytosed hemozoin alters monocyte function. The cells failed to produce an oxidative
burst, were unable to repeat the phagocytic cycle (Schwarzer et al., 1992) and unable to kill
ingested bacteria, fungi and tumor cells (Schwarzer et al., 1999).
Hemozoin is difficult to isolate from the malaria parasite and so a chemically synthesized P-
hematin with chemical characteristics similar to hemozoin was used. p-Hematin was
synthesized from hematin using an alkali-acid-temperature technique (Slater et aI., 1991;
Taramelli et al., 1995). Scanning electron micrographs and X-ray spectra were taken to
monitor any changes that had occurred during the treatment of hematin. The hematin and ~­
hematin have different shaped crystals. Their X-ray spectra are similar with the exception of
elements derived from the preparation processes (Figure 3.6; Figure 3.7). Egan et al. (2001)
examined the mechanism of ~-hematin formation and in one experiment observed the changes
in the external appearance of these materials. Hematin was found to consist of 'large angular
particles with a smooth surface' that ranged in size from 3 to 50 /lm. This is consistent with
the electron micrograph of hematin depicted in Figure 3.6A. The surface of p-hematin was
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described by Egan et al. (2001) as a 'mass of small clearly discernible crystals' of
approximately 150 to 350nm long. This is consistent with the electron micrograph of the
synthesized ~-hematin depicted in Figure 3.7A.
The monocytes were able to phagocytose the ~-hematin, although to a lesser extent than the
unopsonised latex beads. As previously mentioned, hemozoin or ~-hematin 'fed' monocytes
are unable to repeat the phagocytic cycle. The monocytes phagocytosing latex beads would be
unmodified and hence able to phagocytose many more particles than the monocytes
phagocytosing ~-hematin. Shaw and Anderson (1984) found that monocytes phagocytosed
more latex beads than Candida albicans particles and they suggested that this was due to the.
considerable size difference, as well as differences on the external surface. It would be
possible to redo the same experiments with latex beads and ~-hematin opsonized with
antibodies. Thus it could be determined if the ~-hematin is more avidly phagocytosed because
it is unable to exert its effects on the monocytes due to the presence of the bound anti-
hemozoin antibodies which can be obtained from malaria patients. Biswas et al. (2001)
detected antibodies against hemozoin in patients infected with P. falciparum malaria. These
antibodies were mainly IgM types, which appeared to have an anti-disease effect.
These experiments served to confirm the presence of monocytes that are functionally active as
determined by the presence of alkaline phosphatase, peroxidase and phagocytosis of latex
beads. ~-Hematin can also be easily synthesized and phagocytosed by monocytes. Canine and




RAISING ANTIBODIES AGAINST PEPTIDES FROM HEAT SHOCK PROTEIN 70
(HSP70IHSC70)
4.1 INTRODUCTION
Heat shock protein 70 and heat shock cognate protein 70 are part of a multi-gene family of
chaperones, that have four distinct features: highly conserved sequences, molecular mass of
approximately 70 kDa, ATPase activity and the ability to bind and release hydrophobic
segments of an unfolded polypeptide chain (Feige and Polla, 1994). The N-terminal ATPase
domain is the most conserved, with about 64% identity between eukaryotic HSP70s. The C-
terminal domain is more variable where a protease sensitive domain joins it to the ATPase
domain.
The response of cells to environmental stress such as heat or chemicals is to induce the
production of heat shock proteins. Some HSPs, the heat shock cognate proteins, are
constitutively expressed. The HSP proteins are also involved in important functions under
normal conditions (Feige and Polla, 1994). Malaria is one of the stress conditions, which
induces the production of heat shock proteins, where fever, prostaglandins and hydrogen
peroxide stimulate HSP synthesis (Polla, 1988; Clerget and Polla, 1990). HSP 70 is involved
in the regulation of the secondary effects of TNF-u, namely the secretion of PLA2 (J~UitteHi,
1993). In the case of severe malaria, the serum PLA2levels are between 40 - 1100 fold greater
than in healthy individuals (Vadas et aI., 1993). As PLA2 plasma levels are elevated during
malaria and there is fever, it is of interest why the HSP response does not inhibit the
production of PLA2 as it does in other conditions. One possible explanation is that the
expression ofHSP70 is altered by hemozoin. Hemozoin may exert its effect in two ways. The
first being when it is released into the blood when the infected red blood cells burst, and its
presence induces the production of TNF-u and other inflammatory mediators and fever,
ultimately the expression ofHSP70 is altered. The second mechanism is when the monocytes
phagocytose either the infected red blood cells andlor the released hemozoin and the cells
become stressed and produce HSP 70.
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An understanding of these mechanisms could be achieved using immunostaining on western
blots using antibodies against heat shock proteins. Instead of using monoclonal antibodies that
are extremely expensive, anti-peptide antibodies could be produced and used in the present
study. Peptides were utilised in the production of anti-peptide antibodies in chickens, which
are evolutionary distant to mammals and are likely to give a better response to the mammalian
HSP peptides. The antibodies were purified using the PoIson et al. (1985) PEG 6 000
technique as described by Goldring and Coetzer (2003) and affinity purified using a peptide
linked affinity matrix. The titres were evaluated using ELISA and the recognition of the entire
protein by the anti-peptide antibodies confirmed with western blotting.
4.2 SELECTION OF HEAT SHOCK PROTEIN PEPTIDES
The amino acid sequences of heat shock protein 70 (HSP70) and heat shock cognate protein
70 (HSC70) were aligned to determine amino acid regions in the sequences that contained
similar sequences and amino acid regions that were different (Figure 4.1). The N-terminus
shows a higher frequency of conserved amino acids between the two sequences than the C-
terminus. Selecting peptides in regions of the sequences that are dissimilar would hence result
in anti-peptide antibodies that are likely to be specific for each of the parental proteins.
Regions of interest were determined from a range of criteria from the graphs obtained in the
Predict 7 programme (Cannenes et a!., 1989). Initially, the whole protein sequence was used
to determine areas of increased flexibility, hydrophilicity, surface probability and antigenicity
(Figure 4.2A; Figure 4.3A).
Hydrophilicity is an important criterion in the selection of antigenic peptides as the
hydrophilic residues are often on the exterior of the protein where they interact with water.
The hydrophobic residues are frequently buried in the structure of proteins (Van Regenmortel
et aI., 1988). The local maxima in a hydrophilicity plot have been correlated to regions that
are exposed on the surface of the protein as well as parts of epitopes. Thus when predicting
peptides it is preferable to consider the areas containing the highest peaks for all four criteria.
Proteins as well as peptides are not rigid structures; they have dynamic conformational
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variations that are linked to their functional activity. That is the proteins are flexible. There is
a correlation between the peaks in the flexibility plot and the position of epitopes.
Van Regenmortel et a!. (1988) state that although flexibility is not an absolute requirement for
antigenicity, it has been associated with a greater than average antigenic reaction. Surface
probability is linked to the ability of the antibody to bind to the epitope. Epitopes on the
surface are more accessible than those buried deep within the tertiary structure of the protein
(Van Regenmortel et a!., 1988). The last selection criteria was that of antigenicity, this is a
computer generated plot that utilises all the prediction criteria mentioned previously to provide
an educated guess as to where the most antigenic regions are. This is not an. absolute
prediction criterion, as the other three are more accurate, but in combination with them it is an
effective tool. The regions of interest would hence be those where all four criteria had elevated
levels.
Figure 4.2A shows four regions where there are maxima in all four criteria. The first section
in the sequence (200 - 300 aa) was examined, but the sequence identity between HSP70 and
HSC70 was 100%. The region from amino acids 500 - 600 (Figure 4.2B) was selected for
further analysis (Figure 4.2B), as there are three peaks in all the plots (aa 503 - 516; 560 -
574; 586 - 598). The similarity of these regions to the human HSC 70 and chicken HSP 70
sequence was investigated, as well as the similarity to any other protein that may be
encountered in the human, canine or chicken systems. The region of 503 - 516 amino acids
was 93% similar to human HSC 70 and chicken HSP 70. The region of 560 - 574 was 65%
similar to human HSC 70 and 82% similar to chicken HSP 70. The sequence of 586 - 598 was
73% similar to human HSC 70 and chicken HSP 70. The selected peptide sequence is
CLAEKDEFEHKRKE (Table 2.4; Figure 4.1). The position of the selected peptide is shown
in Figure 4.1 (amino acids 586 - 598) and the peptides selection criteria plot is shown in
Figure 4.2C. Ultimately the lack of similarity between human HSP 70 and chicken HSP 70
was the deciding factor in choosing the HSP peptide.
HSC 70 has four regions where all four criteria are maximal (Figure 4.3A). The first maxima
in the sequence (250 - 300 aa) were examined, but the sequence identity between HSC70 and
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HSP70 was 99%. All other regions with possible peptides were examined by a similarity
search and the sequence from 550 - 650 was selected to be examined further (Figure 4.3B).
There are two peaks in all the plots (aa 561 - 574; 586 - 600). The similarity of the identified
regions to the human HSC 70 and chicken HSP 70 sequence was determined. The region of
561 - 574 was 65% similar to human HSP 70 and 82% similar to chicken HSC 70. The
sequence 586 - 598 was 73% similar to human HSP 70 and 85% similar to chicken HSC 70.
The region with the lowest similarity was aa 561 - 574. Thus the peptide sequence
KINDEDKQKILDKC (Table 2.4; Figure 4.1) was chosen. The position of the selected




* * * *****************************************************
HSP 61 LNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEIS
HSC 61 MNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVS
** ************ * * *********** * ** ***** ****** ***** *
******** * ****** *************** **************** ** ** **
**************** ***** ****************** *****************
***** **** ** ************* **** *********** ********** **
IAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNH
IAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNH
********************* ******* *************** *********
KSINPDEAVAYGAAVQAAILMGDKSENVQDLLLLDVAPLSLGLETAGGVMTALIKRNSTI
KSINPDEAVAYGAAVQAAILSGDKSENVQDLLLLDVTPLSLGIETAGGVMTVLIKRNTTI
******************** *************** ***** ******** ***** **
PTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDI
PTKQTQTFTTYSDNQPGVLIQVYEGERAMTKDNNLLGKFELTGIPPAPRGVPQIEVTFDI







********* **** * * * * *** * **
FVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRA
FIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRA























****** *** *** ** **** * * ** *********
Figure 4.1 Amino acid sequence alignment of human heat shock protein 70 with human
heat shock cognate protein 70. The amino acid sequences of heat shock protein 70 (HSP)
and heat shock cognate 70 (HSC) were aligned from the first amino acid to the last. *
Indicates amino acids that are present on both sequences in the same position. Gaps in the
sequence where no alignment is possible due to different numbers of amino acids is depicted
by a -. The peptide sequences that were selected are included, HSP peptide is boxed in"
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Figure 4.2 Prediction criteria used for the selection of an immunogenic peptide from
human heat shock protein 70. The heat shock protein 70 sequence was used in the Predict7
programme and the following peptide selection criteria plotted: hydrophilicity (-), surface
probability (-), antigenicity (-) and flexibility ( ). (A) The entire HSP70 amino acid sequence
(amino acid numbers 0 - 641). (B) A section of the HSP70 sequence from amino acid number
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Figure 4.3 Prediction criteria used for the selection of an immunogenic peptide from
human heat shock cognate protein 70. The heat shock cognate protein 70 sequence was
used in the Predict7 programme and the following peptide selection criteria plotted:
hydrophilicity (-), surface probability (-), antigenicity (-) and flexibility (). (A) The entire
HSC70 amino acid sequence (amino acid numbers 0 - 646). (B) A section of the HSP70
sequence from amino acid number 550 - 650. (C) The selected heat shock cognate protein 70
peptide (HSC), amino acids 561 - 574, used to immunize chickens.
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As mentioned previously, heat shock protein 70 consists of two domains, the highly conserved
N-terminal ATPase binding domain (Figure 4.4A) and the variable C-terminal peptide-binding
domain (Figure 4.4B). The structures of the two domains are extremely different, the peptide-
binding domain is similar to that of the MHC class I molecule. The peptide on the figure
(Figure 4.4.B) is located on the outer a-helices of the peptide-binding domain. This confirms
the surface probability selection criteria in Figure 4.2, and suggests that the anti-peptide
antibodies are likely to bind to the peptide sequence in the native protein.
A B
Figure 4.4 The structure of heat shock protein 70. HSP70 consists of two domains, the
highly conserved N-terminal ATPase domain (A) and the less conserved C-terminal peptide-
binding domain (B). The ATPase domain structure was determined by X-ray crystallography
and the peptide binding domain structure was modelled on the structure of human MHC Class
I molecules. The arrow indicates the peptide position on the native protein. (Adapted from
Feige and Polla, 1994).
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4.3 ANTI-PEPTIDE ANTIBODY ISOLATION AND CHARACTERISATION
Anti-peptide antibodies were isolated from chicken eggs using the PEG 6 000 precipitation
technique and the titres were determined using an ELlSA. Antipeptide antibodies were
separated from the anti-carrier antibodies and other antibodies using affinity chromatography.
The efficiency of each step was evaluated using an ELISA. Finally, the ability of the anti-
peptide antibodies to recognize the native heat shock proteins was evaluated using Western
blotting.











Figure 4.5 12.5 % Reducing SDS-PAGE showing the purification of chicken anti-peptide
antibodies. Chicken antibodies were isolated from egg yolks using the PEG 6 000
precipitation technique. The samples were loaded onto a 12.5% Laemmli SDS-PAGE gel and
stained with Coomassie brilliant blue. Lane 1: Pharmacia molecular mass markers; Lane 2:
egg yolk mixed with 2 volumes of phosphate buffer; Lane 3: filtrate after the first
centrifugation step; Lane 4: supernatant from the initial 12% PEG pellet; Lane 5: the
redissolved initial 12% PEG pellet; Lane 6: supernatant from the second 12% PEG pellet;
Lane 7: final purified IgY pellet.
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Using the PEG 6 000 precipitation technique the average yield for the IgY was 20.48 mg/ml.
The purification procedure was very successful as can be seen on Figure 4.5 and according to
Schade et al. (1999) the purity of IgY using this method is greater than 90%. This has been
recently confirmed by Goldring and Coetzer (2003) who routinely obtain yields of 90% purity
using the same technique. The first sample (Lane 2) contains the egg yolk mixed with two
volumes of 100 mM sodium phosphate buffer (pH 7.6), and there are many proteins present.
Lane 3 contains the filtrate after the first centrifugation step that removes the vitellins and
lipids and had approximately six proteins. Proteins were removed from the filtrate by the
addition of 12% PEG as indicated in Lane 4 by the presence of two protein bands. It appears
that all but two proteins have been removed by the 12% PEG. The pellet (Lane 5), however,
still contains protein but there are fewer bands than in Lane 2. The IgY heavy and light chains
are heavily stained, as their concentration in proportion to all the other proteins has increased.
The second 12% precipitation removed more egg proteins (Lane 6) but less than the first 12%
step (Lane 4).
The [mal IgY pellet is loaded at a higher concentration of protein compared to the other lanes
and contains some minor bands. The bands represent the different reduced forms of the protein
(Lane 7). The most prominent band is the heavy chain at approximately 66 000 Da, which
compares favourably with published values (65 - 70 kDa; Schade et al., 1999). It runs as a
broad band, because of the presence of a substantial amount of carbohydrates and the antigen
binding regions contain variable amino acids. The light chain is also prominent with an
approximate molecular weight of 27 000 Da (22 - 30 kDa; Schade et al., 1999). The minor
protein bands present are: the unreduced protein of approximately 180 000 Da (Warr et aI.,
1995), two heavy chains and one light chain of approximately 155 000 Da, two heavy chains
of approximately 130 000 Da, a heavy and a light chain of approximately 90 000 Da, two light
chains of approximately 55 000 Da. The IgY isolation was successful as there was a good
yield and the SDS-PAGE data show the IgY to be pure (Figure 4.5).
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4.3.2 Evaluation of chicken anti-heat shock protein peptide antibody and anti-rabbit
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Figure 4.6 Progress of anti-peptide antibody production in chickens immunized with the
HSP peptide conjugated to rabbit albumin. Two chickens were immunized with the HSP
peptide conjugated to rabbit albumin: chicken 1 (+) and chicken 2 (x). The HSP peptide was
coated at a concentration of 1 /-lg/ml to microtitre plates and incubated with chicken anti-HSP
peptide antibodies (200 /-lg/ml) collected from eggs. Binding was visualised with goat anti-
chicken IgY horseradish peroxidase. Each point is the mean absorbance at 405 nm of duplicate
samples. The arrows indicate when the chickens were immunized.
The two chickens injected with the HSP-peptide conjugated to rabbit albumin produced anti-
peptide antibodies (Figure 4.6). The antibodies produced by chicken 1 were of higher titre
than those produced by chicken 2, as indicated by the difference between the two curves. In
both cases the titre increased slowly till week two. For chicken 1 the titre peaked during the
_4th week and for chicken 2 during the 6th week post immunization. The titre then decreased
slowly till week 16 where the titre was still higher than that of the non-immune control (data
not shown). The titre of anti-peptide antibodies peaked twice in chicken 2, once at week 6 and
again at week 10. In this chicken the titre remained high but constant after week 10 until week
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16, where it was significantly higher than the non-immune control. Figure 4.6 shows the
difference in the antibody response between two chickens kept under the same conditions and
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Figure 4.7 Progress of anti-peptide antibody production in chickens immunized with the
HSC peptide conjugated to rabbit albumin. Three chickens were immunized with the HSC
peptide conjugated to rabbit albumin: chicken A (+), chicken B (died after four weeks) and
chicken C (died after seven weeks). The microtitre plates were coated with the HSC peptide
at a concentration of 11lg/ml and incubated with chicken anti-HSC peptide antibodies (200
Ilg/ml) collected from eggs. Binding was visualised with goat anti-chicken IgY horseradish
peroxidase. Each point is the mean absorbance at 405 nm of duplicate samples. The arrows
indicate when the chickens were immunized.
The chickens injected with the HSC peptide conjugated to rabbit albumin (Figure 4.7) had a
completely different response to that of the chickens injected with the HSP-conjugate (Figure
4.6). Although three chickens were immunized, two chickens died after 4 weeks and 7 weeks,
respectively, without producing any eggs and hence no antibodies. Chicken 1, however, had
high antibody titres from week 3 to week 9. There was a decrease in titre at week 5. The titre
tapered off from week 9 to week 16. The titre at week 16 was higher than that of the non-
immune control (data not shown).
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Both peptides elicited an immune response in the chickens immunized. The anti-peptide
antibody titre in all three chickens was high irrespective of the peptide used. However,
chicken 1 immunized with the HSP-peptide conjugated to rabbit albumin had the highest titre
(Figure 4.6). Thus the selection of the peptides is considered to be successful as they both
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Figure 4.8 Progress of anti-carrier antibody production in chickens immunized with the
HSP or HSC peptide conjugated to rabbit albumin. Two chickens were immunized with
HSP peptide conjugated to rabbit albumin: chicken 1 (+) and chicken 2 (D). One chicken was
immunized with the HSC peptide conjugated to rabbit albumin (-A.-). Rabbit albumin was
coated at a concentration of l!J.glml to microtitre plates and incubated with chicken anti-rabbit
albumin antibodies (200 /olg/ml) collected from eggs. Binding was visualised with goat anti-
chicken IgY horseradish peroxidase. Each point is the mean absorbance at 405 nm of duplicate
samples. The arrows indicate when the chickens were immunized.
The titres of anti-carrier antibodies fluctuated during the immunisation period (Figure 4.8).
With respect to the rabbit albumin conjugated to the HSP peptide, the titres had peaked at
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weeks 4, 7, 12 and 15 in chicken 1 with the highest titres of antibody during weeks 4 and 12.
In chicken 2 peak titres were observed during weeks 3, 6, 8, 11 and 15, at week 3 the peak was
smaller than the subsequent peaks. The chicken immunized with the HSC peptide conjugated
to rabbit albumin had anti-carrier antibody titre peaks at weeks 3, 8, 11 and 15. In all cases at
week 16 the titre is higher than the non-immune control. The chicken immunized with the
HSC70 peptide generally produced more antibodies against the carrier protein than the
chickens immunized with the HSP70 peptide. Figure 4.8 shows that the chickens produced
antibodies against the carrier protein, rabbit albumin, as well as the peptide of interest. The
anti-carrier antibodies needed to be separated from the anti-peptide antibodies using affinity
purification.
4.3.3 Affinity purification of chicken anti-heat shock protein peptide antibody
The anti-HSP peptide antibodies were pooled into four pools: weeks 1-7, weeks 8-11, weeks
12-14 and weeks 15 & 16. The anti-HSP peptide antibody titre peaked at week 3 and 7
(Figure 4.6), thus the weeks 1-7 pool would be expected to contain the most antibodies (Figure
4.9). The anti-peptide antibody elution profiles for both the HSC peptide and the HSP peptide
were similar (Figure 4.9). The anti-HSP peptides isolated from chicken 1 have been previously
shown to be in high titre between weeks 3 and 7 (Figure 4.6) and were eluted from the affinity
column with a concentration of 15.2 mg/ml. The total yield for chicken 1 immunized with
HSP was 98.27 mg. This yield was significantly higher (7.5 fold) than anti-HSP peptide
antibodies isolated from chicken 2 which, yielded 13.21 mg. The yield of anti-HSC peptide
antibodies was 3.73 mg, significantly lower than the yields for the anti-HSP peptide antibodies
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Figure 4.9 Elution profile of anti-HSP peptide antibodies from the HSP peptide affinity
matrix. HSP peptide was coupled to the Sulfolink® affinity matrix. The isolated polyclonal
chicken antibodies: weeks 1-7 (.); weeks 8 - 11 (.); weeks 12 - 14 (.) and weeks 15 - 16
(x) were allowed to circulate through the peptide affinity column overnight. The unbound
antibodies were washed off the column and the bound antibodies were eluted using a low pH
buffer (pH 2.8). The absorbance of the anti-peptide antibodies was measured at 280 nm. The
samples with an absorbance greater the 0.2 were pooled. This is a representative elution
profile of three peptide columns and anti-peptide antibodies.
4.3.4 Evaluation of affinity purified chicken anti-heat shock protein peptide antibody
titre using ELISA
The anti-HSP peptide antibodies had a higher titre than the non-affinity purified antibodies
(Figure 4.10) and both preparations of antibody are of high titre as they can be used at
concentrations of 10 }lg/ml to 100 }lg/ml with very little difference in the absorbance obtained.
There appears to still be some anti-peptide antibodies remaining in the antibody solution that
had not bound to the column, as the titre is significantly higher than that of the non-immune
control. The anti-HSP antibodies isolated from chicken 2 and the anti-HSC antibodies showed
similar patterns to the anti-HSP antibodies isolated from chicken 1 (data not shown). The
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affinity purification was successful as the anti-peptide antibodies were evidently separated
from the anti carrier antibodies (Figure 4.10).
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Figure 4.10 Evaluation of the affinity purification of chicken anti-HSP peptide
antibodies. The HSP peptide was coated at a concentration of 1 Ilg/ml to microtitre plates and
incubated with serial doubling dilutions of affinity purified chicken anti-HSP peptide
antibodies from weeks 1-7: Non-immune (+); non-affinity purified antibodies (.); affinity
purified antibodies (A) and the remaining antibodies after affinity purification (-x-). Binding
was visualised with goat anti-chicken IgY horseradish peroxidase antibody. Each point is the
mean absorbance at 405 nm of duplicate samples. All affinity purified anti-peptide antibodies
showed similar trends.
4.3.5 Evaluation of affinity purified chicken anti-peptide antibody recognition of the
native protein in lymphocyte lysates using western blotting
The affinity purification of the anti-peptide antibodies was accomplished as mentioned above
(Section 4.3.4). Western blotting was used to determine the possible presence of residual anti-
rabbit albumin as well as to show that the anti-peptide antibodies recognize the peptide
conjugate after electrophoresis (Figure 4.11). The SDS-PAGE gel shows a number of light
bands in Lane 2, but the main band is at 67 kDa which is rabbit albumin. The two peptide
conjugates in Lanes 3 and 4 are not classic thin bands but more a large smear ranging from 68
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kDa to well above 100 kDa. The 'smearing' is a result of between a minimum of one and a
maximum of 40 peptides binding to each rabbit albumin molecule. At a size of 1762 Da for
HSP and 1670 Da for HSC, the combinations can range from 68 kDa if only one peptide binds
to 137 kDa if the calculated number of 40 HSP peptides bind. The affinity purified antibodies
contain no rabbit albumin as there is only recognition of the peptide conjugates in Lane 3 for
the anti-HSP antibodies and Lane 4 for the anti-HSC antibodies. No recognition of the large
rabbit albumin band at 67 kDa, in Lane 2 is evident. Thus no anti-carrier antibodies remained
in the affinity purified anti-peptide antibody preparation. The anti-HSP antibodies (Figure
4.11B) and the anti-HSC antibodies (Figure 4.11 C) recognized the respective peptide
conjugate in a western blot but to visualize the reaction, a higher concentration of the anti-
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Figure 4.11 Evaluation of the affinity purification of the anti-peptide antibodies by
western blotting. (A) Non-reducing SDS-PAGE of rabbit albumin and the peptide
conjugates. The non-reduced samples were loaded onto a 12.5% Laemmli gel and stained
with Coomassie brilliant blue. Lane 1: Pharmacia molecular mass markers; Lane 2: Rabbit
albumin; Lane 3: HSP-peptide conjugated to rabbit albumin; Lane 4: HSC-peptide conjugated
to rabbit albumin. After electrophoresis the proteins were electroblotted onto nitrocellulose
and probed with (B) 100 Ilg/ml anti-HSP peptide antibody and (C) 100 Ilg/ml anti-HSC
peptide antibody. Binding was visualised with goat anti-chicken IgY horseradish peroxidase
antibody.
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Both the anti-HSP antibodies and the anti-HSC antibodies (Figure 4.12) recognized the native
heat shock proteins present in lymphocyte preparations. There is no visible difference on the
SDS-PAGE gel between cells incubated at 37°C (Lane 1, Figure 4.12A) or 44°C (Lane 2;
Figure 4.12A) for 2 h, although there are many bands present at different sizes (Figure 4.12A).
In order to visualize any changes in the expression of heat shock proteins under stress
conditions, SDS-PAGE is insufficient and inconclusive. However, western blotting and the
use of specific antibodies, such as affinity-purified anti-peptide antibodies is likely to give
information about the changes in expression.
The anti-HSP peptide antibody recognised approximately 10 proteins, III both the cells
incubated at 37°C (Lane 1) or 44°C (Lane 2). The heat shock protein 70 band is present at 70
kDa in both Lane 1 and Lane 2 at the same intensity, which seems to indicate there is no
change or increase in the expression of HSP70 under stress conditions (Figure 4.l2B). The
band present at 33 kDa is very intense and broad, which may be as a result of HSP70 being
cleaved between the ATPase domain and the peptide binding domain by cathepsin D (Sehom
et al., 2002). To determine if this is a possible explanation, a protease inhibitor cocktail can
be incorporated with the cells prior to lysis. The anti-HSC antibodies only detected two
proteins (Figure 4.l2C), although both were present in the cells incubated at 37°C (Lane 1)
and 44°C (Lane 2). The protein band at 70 kDa, is most likely heat shock cognate protein 70,
but the protein of 100 kDa that was recognised is unknown. There are two possible
explanations, the anti-peptide antibodies recognise a continuous epitope in a protein present in
human lymphocytes that has not been sequenced yet or it may be another heat shock protein at
100 kDa.








Figure 4.12 Detection of human heat shock proteins present in lymphocyte lysates with
anti-peptide antibodies. (A) Lymphocytes were isolated, incubated at either 37°C or heat
shocked at 44°C for 2 h followed by lysing using reducing buffer and SDS (l0%). The
reduced samples were loaded onto a 12.5% reducing Laemmli SDS-PAGE gel and stained
with Coomassie brilliant blue. Similar numbers of cells were loaded in each lane. Lane 1:
Lysates of lymphocytes at 37°C; Lane 2: Lysates of lymphocytes at 44°C; Lane 3: Pharmacia
molecular mass markers. After electrophoresis, proteins were electroblotted onto
nitrocellulose and probed with (B) 25 j..lg/ml anti-HSP peptide antibody and (C) 25 j..lg/ml anti-
HSC peptide antibody. Binding was visualised with goat anti-chicken IgY horseradish
peroxidase antibody. Arrows indicate position of bands recognized by anti-HSC peptide
antibody.
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Figure 4.13 Detection of human heat shock proteins in lymphocyte lysates in the presence
of protease inhibitors and monocyte lysates with anti-peptide antibodies. (A)
Lymphocytes and monocytes were isolated, incubated at either 37°C or heat shocked at 44°C
for 2 h followed by addition of a protease inhibitor cocktail to some samples and lysis of cells
using reducing buffer and SDS (10%). The reduced samples were loaded onto a 12.5%
reducing Laemmli SDS-PAGE gel and stained with Coomassie brilliant blue. Similar numbers
of cells were loaded in each lane. Lane 1: Pharmacia molecular mass markers; Lane 2: Blank;
Lane 3: Lysates ofmonocytes at 37°C; Lane 4: Lysates ofmonocytes at 44°C; Lane 5: Lysates
of lymphocytes at 37°C; Lane 6: Lysates of lymphocytes at 44°C; Lane 7: Lysates of
lymphocytes at 37°C with protease inhibitors; Lane 8: Lysates of lymphocytes at 44°C with
protease inhibitors. (B) After electrophoresis the proteins were electroblotted onto
nitrocellulose and probed with 25 Ilg/ml anti-HSP peptide antibody. Arrows indicate position
ofbands recognized by anti-HSP peptide antibody.
Monocyte lysates from cells incubated at 37°C (Lane 3; Figure 4.13B) and 44°C (Lane 4;
Figure 4.13B) that do not have protease inhibitors, have insufficient protein when undiluted to
be visualized on a Coomassie stained SDS-PAGE gel (Figure 4.13A) or to be detected by the
anti-HSP antibodies on a western blot (Figure 4.13B). The lymphocyte lysates in Lanes 5 and
6, showed many bands as in Figure 4.12A, The anti-HSP antibodies detected the same two
prominent bands as in Figure 4,12B, those being the HSP70 band at 70 kDa and the large
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intense band at 33 kDa. There appears to be no difference in the intensity of the bands
between the cells incubated at 37°C and 44°C.
The cells that were lysed in the presence of the inhibitor cocktail again had the same number
of bands (Lanes 7 and 8; Figure 4.13B), but, although the 33 kDa band was present it appears
to be thinner and less intense. In contrast the 70 kDa band is slightly more intense than in
Lanes 5 and 6. There is again no difference between the cells incubated at 37°C and 44°C,
even in the presence of inhibitors. The inhibitors may have inhibited some of the proteases as
the intensity of the 33 kDa band has evidently decreased, thus in future experiments a higher
concentration of pepstatin A may be required to inhibit the potential cathepsin D cleavage of
HSP70.
During the selection of the peptides, similarity searches indicated that canine HSP70 and
HSC70 are 100% similar to human HSP70 and HSC70 respectively. As canine cells were
used for the X-ray microanalysis study, the possibility that the anti-human HSP70 peptide
antibodies recognized canine HSP70 was determined. Analysis of canine lyrnphocytes, lysed
in the presence of inhibitors (Lanes 1 and 2; Figure 4.14A) indicated no difference between
the banding patterns at 37°C or 44°C. The same is true when the blots were probed with the
anti-HSP antibodies; there were bands at 70 kDa and 33 kDa in both Lanes land 2 (Figure
4.14B). These bands are the same as those encountered in the human lyrnphocyte lysates in
Figures 4.12 and 4.13. The anti-HSC antibody detected two bands in both lanes containing
canine lyrnphocyte lysates, one at 70 kDa and 100 kDa (Figure 4.14C), which again
correspond to the bands seen in human lyrnphocyte lysates in Figure 4.12.
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Figure 4.14 Detection of canine heat shock proteins in lymphocyte lysates with anti-
peptide antibodies. (A) Lymphocytes were isolated, incubated at either 37°C or heat shocked
at 44°C for 2 h followed by addition of an protease inhibitor cocktail and lysing of cells using
reducing buffer and SDS (10%). The reduced samples were loaded onto a 12.5% reducing
Laemmli SDS-PAGE gel and stained with Coomassie brilliant blue. Similar numbers of cells
were loaded in each lane. Lane 1: Lysates of canine lymphocytes at 37°C; Lane 2: Lysates of
canine lymphocytes at 44°C; Lane 3: Pharmacia molecular mass markers. After
electrophoresis the proteins were electroblotted onto nitrocellulose and probed with 25 /-lg/ml
anti-HSP peptide antibody (B) or 25 /-lg/ml anti-HSC peptide antibody (C). Arrows indicate
position of bands recognized by the anti-HSP peptide (B) antibody and the anti-HSC peptide
antibody (C).
4.4 DISCUSSION
When an organism is exposed to elevated temperatures it responds by rapidly expressing
highly conserved proteins, known as heat shock proteins. The heat shock response is universal,
occurring in every cell and species from eubacteria to humans (Lindquist, 1986). It is widely
hypothesized that the purpose of the heat shock response is to protect the organism from the
toxic effects of heat and other forms of stress. There are many other inducers of heat shock
proteins, these include ethanol, sodium arsenite, cadmium, anaerobiosis, zinc, copper,
mercury, sulfyryl reagents, calcium ionophores, steroids, chelating agents, glucosamine,
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deoxyglucose and oxidative injury (Lindquist, 1986). The presence of the malaria parasite and
its by-products in the bloodstream and in monocyte phagocytic vesicles induces fever and
ultimately the expression of HSPs (Clerget & Polla, 1990). It has previously been mentioned
that the heat shock proteins are unable to inhibit the production of phospholipase A2 in
malaria, whereas in most other situations the HSPs inhibit PLA2 expression. Increased levels
ofphospholipase A2 are associated with severe malaria (Vadas et al., 1993).
HSP70 is the most highly conserved of the heat shock proteins, with the similarity between
human HSP70 and the Drosophila protein being 73%. The majority of the differences can be
accounted for by homologous substitutions (Lindquist, 1986). The antibody response to the
malarial HSP70 proteins is mainly directed toward the non-conserved epitopes (Shinnick,
1991). However, human and monkey immune sera contain antibodies that recognize amino
acid sequences conserved between P. falciparum and human HSP70 (Mattei et al., 1989;
Richman et al., 1989). Pathogenic microorganisms can elicit a humoral and cellular response
to epitopes shared with the hosts; this immunoreactivity may play a role in pathogenicity and
in autoimmune consequences of infection (Shinnick, 1991; Winfield and Jarjour, 1991;
Maresca and Kobayashi, 1994). To elicit an immune response in immunized chickens it was
considered more appropriate to design and use synthetic peptides rather than utilizing the
whole protein.
The sequences ofhuman HSP70 and human HSC70 were aligned so that the regions where the
amino acids are least conserved could be determined (Figure 4.1). One of the peptide
selection criteria was that there be as little similarity between the alternative protein as
possible, thus when the antibodies were produced the anti-HSP70 antibody would not
recognize the HSC70 protein and vice versa. The C-terminal domains of the two proteins
appeared to be the least conserved, which is also further confirmed by this region of HSP70
being reported to contain a variable peptide-binding domain (Feige and Polla, 1994). An
alternative reason for using the C-terminus was that the commercially available anti-HSP70
monoclonal antibodies from Stressgen (www.stressgen.com) were produced against the region
ofamino acids 436 - 640, which is the C-terminal domain ofHSP70.
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The entire protein sequence was analysed using the Predict? programme (Carmenes et al.,
1989) to predict the location of epitopes. Thus HSP70 and HSC70 were analysed in terms of
hydrophilicity (Hopp and Woods, 1981), surface probability (Emini et aI., 1985; Janin et aI.,
1978), flexibility (Karplus and Schulz, 1985) and antigenicity (Welling et aI., 1985). The C-
terminus of both proteins contained regions with high peaks for the four selection criteria
(Figure 4.2A; Figure 4.3A). From the predictions obtained for the whole proteins, smaller
amino acid regions (Figure 4.2B; Figure 4.3B) and ultimately peptides (Figure 4.2C; Figure
4.3C) were selected. Individually, the peptide selection criteria are insufficient to determine
epitopes suitable for eliciting an immune response in chickens. However, the combination of
selecting regions of high hydrophilicity, surface probability, flexibility and antigenicity are a
good indicator for predicting immunogenic peptides.
It has been observed that the locations of epitopes on the native protein also correspond to
areas of high sequence variability i.e. low similarity (Van Regenmortel et al., 1988). The
regions selected, based on the Predict7 programme, were further analysed using similarity
searches, to avoid cross reactivity with other proteins such as HSC70 in the case of anti-
HSP70 peptide antibodies. Ultimately two peptides were selected because they showed
relatively low similarity with the chicken proteins. Based on these percentage similarities the
HSP peptide is most likely to elicit the better immune response. Since the peptides were able
to elicit an immune response and the isolated antibodies recognized the native proteins in
human and canine lymphocyte lysates, the criteria used to select the peptides were successful.
The three dimensional structure of HSP70 (Figure 4.4), suggests that the selected peptides are
on the surface of the protein. More precisely, they are on the a-helix that lines the exterior of
the peptide-binding groove of the variable substrate recognition domain (Feige and Polla,
1994). Thus the probability that the antibodies produced against the HSP70 and HSC70
peptides will be able to recognize the respective native proteins is high.
As discussed previously, chickens were used for the production of the anti-peptide antibodies.
The immunization of the chickens with the HSP-rabbit albumin conjugate was successful and
both chickens laid eggs until the collection of eggs was terminated. In the case of the three
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chickens immunized with the BSC-rabbit albumin conjugate, the immunization was successful
in one chicken but the other two chickens died.
The average yield of IgY isolated from eggs was 20.48 mg/ml, which corresponded to 45 mg
per egg. Goldring and Coetzer (2003) routinely isolate 60 mg per egg, the difference in the
amount of antibodies isolated depends on numerous factors influencing the chickens. SDS-
PAGE was used to confirm the purity of the IgY isolated (Figure 4.5). The removal of
proteins by each step in the isolation procedure is clearly visible until two major bands remain
in the final pellet. These two bands are the heavy and the light chain of IgY. A number of
minor bands were present in the final pellet, these are the different reduced forms of IgY as
confirmed by Goldring and Coetzer (2003) using a western blot. The isolation of IgY was
successful as there was a high yield and the antibodies were relatively pure.
ELISAs were used to monitor the antibody production in chickens by titrating test antibodies
against the respective free peptide, BSP or HSC, coated as antigen. The antibodies raised
against the peptides conjugated to rabbit albumin bound well to the free peptides. The
antibodies raised against the HSP-rabbit albumin conjugate, bound well to the free HSP
peptide (Figure 4.6). There were differences in the response of the antibodies from the
different chickens with BSP chicken 1 having a higher titre than HSP chicken 2. The
antibodies produced against the BSC-rabbit albumin conjugate bound well to the free BSC
peptide (Figure 4.7).
The anti-carrier antibody titres for all the immunized chickens fluctuated from the first
immunization till the termination of egg collection (Figure 4.8). The ELISA confirmed that
the chickens immunized with the peptide-rabbit albumin conjugate made antibodies against
both the peptide and the rabbit albumin. Of interest is that chicken immunized with the BSC-
rabbit albumin conjugate produced higher titre anti-carrier antibodies than the two chickens
immunized with the HSP conjugate. However, the reverse was true for the anti-peptide
antibodies. Previously it was thought that the HSP peptide might elicit the better immune
response, based on the percentage similarities between the human derived peptides and the
chicken proteins. However, it would require a larger number of chickens to determine the
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statistical relevance of the data presented, thus it is premature to draw any conclusions about
the immunogenic performances ofthe peptides.
The isolated IgY contained both antibodies against the peptides and the carrier. The anti-
peptide antibodies were purified from the anti-carrier antibodies and the remaining pool of
polyclonal antibodies by affinity purification. The anti-HSP and anti-HSC antibodies showed
similar elution profiles (Figure 4.9), however the yields of anti-peptide antibodies obtained
were different. This difference is most likely due to differences exhibited by individual
chickens. An ELISA was performed to confirm the affinity purification of the anti-peptide
antibodies was successful (Figure 4.10). Both the anti-HSP and anti-HSC affinity purified
antibodies showed similar trends. As expected the affInity purified antibodies had higher
specific titres than the unpurified antibody pool. A minor portion of anti-peptide antibodies
remained in the unbound affinity matrix eluant. As yields of antibodies were high it was not
necessary to repeat the affInity purification. A western blot confirmed that the affinity purified
anti-peptide antibodies no longer contained anti-carrier antibodies (Figure 4.11).
There appeared to be no visible difference in the protein banding between the human or canine
lymphocytes incubated at 37°C or at 44°C, whether the lysates were in the presence of
protease inhibitors (Figure 4.l3A; Figure 4.14A) or not (Figure 4.12A). It was expected that
HSP70 expression would not occur at 37°C (Lindquist, 1986). However, in the western blot
HSP70 was expressed at both 37°C and 44°C, and there was no apparent difference in the
levels of expression. There may be many reasons why cells produce HSP70 at 37°C. The
isolation of lymphocytes using the hypertonic density centrifugation method of by Boyum
(1968) subjects the cells to physical stress, which results in spontaneous PGE2 and IL-1
production (Thiem et al., 1988). Cytokine production can induce intracellular HSP70
expression in peripheral blood mononuclear cells (Njemini et al., 2002). HSP70 may also be
stimulated by serum (Wu et al., 1986). Since HSP70 expression has been induced at 37°C, it
is suggested that an alternative isolation procedure be investigated. However, adherence
should not be used as monocytes isolated by using this method are subject to transient
activation (Fincato et aI., 1991; Hall, 1994; De Almeida et al., 2000) because adherence
represents an activation signal (Njemini et al., 2002). Clerget and Polla (1990) have shown
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that activation ofmonocytes induces the expression ofHSP70 and Njemini et al. (2002) found
a significant increase in the production level of HSP70 by adherent cells incubated at 37°C.
From western blots the possibility that the anti-HSP antibody may be cross-reacting with the
HSC70 in those 1ysates cannot be ruled out. Pure HSC70 and HSP70 were not available at the
time, to determine the level ofcross-reactivity.
The anti-HSP antibodies recognized two major bands, one at 70 kDa and one at 33 kDa, in all
lymphocyte lysates examined irrespective of incubation temperature, the presence or absence
of protease inhibitors, or whether the blood was human or canine (Figure 4.l2B; 4.13B and
4.14B). As has been mentioned before HSPs have relatively stable characteristic breakdown
products, with HSP70 being reduced to doublets of 40 kDa and 22 kDa by proteolysis
(Lindquist, 1986). As previously mentioned Sehorn et al. (2002) found that the cleavage of
DnaK, by cathepsin D yielded fragments of the C-terminal binding domain with molecular
weights greater than 20 kDa. The protein band of 33 kDa may be the result of HSP70 being
cleaved between the ATPase domain and the peptide binding domain by cathepsin D. The
HSP peptide was derived from the C-terminal domain of human HSP70, so the antibodies
would recognize these cleavage products. There are a number of lighter bands that are greater
than 20 kDa with the largest being 33 kDa. The anti-HSP antibodies recognized the native
protein at 70 kDa. There were also a number of lighter bands in the region greater than 100
kDa, but the identity of these proteins was not confirmed.
The only major difference between the uninhibited and the protease inhibited lymphocyte
lysates was the intensity of the bands, thus indicating there may have been partial inhibition of
proteolysis. If cathepsin D, a ubiquitous aspartic protease that has an operating pH of 2.8 -
5.0 and a pI of 5.5 - 6.5 (Pillay et al., 2002), was in fact cleaving the HSP70 then using an
inhibitor cocktail containing a higher concentration of the cathepsin D inhibitor, pepstatin A,
would likely lead to recognition of the 70 kDa protein by the anti-HSP antibodies. Although it
appears that the inhibitor cocktail did not inhibit the action of proteases on the HSPs, this may
be due to the cells being activated for a long period of time, and the natural breakdown of
HSPs by the cell may already be underway. Thus as the inhibitors were added to the cell
lysates the cellular cleavage products ofHSP70 are likely to have been present.
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The anti-HSC antibodies recognized two proteins in both the 37°C and 44°C lysates of human
(Figure 4.12C) and canine 1ymphocytes (Figure 4.14C). One was 70 kDa, which was most
likely HSC70, and the other was a band of 100 kDa which, as in the case of the anti-HSP blot,
may be a related protein.
It was previously noted that there was 100% similarity between the human derived heat shock
protein peptides and the same sequence in canine HSP70 and HSC70, thus both the anti-
peptide antibodies should, and did, recognize any protein with the respective peptide
sequences. Lindquist (1986) found that a monoc1onal antibody produced against Drosophila
HSP70, reacted with 70 kDa proteins found in Drosophila, sea urchins, nematodes, chickens
and humans.
Further investigations into the difference in expression ofHSP70 and HSC70 at 37°C or 44°C
could be done using 35S-methionine or [H]3-amino acid labelling. Western blots could be
made more sensitive using a chemiluminescent detection method. Alternatively, the
expression of HSP70 mRNA in the cells of interest could be determined using northern blot
analysis (Fincato et aI., 1991). To determine the degree of cross-reactivity between the anti-
peptide antibodies and HSP70 or HSC70, it would be necessary to obtain pure HSP70 and
HSC70 to be used in ELISAs or competitive assays using western blots.
In summary, the anti-peptide antibodies raised recognized both the free peptide and an
appropriate protein of 70 kDa in celllysates.
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CHAPTERS
ELECTRON PROBE X-RAY MICROANALYSIS OF CANINE MONOCYTES
5.1 INTRODUCTION
Electron probe X-ray microanalysis (EPXMA) is a technique that enables determination of the
elemental composition of a specimen (Warley, 1997). When the electron beam interacts with
the specimen, X-rays are generated and these carry information about the elemental
composition of the cell. The advantages of EPXMA are the simultaneous detection of
elements, analysis at the individual cell level and the intracellular localization of elements.
This technique is also unique in the fact that it combines the ability to undertake chemical
analysis with the high resolution of the electron microscope, hence one is able to correlate
chemical information with the ultrastructural aspect (Warley, 1997). As mentioned before,
Warley et al. (1994) state that this is an ideal method for measuring elemental concentrations,
elemental fluxes and for studying the effects of drugs on a given cell type. Elemental profiles
of the monocytes may give insights into the mechanisms of action of each drug. Monocytes
were incubated with therapeutic concentrations of the drugs, thus the results can be correlated
to clinical observations (Goldring and Nemaorani, 1999). Incubations with the drugs were
stopped after 0 min, 10 min and 18 h. The 10 min time point used in the present study was
chosen as Warley et al. (1994) found changes in elemental concentrations occur almost
immediately, and the 18 h time point was utilised, as anti-malarial drugs were found to
modulate the expression of monocyte surface receptors after 18 h (Goldring and Nemaorani,
1999). Air-drying was used, so although the specimen's structure is disrupted, the total
elemental content ofthe cell can still be measured (Warley, 1997).
5.2 ELEMENTAL PROFILES OF CANINE MONOCYTES INCUBATED WITH
ANTI-MALARIAL DRUGS
Monocytes were incubated with therapeutic concentrations of the eight anti-malarial drugs:
quinine, chloroquine, primaquine, artemisinin, pyrimethamine, tetracycline, doxycycline and
dapsone and suramin, a trypanocidal drug. Figure 5.1 shows a spectrum of a canine monocyte
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incubated in medium only, this spectrum is representative of all the control spectra obtained.
The peaks visible are Na, P, S, Cl, K, Ca and Au. The Au peak is from the grid and the
remaining elements are from the monocyte. It should be noted that a spectrum only shows the
number of counts obtained for each element and thus is qualitative d~ta. Quantitative data is
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Figure 5.1 A typical elemental X-ray spectrum produced by EPXMA of canine
monocytes. Canine monocytes were allowed to adhere to gold electron microscope grids. The
grids were removed from the medium, washed and airdried. Spectra were obtained in a Philips
CM120 transmission electron microscope equipped with an EDAX detector.
5.2.1 Elemental profiles of canine monocytes incubated with chloroquine, primaquine,
tetracycline, dapsone and pyrimethamine
Chloroquine, primaquine, tetracycline, doxycycline and dapsone have been grouped together
due to similarities in the elemental profiles, but it must be noted that the profiles are unique for
each drug (Figure 5.2). There was no significant difference in the concentration of Na after
10 min incubation with chloroquine, primaquine, tetracycline, pyrimethamine and dapsone
(Figure 5.2A; B; C; D and E; P>0.05). Between 10 min and 18 h there is a large increase in
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Na for all the drugs, which is statistically significant. Chloroquine, tetracycline and
pyrimethamine did not significantly affect the Mg concentration at either of the two time
points (Figure 5.2A; C and D; P>0.05). Primaquine induces a significant decrease in the Mg
concentration between 10 min and 18 h (Figure 5.2B; P>0.05). There was a significant
increase in the Mg concentration after 18 h incubation with dapsone (Figure 5.2E; P>0.05).
There was a significant increase in the P concentration after 10 mm incubation with
chloroquine (Figure 5.2A; P>0.05). Primaquine and pyrimethamine do not alter the P
concentration after 10 min, but after 18 h the concentration was significantly decreased below
that of the control in the monocytes incubated with chloroquine, primaquine and
pyrimethamine (Figure 5.2A; Band D; P>0.05). Tetracycline and dapsone did not
significantly alter the P concentration at any time point (Figure 5.2 C and E; P>O.05).
The concentration of S remams constant after 10 mm incubation with chloroquine,
primaquine, pyrimethamine and dapsone (Figure 5.2A; B; D and E; P>0.05), but there is a
significant decrease upon incubation with tetracycline (Figure 5.2C; P>0.05). After 18 h
incubation with all five drugs there is a significant increase in the concentration of S (Figure
5.2; P>O.05).
There was no significant difference in the concentrations of Cl after 10 min incubation with
primaquine, tetracycline, pyrimethamine and dapsone (Figure 5.2 B; C; D and E; P>0.05), but
there is a significant increase upon incubation with chloroquine, (Figure 5.2A; P>0.05). After
18 h incubation with all five drugs there is a significant increase in the concentration of Cl
(Figure 5.2; P>0.05).
The K concentration remams constant after 10 mm of incubation of monocytes with
chloroquine, primaquine, tetracycline and dapsone (Figure 5.2A; B; C; E; P>0.05). There was
a significant decrease in the K concentration after 10 min incubation with pyrimethamine
(Figure 5.2D; P>0.05). Monocytes incubated with tetracycline and dapsone after 18 h showed
a significant decrease in the K concentration (Figure 5.2C and E; P>O.05). The cells incubated
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Figure 5.2 Elemental composition of canine monocytes incubated with chloroquine,
primaquine, tetracycline, pyrimethamine and dapsone. Canine monocytes on gold electron
microscope grids were incubated with therapeutic concentrations of (A) chloroquine, (B)
primaquine, (C) tetracycline, and (D) pyrimethamine and (E) dapsone. The grids were
removed, washed and airdried after 0 min ( ), 10 min (.) and 18 h (.). Analysis took place
in a Phi1ips CM120 transmission electron microscope equipped with an EDAX detector.
Spectra were obtained and the concentrations determined using the continuum method. The
significant difference was determined using the Mann-Whitney U-test (P>0.05; statistical
difference between 0 min and 10 min* or 18 h#). Bars represent the standard error of the mean
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There was no significant difference in the Ca concentration of cells incubated with
chloroquine and pyrimethamine for any length of time (Figure 5.2A and D; P>0.05). The Ca
concentration was unaffected after 10 min of exposure to tetracycline and dapsone (Figure 5.2
C and E; P>0.05). There was a significant decrease in the Ca concentration in cells incubated
with primaquine. Tetracycline and dapsone induced a significant increase in the concentration
of Ca after 18 h. (Figure 5.2C and E; P>0.05).
All the drugs mentioned increased the concentrations of Na, S, and Cl. Differences between
the drugs are seen in their effects on Mg, P, K and Ca. Chloroquine is the only drug to
decrease P and increase K. Primaquine and pyrimethamine both decrease P. Primaquine was
the only drug to decrease Mg and Ca. Tetracycline and dapsone have no effect on P but
decrease K and increase Ca. Dapsone increases Mg concentrations. Thus even though these
dugs appear to alter the elemental profiles in a similar way, each drug induces individual
alterations in unique ways.
5.2.2 Elemental profiles of canine monocytes incubated with quinine and artemisinin
Artemisinin (Figure 5.3A) and quinine (Figure 5.3B) appear to influence the majority of the
elemental concentrations determined, in a similar manner. The concentrations ofNa, S and Cl
at 10 min are significantly decreased in monocytes incubated with both drugs. After 18 h the
concentrations of the Na and Cl are significant increased upon incubation with artemisinin
(Figure 5.3A; P>0.05) but are unaffected by quinine (Figure 5.3B; P>0.05). The concentration
of S returns to the levels of the control. There is a significant increase in the Mg
concentrations after 10 min but no significant difference after 18 h in the case of both drugs.
The P concentration is unaffected by the presence of artemisinin at 10 min and 18 h (Figure
5.3A; P>0.05). Quinine brings about a significant increase in the P concentration at 10 min.
(Figure 5.3B; P>0.05). Artemisinin significantly increased the concentration of Kat 10 min,
the concentration decreases significantly to levels below that of the control after 18 h (Figure
5.3A; P>0.05). Quinine causes a significant decrease in the K concentration within 10 min,
but the concentration was at pre-incubation levels after 18 h (Figure 5.3B; P>0.05).
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Artemisinin had no significant effect on the concentration of Ca at any time point studied,
whereas quinine induced a significant increase after 18 h (Figure 5.3; P>0.05).
Although these two drugs have completely different structures they seem to influence the
concentrations of certain elements in canine monocytes in a similar manner. Both drugs
significant decrease the concentrations ofNa, S and Cl after 10 min and significantly increase
the concentration of Mg after 10 min. With respect to P, K and Ca they influence the
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Figure 5.3 Elemental composition of canine monocytes incubated with artemisinin and
quinine. Canine monocytes on gold electron microscope grids were incubated with
therapeutic concentrations of (A) artemisinin and (B) quinine. The grids were removed,
washed and airdried after 0 min ( ), 10 min (.) and 18 h (.). Analysis took place in a Philips
CM120 transmission electron microscope equipped with an EDAX detector. Spectra were
obtained and the concentrations determined using the continuum method. The significant
difference was determined using the Mann-Whitney V-test (P>0.05; statistical difference
between 0 min and 10 min* or 18 h#). Error bars represent the standard error of the mean.
The monocytes incubated with quinine were subjected to a high concentration ofDMSO. Thus
to determine if DMSO contributed to the elemental concentration changes, the monocytes
were incubated with DMSO at the same concentration. The elemental profiles observed for
DMSO was very different to that observed in the monocytes incubated with quinine (data not
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shown). The concentrations of Na, P, S, Cl and K were unaltered after 10 mm but
significantly decreased after 18 h. The concentration of Mg was not affected at all by DMSO.
Ca concentrations decreased significantly after 10 min and increased to pre-controllevels after
18 h. Quinine altered the concentrations of elements after only 10 min whereas DMSO altered
the concentrations after 18 h. It is most likely that quinine overrides elemental changes
induced by the DMSO.
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Figure 5.4 Elemental composition of canine monocytes incubated with doxycycline.
Canine monocytes on gold electron microscope grids were incubated with therapeutic
concentrations of doxycycline. The grids were removed, washed and airdried after 0 min ( ),
10 min (.) and 18 h (.). Analysis took place in a Philips CMl20 transmission electron
microscope equipped with an EDAX detector. Spectra were obtained and the concentrations
determined using the continuum method. The significant difference was determined using the
Mann-Whitney V-test (P>0.05; statistical difference between 0 min and 10 min* or 18 h#).
Error bars represent the standard error ofthe mean.
Doxycycline is unique amongst the anti-malarial drugs tested and produced unique alterations
in monocyte elemental concentrations (Figure 5.4). Doxycycline significantly decreased the
concentrations of Na, Mg, S and Cl at 10 min, the concentrations increased at 18 h to the
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levels of the controls (Figure 5.4; P>0.05). The concentration of P is not significantly altered
at any time points measured. The concentraion of K remains constant after 10 min but
significantly decreases after 18 h. Doxycycline significantly decreased the concentration of
Ca at 10 min, the concentration significantly increased at 18 h to levels higher than the control·
(Figure 5.4; P>0.05). The major difference between the trends seen for doxycycline and the
drugs previously mentioned in Figures 5.2 and 5.3, is at 10 min the elemental concentration of
Na, S, Cl and Ca was decreased, and the [Ca] increased after 18 h.
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Figure 5.5 Elemental composition of canine monocytes incubated with suramin. Canine
monocytes on gold electron microscope grids were incubated with therapeutic concentrations
of suramin. The grids were removed, washed and airdried after 0 min ( ), 10 min (.) and 18
h (.). Analysis took place in a Philips CM120 transmission electron microscope equipped
with an EDAX detector. Spectra were obtained and the concentrations determined using the
continuum method. The significant difference was determined using the Mann-Whitney V-test
(P>0.05; statistical difference between 0 min and 10 min* or 18 h#). Error bars represent the
standard error of the mean.
Suramin causes a significant increase in the concentrations of Na, S and Cl after 10 min, but
after 18 h the concentrations return to pre-controllevels (Figure 5.5; P>0.05). There is no
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significant difference in the concentrations of Mg and P for the time points measured. In the
case of K, the concentration remains constant until 10 min and thereafter it decreased
significantly. There is a significant increase in the concentration of Ca after 18 h. The profile
of this trypanocidal drug is different to any of the anti-malarial drugs previously discussed in
this chapter.
5.2.5 Summary
This is a brief summary pointing out the similar effects of drugs on the individual elements
(Table 5.1). The relevance of these effects will be discussed later at the end of the chapter
(Section 5.6). All the drugs altered the concentrations of sodium significantly (Table 5.1).·
However, there were differences in the time when the changes occurred and whether there was
an increase or a decrease. Suramin was the only drug that increased the concentration of Na
after 10 min (Figure 5.5), where as chloroquine, primaquine, tetracycline, pyrimethamine,
dapsone (Figure 5.2) and artemisinin (Figure 5.3A) increased the concentration after 18 h.
The concentration of Na was decreased by artemisinin, quinine (Figure 5.3) and doxycycline
(Figure 5.4) after 10 min. It was interesting to note that artemisinin decreased the
concentration of Na rapidly but after 18 h the concentration was increased above that of the
control. Artemisinin was the only drug to induce two changes in the Na concentration at the
two time points measured with respect to the control.
The concentration of Mg was affected by a few drugs (Table 5.1). Artemisinin and quinine
increased the concentration after 10 min (Figure 5.3), whereas only dapsone increased the
concentration after 18 h (Figure 5.2E). Doxycycline (Figure 5.4) decreased the concentration
immediately and primaquine (Figure 5.2B) decreased the concentration after 10 min and 18 h,
suggesting that the Mg concentration stays at a lowered level for the full 18 h.
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Table 5.1 Anti-malarial drugs inducing significant alterations in elemental
concentrations in canine monocytes. Drugs inducing different effects at 10 min and 18 h# (P>0.05);
drugs inducing similar effects at 10 min and 18 h* (P>0.05).
Element Time Increase Decrease









Mg 10 min Artemisinin Primaquine*
Quinine Doxycycline
18 h Dapsone Primaquine*























K 10 min Artemisinin# Pyrimethamine
Quinine












In Table 5.1 the concentration of P was increased by chloroquine (Figure 5.2A) and quinine
(Figure 5.3B) immediately, but after 18 h the concentration was decreased by chloroquine,
primaquine and pyrimethamine (Figure 5.2A; B and D). It was interesting to note that
chloroquine increased the concentration of P after 10 min but after 18 h the concentration was
decreased below control levels.
Suramin (Figure 5.5) was the only drug that increased the concentration of S rapidly (Table
5.1), however after 18 h the concentration was increased by chloroquine, primaquine,
tetracycline, pyrimethamine and dapsone (Figure 5.1). Tetracycline (Figure 5.2C), artemisinin,
quinine (Figure 5.3) and doxycycline (Figure 5.4) decreased the concentration of S after 10
min. Tetracycline had a dual effect by decreasing the concentration after 10 min and then
increasing it above control levels after 18 h.
The chlorine concentration was increased after 10 rnin by chloroquine (Figure 5.2A) and
suramin (Figure 5.5), and after 18 h by chloroquine, primaquine, tetracycline, pyrimethamine,
dapsone (Figure 5.2) and artemisinin (Figure 5.3A). Chloroquine induced what appears to be
a permanent increase in the Cl concentration, this may be due to the presence of a chlorine
group in the structure but it is premature to draw any conclusions. Artemisinin, quinine
(Figure 5.3) and doxycycline (Figure 5.4) decreased the Cl concentration after 10 min.
Artemisinin again shows a dual effect where after 10 min it induces a decrease but after 18 hit
causes an increase of the Cl concentration above the control level (Table 5.1).
Potassium was increased in concentration after 10 min by artemisinin (Figure 5.3A) and after
18 h by chloroquine (Figure 5.2A). Pyrimethamine (Figure 5.2D) and quinine (Figure 5.3B)
decreased the concentration of K immediately, where as tetracycline, dapsone (Figure 5.2 C
and E), artemisinin (Figure 5.3A), doxycycline (Figure 5.4) and suramin (Figure 5.5). Again
arternisinin induced a dual effect by increasing the K concentration after 10 min and then
decreasing it with respect to the control after 18 h.
Quinine (Figure 5.3B) increased the concentration of calcium after 10 min and after 18 h,
tetracycline, dapsone (Figure 5.2 C and E), doxycycline (Figure 5.4) and suramin (Figure 5.5)
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increased the concentration. The concentration was decreased after 10 min by primaquine
(Figure 5.2B) and doxycycline (Figure 5.4). In this case doxycycline induced a dual effect on
the Ca concentration, by decreasing it after 10 min and increasing it after 18 h.
The reported dual effects (Table 5.1) are interesting and unexpected, especially where at one
time point the concentration of the element is decreased significantly below the control and
then after 18 h the concentration is increased above the control, or vice versa. Artemisinin is
interesting in that it affects three elements in this dual manner: Na and Cl with a decrease after
10 min and an increase after 18 h, and K where the opposite happens. Tetracycline and
doxycycline also exhibit dual effects on S and Ca respectively i.e. decrease after 10 min and
increase after 18 h. Chloroquine exhibits two types of dual effect: P is increased after 10 min
and decreased after 18 h; and Cl is increased over both time points. Primaquine decreases the
Mg concentration at both time points measured.
An interesting occurrence to note is all of the elemental concentrations altered by quinine
occurred after 10 min, thereafter the concentrations returned to normal levels. Dapsone
induced its effects after 18 h on all the elements where the concentrations were altered. All
the other drugs measured altered the concentrations of elements at both 10 min and 18 h. All
the drugs used in this study induced both increases and decreases in the elemental
concentrations.
As important as the increases and decreases in the elemental concentrations may be, the drugs
that do not induce any effect on specific elements may also be important (Table 5.2). Mg
concentration was unaltered by chloroquine, tetracycline, pyrimethamine (Figure 5.2A, C and
D) and suramin (Figure 5.5). Tetracycline, dapsone (Figure 5.2 C and E), artemisinin (Figure
5.3A), doxycycline (Figure 5.4) and suramin (Figure 5.5) did not alter the concentration of P
in canine monocytes. The concentration of K was only unaffected by one drug, primaquine
(Figure 5.2B). Calcium concentrations were unaltered by incubation of canine monocytes
with chloroquine, pyrimethamine (Figure 5.2A and D) and artemisinin (Figure 5.3A).
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Table 5.2 Anti-malarial drugs that do not induce significant alterations in elemental





















It was interesting to note that although some of the drugs altered the concentrations of specific
elements in a similar manner, none of the drugs altered the concentrations in the same way as
any other drug. The similarities and the differences can most likely be accounted for by the
similarities or differences in the structures of the drugs and their modes of action.
5.3 PHOSPHOROUS I POTASSIUM (P/K) RATIOS OF CANINE MONOCYTES
INCUBATED WITH ANTI-MALARIAL DRUGS
Although the elemental profile gives a lot of information about the effects of the various
drugs, the PIK ratios give information about fluxes within the cell, such as the opening and
closing of K channels. K channels also maintain the [K] and exist in either a closed or open
conformation depending on the voltage across the membrane (Karp, 1996). When the K
channel opens, more than a million K ions can flow through in one second, thus changes in
intracellular K concentration are extremely rapid. The opening of a small number of K
channels impacts significantly on the electrical properties of the cell. There may be a variety
of different K channels in a single cell that open and close in response to different voltages
(Karp, 1996). P concentrations remain fairly constant in cells, as the majority of the element
is present in DNA. However, this is not an infallible rule as there are proteins which contain P.
The concentration is also dependent on the stage of the cell cycle, i.e. a cell undergoing
division is likely to have a much higher concentration of P than a cell not dividing. In
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comparison to all the other elements P is the best to use as a constant in a ratio (Skepper et al.,
1999).
5.3.1 P/K ratios of canine monocytes incubated with chloroquine and primaquine
The P/K ratios of cells incubated with chloroquine (Figure 5.6A) and primaquine (Figure
5.6B) are similar in profile. There is no significant difference (P>O.05) in the P/K ratios for
both drugs after 10 min. However, after 18 h there is a significant decrease (P>O.05) in the
P/K ratios of both drugs. The K concentration is increased with respect to the P concentration,
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Figure 5.6 PIK ratios of canine monocytes incubated with chloroquine and primaquine.
Canine monocytes on gold electron microscope grids were incubated with therapeutic
concentrations of (A) chloroquine and (B) primaquine for 0 min, 10 min and 18 h. Once the
spectra were obtained and the concentrations determined the P/K ratio was calculated. The
significant difference was determined using the Mann-Whitney V-test (P>O.05; statistical
difference between 0 min and 18 h#).
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5.3.2 P/K ratios of canine monocytes incubated with tetracycline, doxycycline,























































Figure 5.7 PIK ratios of canine monocytes incubated with tetracycline, doxycycline,
artemisinin, suramin and dapsone. Canine monocytes on gold electron microscope grids
were incubated with therapeutic concentrations of (A) tetracycline, (B) doxycycline, (C)
artemisinin, (D) suramin and (E) dapsone for 0 min, 10 min and 18 h. Once the spectra were
obtained and the concentrations determined the P/K ratio was calculated. The significant
difference was determined using the Mann-Whitney V-test (P>0.05; statistical difference
between 0 min and 10 min* or 18 h#).
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The P/K ratios of tetracycline (Figure 5.7A), doxycycline (Figure 5.7B), artemisinin (Figure
5.7C), suramin (Figure 5.7D) and dapsone (Figure 5.7E) show a similar trend. After 10 min
there. is a significant increase in the P/K ratio of cells incubated with dapsone only (Figure
5.7D; P>0.05). After 18 h there is a significant increase in the P/K ratios of cells incubated
with tetracycline, doxycycline, suramin and dapsone (Figure 5.7A; B; D and E; P>0.05).
Although artemisinin appears to have a similar trend to the other four drugs, there is in fact no
significant difference in the P/K ratios at both the time points studied. Thus K concentration
was decreased with respect to the P concentration, which indicates the opening ofK channels.
The channels were open after 10 min and 18 h in cells incubated with dapsone, but opened
only after 18 h in cells incubated with tetracycline, doxycycline and suramin. The only
exception was artemisinin where the channels were unaffected.
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Figure 5.8 P/K ratios of canine monocytes incubated with pyrimethamine. Canine
monocytes on gold electron microscope grids were incubated with therapeutic concentration
of pyrimethamine for 0 min, 10 min and 18 h. Once the spectra were obtained and the
concentrations determined the P/K ratio was calculated. The significant difference was
determined using the Mann-Whitney V-test (P>0.05; statistical difference between 0 min and
10 min* or 18 h#).
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The PIK ratios of monocytes incubated with pyrimethamine show a large fluctuation (Figure
5.8). After 10 min the PIK ratio was significantly increased (P>0.05), however after 18 h it
had decreased significantly to below control values. In this case it is possible that after 10 min
where the K concentration is decreased with respect to the P concentration, the K channels
may be opening. But after 18 h the K channels may be closed as K is increased with respect to
P.
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Figure 5.9 P/K ratios of canine monocytes incubated with quinine. Canine monocytes
on gold electron microscope grids were incubated with therapeutic concentration of quinine
for 0 min, 10 min and 18 h. Once the spectra were obtained and the concentrations determined
the PIK ratio was calculated. The significant difference was determined using the Mann-
Whitney V-test (P>0.05; statistical difference between 0 min and 10 min* or 18 h#).
Quinine (Figure 5.9) shows a profile similar to pyrimethamine (Figure 5.8) with the ratios
after 10 min significantly elevated (P>0.05) to a ratio of 10.04. After 18 h the ratio has
returned to pre-incubation levels. Thus after 10 min the K channels are opening, as [K] is
decreased with respect to [P], but after 18 h the K channels have closed and returned to the
normal state. Monocytes incubated with DMSO at the high concentration used to solubilize
quinine, showed no significant difference in the PIK ratio after 10 min, but increased
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significantly (P>0.05) to a ratio of 5.2 after 18 h. This indicates that a K channels was
opening after 18 h. There were differences in the trends and the P/K ratio values where
significant increases were observed in monocytes incubated with quinine and DMSO.
5.3.5 Summary
This is a brief summary pointing out the similar effects of drugs on the P/K ratios of canine
monocytes (Table 5.3). The relevance of these effects will be discussed later at the end of the
chapter (Section 5.6).
Table 5.3 Anti-malarial drugs inducing significant alterations in the P/K ratios of canine·
monocytes.

















An increase in the P/K ratio i.e. the K concentration is decreased with respect to the P
concentration indicates that K channels is opening and vice versa. The P/K ratios (Table 5.3)
of canine monocytes were increased significantly above pre-incubation levels by dapsone
(Figure 5.7E; P>0.05), pyrimethamine (Figure 5.8; P>0.05) and quinine (Figure 5.9; P>0.05)
after 10 min and by tetracycline, doxycycline, suramin and dapsone (Figure 5.7 A, B, D and E;
P>0.05). There was a significant decrease in the P/K ratios after 18 h, induced by chloroquine,
primaquine (Figure 5.6; P>0.05) and pyrimethamine (Figure 5.8; P>0.05). Artemisinin (Figure
5.7C; P>0.05) had no effect at all on the P/K ratios of the canine monocytes at any of the time
points measured. As noted in the elemental concentrations, there are also dual effects in the
alterations of the P/K ratios. However, these dual effects are exerted by drugs that altered the
elemental concentrations at one time point only. Dapsone increased the P/K ratio after 10 min
and 18h. Pyrimethamine increased the P/K ratio after 10 min and then after 18 h decreased
the ratio below the pre incubation levels.
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5.4 ELECTRON PROBE X-RAY MICROANALYSIS OF PHAGOCYTICALLY
ACTIVE CANINE MONOCYTES
Previous chapters have shown that the monocytes are phagocytically active with 72% and
70.5% phagocytosing latex beads and ~-hematin respectively. Thus the chances that
phagocyticallyactive cells were analysed were high. ~-Hematin has been shown to disrupt the
normal functioning of human monocytes (Arese and Schwarzer, 1997) in an unknown way.
EPXMA may unlock the mechanism of how ~-hematin disrupts further phagocytic activity of
monocytes.
5.4.1 Elemental profiles of canine monocytes that phagocytosed latex beads or ~­
hematin
Monocytes that have phagocytosed latex b~ads (Figure 5.10A) or ~-hematin (Figure 5.10B)
have different elemental profiles. Latex beads do not significantly alter the Na concentration
at 10 min or after 18 h, whereas ~-hematin causes a significant decrease in Na concentration
after 10 min, followed by a return to control levels after 18 h. Mg concentration was
significantly increased by latex beads after 10 min , but after 18 h the concentration returned
to control levels. There was no significant difference in the concentration of Mg in cells
phagocytosing ~-hematin for 10 min but there was a significant increase after 18 h. Latex
beads do not alter the P concentration at any of the time points used (Figure 5.l0A; P>0.05).
The P concentrations of monocytes after phagocytosis of ~-hematin were significantly
increased after 10 min and after 18 h. The S concentrations were not significantly affected by
either latex bead or ~-hematin phagocytosis. Cl concentrations remained within pre-incubation
levels at 10 min and at 18 h after phagocytosis of latex beads. p-hematin induced a significant
decrease in the Cl concentration at 10 min but after 18 h the concentration returned to control
values (Figure 5.10B; P>0.05). Latex beads had no significant effect on the concentration of
K at 10 min, but after 18 h there was a significant decrease in its concentration. p-hematin had
no significant effect on the K concentration at all time points examined. The Ca concentration
was unaffected after 10 min but after 18 h there was a significant increase in concentration in
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cells phagocytosing latex beads and p-hematin. There are no similarities between the
elemental profiles of monocytes that phagocytosed latex beads or p-hematin, with the
exception of the effects on the concentration of Ca. The latex beads stimulate the normal
processes that occur after phagocytosis, such as the generation of reactive oxygen
intermediates, whereas p-hematin has a completely different effect on the elemental
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Figure 5.10 Elemental composition of canine monocytes that phagocytosed latex beads
or p-hematin. Canine monocytes on gold electron microscope grids were allowed to
phagocytose (A) latex beads and (B) p-hematin. The grids were removed, washed and air
dried after 0 min ( ), 10 min (.) and 18 h (.). Analysis took place in a Philips CM120
transmission electron microscope equipped with an EDAX detector. Spectra were obtained
and the concentrations determined using the continuum method. The significant difference
was determined using the Mann-Whitney U-test (P>0.05; statistical difference between 0 min
and 10 min* or 18 h#). Error bars represent the standard error of the mean.
5.4.2 PIK ratios of canine monocytes that phagocytosed latex beads or p-hematin
After 10 min the PIK ratio of the monocytes that had phagocytosed latex beads was not
significantly altered, but there was a significant increase in the ratio after 18 h (Figure 5.IIA;
P>0.05). This indicates that the K channels may be opening. In the case of p-hematin, the
PIK ratio is significantly elevated above the control value after 10 min and after 18 (Figure
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5.11B; P>0.05), indicating the opening ofK channels after 10 min, and maybe after 18 h a
small number of the K channels have closed. As was seen in the elemental profiles there is a
difference between the PIK ratios of monocytes that had phagocytosed either latex beads or
hemozoin. The only similarity that can be drawn between the two is that after 18 h the K
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Figure 5.11 P/K ratios of canine monocytes that have phagocytosed latex beads and ~­
hematin. Canine monocytes on gold electron microscope grids were allowed to phagocytose
(A) latex beads and (B) ~-hematin. The grids were removed, washed and air dried after 0 min,
10 min and 18 h. Once the spectra were obtained and the concentrations determined the PIK
ratio was calculated. The significant difference was determined using the Mann-Whitney U-
test (P>0.05; statistical difference between 0 min and 10 min* or 18 h#).
5.4.3 Summary
When latex beads or ~-hematin are phagocytosed they will activate the monocytes, but
because of their physical characteristics the type of activation is likely to be different. In Table
5.4, the differences between the effects of the latex bead and ~-hematin phagocytosis on the
elemental concentrations are summarised. The only similarities are that both of these
compounds increase the concentration of Ca after 18 h, and both have no effect on the
concentration of S; all other effects are completely different. Na is only altered by ~-hematin
after 10 min. The concentration of Mg is increased after 10 min by latex beads and decreased
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after 18 h with p-hematin. The P concentration was increased by p-hematin for the duration of
the study. p-hematin decreased the concentration of Cl after 10 min and the latex beads
decreased the concentration of K after 18 h. The PIK ratio of canine monocytes that have
phagocytosed p-hematin were increased after 10 min and 18 h, where as the cells that
phagocytosed latex beads, the PIK ratio was increased after 18 h only (Figure 5.11).
Table 5.4 Phagocytosis of latex beads or, p-hematin inducing significant alterations in
elemental concentrations in canine monocytes. Similar effect exerted by one condition* (P>O.05).
Time Elemental concentration significantly
Increased Decreased
Latex Beads 10 min--------"""-----------------
18 h





5.5 ELECTRON PROBE X-RAY MICROANALYSIS OF HEAT SHOCKED CANINE
MONOCYTES
One of the symptoms of malaria is high fever. All living orgamsms have developed
mechanism to deal with the stress of elevated temperatures, in fact as mentioned before the
proteins involved are the most conserved proteins in animals. However, in the present study
the proteins are not the focus but rather the question addressed was how does the elemental
composition change between monocytes incubated at 37°C and those cells incubated under
heat shock or stress conditions at 44DC?
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Figure 5.12 Elemental composition of canine monocytes incubated at 37°C or 44°C.
Canine monocytes on gold electron microscope grids were incubated at (A) 37°C and (B)
44°C. The grids were removed, washed and air dried after 0 min ( ), 10 min (-), 30 min (-)
and 2 h (-). Analysis took place in a Philips CM120 transmission electron microscope
equipped with an EDAX detector. Spectra were obtained and the concentrations determined
using the continuum method. The significant difference was determined using the Mann-
Whitney V-test (P>0.05; statistical difference between 0 min and 10 min*, 30 min# or 2 h+).
Error bars represent the standard error of the mean.
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As described in Chapter 4, the monocytes were incubated for 2 h and grids were removed after
0, 10 and 30 min, as well as 2 h. These incubation times are different from those used in the
drug study as continued heat shock for 18 h would be ultimately detrimental to the integrity
and viability of the cells. The Na concentration at 37°C (Figure 5.12A; P>0.05) was
significantly decreased after 10 min but after 30 min there was a significant increase above the
value of the control, the concentration then returned to normal levels after 2 h. The Na
concentration was not affected, at any time by incubation at 44°C (Figure 5.l2B; P>0.05).
Incubation at 37°C and 44°C at the times stipulated had no significant effect on the Mg, P, S
and Ca concentration. The Cl and K concentrations were not significantly altered after
incubation at 37°C for all the time points measured. The concentration of Cl and K after
incubation at 44°C was significantly decreased below that of the control after 10 min and
remained at the same concentration at 30 min and 2 h.
5.5.2 P/K ratios of heat shocked canine monocytes
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Figure 5.13 P/K ratios of canine monocytes incubated at 37°C or 44°C. Canine
monocytes on gold electron microscope grids were incubated at (A) 37°C and (B) 44°C. The
grids were removed, washed and air dried after 0 min, 10 min, 30 min and 2 h. Once the
spectra were obtained and the concentrations determined the P/K ratio was calculated. The
significant difference was determined using the Mann-Whitney U-test (P>0.05; statistical
difference between 0 min and 10 min*, 30 min# or 2 h+).
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Incubation at 37°C for all time points resulted in no significant difference in the P/K ratio
(Figure 5.13A; P>0.05). The P/K values for the monocytes incubated at 44°C was not
significantly altered after 10 min, but significantly increased after 30 min and 2 h (Figure
5.13B; P>0.05). Thus K channels have opened after 30 min and remained open for the 2 h.
There is a difference between the P/K ratios of cells incubated at 37°C and 44°C after 30 min
and 2 h.
5.5.3 Summary
The control cells incubated at 37°C exhibited a dual change in the concentration of Na; after
10 min the concentration was decreased but after 30 min the concentration was increased
above that of the control. These effects at 37°C were unexpected. Incubation at 44°C did not
alter the cells' Na concentration but, the concentrations of Cl and K were decreased for a the
duration of the study. Mg, P, S and Ca concentrations were unaffected by incubation at 37°C
or 44°C (Figure 5.12). The P/K ratios of the canine monocytes incubated at 37°C were
unaltered for the duration of the study, whereas the ratios of the cells incubated at 44°C were
increased after 30 min and 2 h (Figure 5.13).
5.6 DISCUSSION
There was very little difference between the spectra of human monocytes and canme
monocytes (data not shown). However, the spectra of normal human monocytes obtained by
Fishman et al. (1985) were different to the spectra obtained in this study (Figure 5.1). The·
discrepancies between the spectra are most likely due to the preparation techniques used, as in
this study the monocytes were air dried whereas Fishman et al. (1985) fixed and embedded the
cells in resin. It is likely that the spectra obtained in this study are more representative of the
elemental concentrations in the monocyte as air-drying only removes the water whereas fixing
and resin embedding would alter the elemental concentrations considerably.
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Mammalian cells contain twenty different chemical elements, and the distribution of these
elements is controlled by highly organised mechanisms (Williams and Frausto da Silva, 2000).
There are intense feedback mechanisms that maintain the distribution and the homeostasis of
each element. The distribution of an element has two characteristics: one is the incorporation
of the element in certain compounds (e.g. DNA) and the second is the disposition of the
compound in different compartments (e.g. DNA in the nucleus) and parts of a cell or organism
(Williams and Frausto da Silva, 2000).
The major chemical elements in the cell are C, H, 0 and N. These elements form kinetically
stable organic molecules such as proteins, fatty acids, polynucleotides and polysaccharides
(Williams and Frausto da Silva, 2000). In this study, however, these were not measured, as
the X-rays emitted by these elements are below the detection limits of the beryllium window
used.
The concentration of su1fur in canine monocytes in this study was altered by all the drugs
tested but in different ways and at different times (Table 5.1). Monocytes phagocytosing latex
beads and ~-hematin, as well as those incubated at 37°C and 44°C, showed no alterations in
the [S] at the time points studied. The distribution of S is described as 'peculiar' by Williams
and Frausto da Silva (2000). This element is dominantly situated in the metabolic pathways of
all organisms such as the pathway of oxidative phosphorylation. Many coenzyme structures
and activities are based on thiol (cysteine) and thioethers (methionine). The intracellular pool
of methionine is low and carefully regulated, which is why S35-methionine labelling is
successful in determining the expression of new proteins. The extracellular saccharides of
higher organisms contain sulphate. S is essential for the production ofATP by aerobic cellular
respiration (Tortora and Grabowski, 2000). Bouchot et al. (1999) found an increase in the [S]
in the nucleus of THP-1 cells infected with Toxoplasma gondii, which may be due to an
increase in DNA transcription and protein synthesis. The increase in [S] brought about in this
study by chloroquine, suramin, primaquine, tetracycline, pyrimethamine and dapsone, may be
due to the same process. The relevance of and the reason for the decrease in the [S] brought
about by tetracycline, artemisinin, quinine and doxycycline, is unknown in some instances as
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is the reason why tetracycline induces a decrease in [S] at 10 min followed by an increase at
18 h.
Phosphorous exists in an organism in one oxidation state, phosphate. The distribution of P is
in irreversible covalent compounds such as phospholipids, DNA, RNA and ATP (Tortora and
Grabowski, 2000), which are connected to transcription factors and membrane pumps. It has
been observed that the levels of nucleotide phosphates, e.g. ATP are fixed for a specific·
metabolic state of the cell. Williams and Frausto da Silva (2000) mention that the distribution
ofP is extremely complex and influenced by numerous control mechanisms.
The [P] was increased by chloroquine and quinine at 10 min, and decreased by chloroquine,
primaquine and pyrimethamine after 18 h (Table 5.1). Phagocytosis of p-hematin induced an
increase in [P] at the time points studied (Table 5.4). Skepper et al. (1999) also observed
unexpected changes in the [P], which they considered difficult to explain, but suggest that the
fluctuations observed in [P] may be related to the cellular region analysed. These regions will
contain both the cytoplasm and nucleoplasm, so any variations in the shape of the cell may
alter the ratio of cytoplasm to nucleoplasm. However, this is unlikely to be the case in this
study as not all the drugs examined altered the [P] and several cells were measured per
experimental condition, statistically reducing this likelihood.
THP-l cells infected with Toxoplasma gondii showed lower [P] in the nucleus than the
uninfected cells (Bouchot et al., 1999). Bouchot et al. (1999) mentions that the [P] may be
correlated with phosphorylation of the nuclear components and this is most likely the reason
for the changes in [P]. It is unknown why chloroquine initially triggers the cell in a way that
decreases the [P], but after prolonged exposure there is a change in the cells response by
increasing [P]. The cells that have phacogytosed p-hematin have increased [P] after 10 min
and 18 h, suggesting that the p-hematin exerts both an immediate and a prolonged effect.
The majority of the elements studied cations (Na, Mg, K and Ca) but there are a few anions
(Cl). These elements are handled by simple ionic transport processes and their distribution is
directly related to the concentration of their respective free ions in equilibrium with the bound
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fonns. Concentrations of these elements in the extracellular and intracellular environments
are generally uneven, which is directly related to the pumps, exchangers and channels which
control them (Beames Jr., 1971; Eckert, 1988; Williams and Frausto da Silva, 2000).
Immediately after addition of the drugs to the monocytes, major fluctuations in the elemental
concentrations may occur as a result of the pumps being activated. However, after 18 h of
incubation the cells are likely to reach equilibrium, thus giving an indication as to the
prolonged increases and decreases brought about by the drugs.
Sodium ions represent approximately 90% of the extracellular cations (Tortora and
Grabowski, 2000). The most abundant cation in the intracellular fluid is K. NaIK ATPase
actively maintains the concentrations ofK and Na in the cell. The pump actively transports Na
out of the cell and K into the cell to maintain a balance in the concentrations: because the ions
are able to diffuse back across the membrane the pumps operate continually (Tortora and
Grabowski, 2000). The sodium pumps, are also responsible for maintaining nonnal cell
volume. Glucocorticoids exert their effect by increasing the cell volume in U937 macrophages
(Gamper et a!., 2000). The activation of Na conductance into the cell by osmotic shrinkage is
thought to depolarise the cell membrane, which then facilitates the entry of Cl and ultimately
increases the volume ofthe cell (Gamper et al., 2000).
Cl ions are the most abundant extra cellular anions (Tortora and Grabowski, 2000). Fluxes in
[Cl] have been implicated in apoptosis, where the CD95 receptor is triggered to activate an
outwardly rectifying chloride channel (ORCC). The efflux of Cl in staurosporine-induced
apoptosis activates Ced-3/ICE proteases (Femandez-Segura et al., 1999). If the decrease in
[Cl] brought about by incubation corresponded to cell death, then it would be expected that
cells that show low levels after 10 min would show even lower levels after 18 h, but this was
not the case. Artemisinin induced the opposite effect by producing high levels of Cl after 18 h,
even though the [Cl] was low after 10 min. The [Cl] remains elevated after 10 min and 18 h
incubation with chloroquine. This may just be due to the presence of the Cl in the structure of
the drug, but a significant difference was noted between the [Cl] at 10 min and at 18 h which
suggests that this is unlikely to be the case.
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Decreases in [K] and [Cl] and increases in [Na] precede the appearance of apoptosis markers,
but these changes were not associated with loss of membrane integrity (Femandez-Segura et
al., 1999; Skepper et al., 1999). War1ey (2002, pers. comm:) found that K channels were
activated early in apoptosis, while the exposure of apoptotic cells to high [K] attenuates
apoptosis. K has been implicated in the activation of caspase-1 and caspase-3 (CPP32)-like
proteases. The loss ofK is crucial for the activation of endonucleases in intact cells, which are
thought to be involved in phagocytosis. With regard to the drugs used in this study, none
induced decreases in [K] and [Cl] or increases in [Na], suggesting that they did not induce
apoptosis.
Nkamgueu et al. (2000) found that human monocytes challenged with microorganisms or
alumina particles manifested an increase in [Na] and [Cl] and a decrease in [K]. Canine
monocytes incubated with tetracycline, dapsone and artemisinin for 18 h· showed similar
results. ~-Hematin induced an increase in [Na] and a decrease in [Cl] at all the time points
measured, and had no effect on the [K]. The phagocytosis of latex beads induced a decrease in
the [K] concentration after 18 h. Drugs induced similar effects, but the increases of [Na] and
[Cl] and the decrease in [K] occurred at different time points. Suramin increased [Na] and
[Cl] after 10 min, and decreased [K] after 18 h, whereas pyrimethamine increased [Na] and
[Cl] after 18 h and decreased [K] after 10 min. Primaquine increased the concentrations ofNa
and Cl after 18 h, but had no effect on the concentration of K at any of the time points
measured.
Artemisinin-treated malaria-infected red blood cells have lower [K] and [P], and higher [Na],
in the early stage parasites than the late stage parasites. These effects are most likely due to the
drug acting on membrane transport and phosphorous metabolism (Lee et al., 1988). Unlike the
infected red blood cells, canine monocytes incubated with artemisinin showed no significant
change in the [P]. Chloroquine induces a decrease in [K] and an increase in [Na] in the late
stage parasites (Lee et al., 1988). In canine monocytes chloroquine increased the
concentrations of Na, Cl and K. The [K] is decreased and the [Na] increased in red blood
• Dr A. Warley, Division of Physiology, United Medical and Dental Schools, St Thomas's Hospital Campus,
Lambeth Palace Road, London, SEl 7EH, United Kingdom.
162
cells infected with late stage parasites, whereas the parasites have high [K] and low [Na] (Lee
et al., 1988). After 20 h of infection the [Na] decreased and the [K] increased in THP-I cells
infected with Toxoplasma gondii (Bouchot et al., 1999). The only drug to induce high [K]
and low [Na] in canine monocytes was artemisinin after 10 min.
Cells that are subjected to heat shock showed depressed levels of K and Cl at all time points
measured. There are numerous changes in the physiology of a cell after heat shock (Welch et
al., 1991). These include alterations in the activity of the NaIK ATPase, thus altering the
levels of intracellular Na and K (Welch et al., 1991). There may be a role for K and K
channels in heat shock. Separate activation of K and Cl transporters during heat shock,
oxidative injury or other inducers of the stress response (Polla et al., 1991).
Quinine decreased the concentrations ofNa, Cl and K after 10 min, doxycycline decreased the
concentrations of Na and Cl after 10 min, and K after 18 h. At present there is no literature
available which describes any situations where the concentrations of Na, K and Cl are all
depressed.
Skepper et al. (1999) mention that a small but significant fall in the [Na] of the control over
the experimental period indicated a healthy NaIK ATPase mechanism and viable cells. The
canine monocytes incubated at 37°C in this study showed decreased [Na] after 10 and 30 min.
Adams and Hamilton (1992) noticed that with the addition of IFNy to macrophages there was
an immediate rise in the concentration of Na. IFNy activates macrophages in vivo thus an
immediate increase in the [Na] may indicate the activation of the cells. In this study suramin
was the only drug to increase the [Na] immediately. Thus suramin may be activating the
monocytes or inducing the secretion ofIFNy.
If the P/K ratio is close to unity in the control but significantly elevated or depressed on
treatment with drugs, this indicates a relatively stable P contribution and a large contribution
to the P/K ratio from changes in the K concentration (Skepper et al., 1999). However, in the
case of this study the PIK ratios of the controls were not close to unity but the majority had a
ratio of 2, indicating that the [P] was not stable in the monocytes studied and further indicating
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a contribution from both [K] and [P]. Until further studies are performed on normal canine
monocytes to determine the normal PIK ratios, no conclusions can be made from these data.
The canine monocyte PIK ratios in this study were increased by dapsone, pyrimethamine,
quinine and ~-hematin phagocytosis after 10 min, and by tetracycline, doxycycline, suramin,
dapsone, ~-hematin and latex bead phagocytosis after 18 h. The PIK ratios were decreased
after 18 h by chloroquine, primaquine and pyrimethamine. It was interesting to note that cells
incubated at 37°C and 44°C, and with artemisinin, showed no significant change in the PIK
ratio at all the time points studied. ~-hematin phagocytosis resulted in an elevated PIK ratio at
both 10 min and 18 h, which indicated the opening of K channels. Pyrimethamine increased
the PIK ratio after 10 min and then decreased it after 18 h, indicating the K channels were
open and then closed. Quinine is able to block K channels in a concentration dependent
manner from 50 to 200 ~M (Maruyama et al., 1994), which was much higher than the
therapeutic concentration (15 ~g/m1 == 40 ~M) used in this study. Quinine appeared to induce
the rapid opening of the K channels in this study, but after 18 h they appeared to be closing
which may indicate that quinine is blocking the K channels.
In this study the concentration of Mg was increased by artemisinin, quinine and phagocytosis
of latex bead after 10 min and after 18 h by dapsone and phagocytosis of ~-hematin. A
decrease was induced by doxycycline and primaquine after 10 min and primaquine after 18 h
(Table 5.1). The concentration was unaltered by chloroquine, tetracycline, pyrimethamine and
suramin (Table 5.2). Approximately 46% of all Mg ions occur in the intracellular fluid. Mg is
able to bind directly to highly charged substances such as DNA, RNA, ATP, ADP, citrate and
proteins, which is thought to affect the activity of the cell (Giinther, 1990; Williams and
Frausto da Silva, 2000). Mg is found bound and free in the cytosol, nucleus, ribosomes,
mitochondria and the cell membrane. When [Mg] is depleted, numerous cellular functions are
altered such as glycolysis, respiration, DNA, RNA and protein synthesis (Giinther, 1990). The
intracellular [Mg] is tightly regulated, thus it is thought that it has a regulatory function in the
cell (Maguire, 1990). Mg has been shown to be involved in the activation or inhibition of a
number of enzymes, such as acetyl CoA synthetase,S'-nucleotidase, phosphorylase kinase,
. phosphoribosyl pyrophosphate transferase, phosphoglucomutase, malic enzyme, NaIK
ATPase, Ca ATPase, DNA polymerase, glutamine synthase, adenylate cyclase and channels
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such as the Ca release channel and the inward rectifying K channel (Maguire, 1990). As
mentioned for the other elements, little is known about the influences of increases and
decreases in the concentration ofMg induced by the anti-malarial drugs in monocytes.
Ca has been studied by numerous groups because it is a secondary messenger and is involved
in apoptosis. Ca exchanges rapidly across the cell membrane, but the concentration in the
cytoplasm of cells remains low due to the activity of the Na/Ca antiporters (Tortora and
Grabowski, 2000). The extracellular levels of Ca are thought to be linked to the level of
phosphate and the pR (Williams and Frausto da Silva, 2000). Calcium is a well-known
secondary messenger; because its fast entry into the cell generates a novel and temporary state
of the cell. The calcium messenger may act almost simultaneously on as many as 40 proteins,
such as mechanical switches (troponins), membrane adjusters (annexins), transcription factors
(calcineurin) and metabolic switches (calmodulins and SI 00) (Williams and Frausto da Silva,
2000). Thus Ca acts as a coordinating agent for short durations in exited cells and as a
homeostatic agent for longer alterations of state. In this study, elevated calcium levels were
found in canine monocytes incubated with quinine after 10 min, and with tetracycline,
dapsone, doxycycline, suramin, latex bead and 13-hematin phagocytosis after 18 h. A decrease
in the [Ca] was induced by primaquine and doxycycline after 10 min. The intracellular
mobilization of Ca is essential for monocyte responses to chemotactic factors, which result in
dose-dependent increases in the cytosolic Ca concentration (Verghese and Snyderman, 1989).
Apoptosis is mediated primarily by the release of Ca into the cytosol (Karp, 1996).
Doxycycline induced a dual effect by decreasing the [Ca] after 10 min and increasing it after
18 h.
The [Ca] was increased in canine monocytes after 18 h incubation with suramin. Suramin
induces multiple effects on the homeostasis of Ca in cells (Emmick et al., 1994). It induces
Ca release from skeletal muscle sarcoplasmic reticulum vesicles in a concentration-dependent
manner. Suramin inhibits the Ca-ATPase and the Ca 'release channel. Suramin has also been
found to cause concentration-dependent inhibition of ADP-induced increases in [Ca] in
platelets (Hall and Rourani, 1994). Serum calcium levels in human cancer patients are
depleted after suramin administration (Walther et a!., 2000). The calcium concentration is
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elevated in numerous cells by the presence of suramin, thus the canine monocytes incubated
with suramin wouldbe expected to show increased levels of Ca. In fact suramin increased the
[Ca] substantially in this study and, of all the drugs to elevated the [Ca], suramin increased it
the most. Thus the other drugs that elevate the [Ca] at the same time points as suramin may
inhibit the Ca-ATPase and the Ca release channel but this could only be proven with further
investigations. The [Ca] was unaltered in cells incubated with chloroquine, pyrimethamine and
artemisinin.
Phagocytosed ~-hematin affects monocyte functionality. Changes in the concentration of
cytosolic Ca in macrophages have been measured using a calcium sensitive fluorescent dye.
Hishikawa et al. (1991) found that, prior to phagocytosis of an IgG-coated latex bead, there is
a dramatic rise in [Ca]. Calcium plays a major role in phagocytosis and is involved at
different stages in the lead-up to the ingestion of the particle. Calcium is a prerequisite for the
activation of c-fos expression, which is an important candidate for the induction of the heat
shock response during phagocytosis (Donati et al., 1991). The [Ca] was found to be elevated
in cells phagocytosing latex beads and ~-hematin after 18 h, but not after 10 min. Prior to
phagocytosis there is likely to be an increase in [Ca] but after 10 min the majority of the
particles have either been ingested or are attached to the monocyte, thus the [Ca] will have
returned to normal. After 18 h, phagocytosis will be complete and the increase in [Ca] is most
likely the result of the presence of the latex beads and the ~-hematin in the phagosome. An
early consequence of heat shock is a decrease in intracellular pH, reduced levels of ATP, and
an increase in cytosolic Ca levels (Welch et al., 1991). This change in [Ca] was not detected in
this study. However, Polla et al. (1991) found no increase in the [Ca] in U937 cells during heat
shock. The binding of extracellular HSP70 leads to intracellular Ca fluxes and the induction of
pro-inflammatory cytokines (pockley, 2001).
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Table 5.5 Anti-malarial drugs inducing the greatest alterations in elemental
concentrations in canine monocytes.
Element Time Increase Decrease
Drug % Drug °/0
Na 10min Suramin 41 Quinine 47
18 h Artemisinin 291
Mg 10min Artemisinin 21 Doxycycline 16
18 h Dapsone 30
P 10min Quinine 52
18 h Pyrimethamine 56
S 10min Suramin 8 Tetracycline 44
18 h Chloroquine 212
Cl 10min Suramin 59 Quinine 70
18 h Artemisinin 389
K 10min Artemisinin 38 Quinine 67
18 h Chloroquine 2 Suramin 64
Ca 10min Quinine 72 Doxycycline 36
18 h Suramin 356
Although no conclusions can be made from the changes in elemental concentrations induced
by the various drugs, the drugs that induce the greatest changes are worth considering further
(Table 5.5). The percentage increase or decrease in the concentration of the respective
element was determined using the baseline levels determined for the canine monocytes from
all the control samples used in this study. The baseline concentrations of the elements in
canine monocytes, as analysed in 150 cells were: 518.2 mmoleslkg for Na; 199.1 mmoleslkg
for Mg; 439.7 mmoleslkg for P; 316.3 mmoleslkg for S; 279.7 mmoleslkg for Cl; 204
mmoleslkg for K and 81.3 mmoleslkg for Ca.
Suramin increased the concentrations of Na by 41 %, S by 8 %, and Cl by 59 % after 10 min
and Ca by 356% after 18 h. The drug substantially decreased [K] by 64% after 18 h. Quinine
decreased [Na] by 47%, [Cl] by 70% and [K] by 67% and increased [P] by 52% and [Ca] by
72% after 10 min. Artemisinin induced small increases in Mg (21%) and K (38%)
concentrations within 10 min and massive increases in [Na] (291 %) and [Cl] (389%) after 18
h. Doxycycline decreased [Mg] by 16% and [Ca] by 36% after 10 min. The concentrations of
[S] and [K] were maximally increased by chloroquine after 18 h by 212% and 2%
respectively. After 18 h dapsone maximally increased [Mg] by 30% and pyrimethamine
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decreased [P] by 56%. Tetracycline decreased the concentration of [S] after 10 min by 44%.
Suramin, quinine and artemisinin induced numerous changes in the elemental concentrations
and the majority of these changes were larger than any of the other drugs used. However,
quinine induced these changes after 10 min whereas artemisinin and suramin induced these
changes after 18 h. Although artemisinin did increase the concentrations of certain elements
after 10 min, it was by much smaller amounts than after 18 h. Chloroquine was the only other
drug to induce a large increase in S, which was increased by 212%. Interestingly, quinine and
artemisinin at present are only used in the treatment of malaria and not for prophylaxis due to
the severity of the side affects if administration is not controlled (Raynes, 1999 Van Agtmael
et al., 1999). The same applies for suramin in the treatment of trypanosomiasis, AIDS and
cancer (Schiller et al., 1994).
Drugs that altered the P/K ratios by the greatest margm were: qumme, suramm and
pyrimethamine. The P/K ratio was increased by quinine by 348% after 10 min and suramin by
261 % after 18 h. Pyrimethamine decreased the P/K ratio after 18 h by 49%. Interestingly
although artemisinin has a great influence on the concentrations of other elements it had no
detectable effect on the P/K ratio.
Interestingly, Cl and Ca are likely to be important in chloroquine resistance in the malaria
parasite. Chloroquine susceptibility was increased two-three fold in resistant and susceptible
parasites in Cl-free media (Martiney et a!., 1999). The exact mechanism of the Cl modulation
of chloroquine susceptibility is unknown. The calcium channel blockers, verapamil,
desipramine, chlorpromazine, ketotifin, tetrandrine, cyproheptidine and fluoxetin, are able to
reverse chloroquine resistance in P. falciparum isolates in vitro (De et aI., 1993; Agrawal et
al., 2002).
The individual changes in the elemental concentrations of the cells under different conditions
may be important, but changes in the concentration of one element may be linked to changes
in the concentrations of other elements. Digitalis is a drug given to patients with heart failure;
it exerts its effect by altering the intracellular concentrations of elements. Specifically,
digitalis slows down the NaIK ATPase thus allowing Na to accumulate in the cells and
168
reducing the concentration gradient across the cell membrane. The NalCa anti-porters slow
down causing Ca to accumulate in the cell (Tortora and Grabowski, 2000). None of the drugs
used in this study effect the same elemental changes brought about by digitalis. However, this
example serves to highlight that there are many factors involved in the elemental changes and
to try to explain what is happening in 14 experimental conditions, each with different time
points, requires more investigation and a complete knowledge of all the processes under
. elemental regulation. This study was unique as no others of its kind have been undertaken.
The changes in the elemental concentrations in canine monocytes induced by drugs,
phagocytosis and heat shock are evidence that further investigations are required. These will
enable development of a. fuller understanding of the mechanisms for the increases and
decreases of the elemental concentrations in canine monocytes, as well as the cellular
responses to the changed concentrations. Once this greater understanding has been achieved,
the results could be extrapolated to the mechanisms of action of the various drugs on
monocytes. Further analysis of each individual drug at different time points or analysis of a
simpler cell such, as the red blood cell may give further insight into the changes that are
occurring. Due to the complexity of the monocyte it may be better to study the effects of the
various drugs on red blood cells first to determine the relationships between the elements. Not
much is known about the influence of elemental changes within red blood cells but numerous
investigators have studied the transport of ions across the red blood cell membrane as well as




Plasmodium falciparum malaria is a globally and economically important disease. Peripheral
blood monocytes are the first line of defence during infection (Asch, 1991) and perform many
immunomodu1atory functions, such as phagocytosis, intracellular and extracellular killing by
the generation of reactive oxygen intermediates (Schwarzer et al., 1992; Fiori et al., 1993) and
the production of cytokines (Thuma et a!., 1996). However, in the case of malaria some of
these functions are suppressed or induced to a greater extent by hemozoin phagocytosis
(Francis et al., 1997; Sherry et aI., 1995; Schwarzer et al., 1998; Scorza et al., 1999), the
presence of malaria glycosy1phosphatidy1inosito1 (GPI) in blood (Schofie1d et a!., 1996;
Tachado et al., 1996), fever conditions (heat shock) (C1erget and Polla, 1990; Polla and
Kantengwa, 1991; JaatteHi, 1993; Vadas et aI., 1993) and the presence of anti-malarial drugs in
the bloodstream of the patient (Schwartz et al., 1985; Gabay et al., 1994; Go1dring et aI., 1999;
Go1dring and Nemaorani, 1999; Go1dring and Ramoshebi, 1999).
Canine monocytes were isolated in this study using the Histopaque@-1077 density gradient
centrifugation method followed by adherence to glass covers1ips (Go1dring et al., 1992). The
morphology (Auger and Ross, 1992), presence of peroxidase (Krakowka and Wallace, 1983;
Stachura, 1989) and alkaline phosphatase (Van Noorden and Frederiks, 1992) as well as the
ability of the cells to phagocytose latex beads and ~-hematin (Auger and Ross, 1992;
Schwarzer et aI., 1999) confirmed the identity and viability of the isolated monocytes. ~­
Hematin was synthesized from hematin using a protocol used by Slater et al. (1991) and
Taramelli et a!. (1995). In further studies, it may be interesting to look at the effects of the
various anti-malarial drugs on monocyte phagocytosis of latex beads, ~-hematin, hemozoin
and malaria infected red blood cells.
Antigenic peptides were selected from the highly conserved human HSP70 and HSC70
proteins using the Predict7 programme (Carmenes et al., 1989) and protein similarity searches
performed on the Swiss Prot website using BLAST2.0. The anti-peptide antibodies raised in
chickens immunized with the peptide rabbit albumin conjugate, were able to recognise the free
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peptide in an ELISA and the native 70 kDa proteins in human and canine heat shocked
lymphocyte lysates on western blots. HSP70 was not expected to be expressed at 37°C
(Lindquist, 1986), but in this study it was expressed at both 37°C and 44°C. The lymphocytes
were most likely activated by the isolation (Wu et aI., 1986; Thiem et al., 1988, Njemini et al.,
2002) thus for future experiments alternative isolation methods need to be investigated.
The anti-HSP peptide recognized approximately 10 proteins III the isolated lymphocyte
lysates; these may be products of cathepsin D cleavage ofHSP70 (Sehorn et aI., 2002) or
normal breakdown products of HSP70 (Lindquist, 1986). Further investigations would require
the use of a higher concentration of the cathepsin D inhibitor, pepstatin A or using numerous
increments in time and/or temperature. As mentioned in Chapter 4, 35S-methionine or [H]3_
amino acid labelling or northern blot analysis of the HSP70 mRNA, would provide
information about the expression of new proteins at the onset of heat shock. In this study the
possibility that the anti-HSP antibody was also cross-reacting with HSC70 in the lymphocyte
lysates could not be ruled out. Unfortunately, pure HSP70 and HSC70 were unavailable but
for future studies have both proteins will be required for an extensive study on HSP
expreSSIOn. Another possibility would be to obtain numerous lymphocyte or monocyte
lysates, to use the anti-peptide antibodies to affinity purify the proteins, and determine if they
are fragments of HSP70 or represent other proteins recognized by the antibodies. If these
problems are resolved then the effects of anti-malarial drugs on the expression of heat shock
proteins in the presence or absence of ~-hematinor hemozoin could be undertaken.
The X-ray microanalysis study showed that all the drugs, the phagocytosis of latex beads and
~-hematin as well as heat shock altered the elemental concentrations and the P/K ratios of
canine monocytes in unique ways. However, there were differences in the time when the
changes occurred and whether there was an increase, a decrease or no change in the elemental
concentrations. Although the mechanisms for these changes and the cellular responses to
them. are as yet uncharacterised, the data obtained in this study can be compared to a certain
extent with other studies. The comparisons must be conservatively approached as the present
study was performed using canine monocytes whereas most other studies examined human
monocytes. Thobakgale (2002) detected primaquine in the cytoplasm and granules of canine
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monocytes, thus confinning that this drug is present within the cell. The other anti-malarial
drugs used in this study are also likely to be internalized in the monocytes.
The most influential drugs on the concentrations of elements were suramm, qumme and
artemisinin as the alterations they induced were greater than any of the other drugs used.
Quinine was the only drug to influence the concentrations of all the elements, with the
exception of Mg after 10 min; suramin and artemisinin affected the concentrations at 10 min
and 18 h. As mentioned previously suramin and quinine altered the P/K ratios by the greatest
margins but artemisinin had no effect. In future studies it may be interesting to investigate
these three drugs further, as altering the concentrations of elements may in part lead to a better
understanding ofhow these three drugs act on nonnal cellular metabolism.
Goldring and Nemaorani (1999) examined the modulation of human monocyte surface
receptors by anti-malarial drugs (quinine, artemisinin, chloroquine, primaquine,
pyrimethamine), the trypanocidal drug, suramin, and a protein kinase C inhibitor,
staurosporine. All the drugs used were found to reduce the expression of monocyte receptors
at therapeutic doses in unique ways. The most effective drug in reducing receptor expression
after 18 h was quinine (65% reduction), followed by pyrimethamine (60% reduction). After 18
h incubation in this study, both quinine and pyrimethamine had no effect on the concentrations
ofK and Ca. However, artemisinin (40% reduction) was the least effective anti-malarial drug
in reducingreceptor expression and suramin reduced expression by only 7%. These two drugs
showed only one similarity in altering the elemental concentrations in monocytes, they
decreased the concentration of K after 18 h. Primaquine and chloroquine reduced receptor
expression to a lesser degree than pyrimethamine, but primaquine had no effect on the
concentration of K whereas chloroquine increased it. This indicates that changes in the K
concentration may be involved in the regulation of the expression of monocyte receptors.
However, it must be remembered that there are many other contributing factors that will alter
the expression of monocyte receptors. Staurosporine was found to reduce monocyte receptor
expression by 98% (Goldring and Nemaorani, 1999), as well as prevent the adherence of
malaria infected erythrocytes to human monocytes (Goldring and Ramoshebi, 1999). This may
be related to the efflux of Cl found by Fernandez-Segura et al. (1999) in staurosporine-
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induced apoptosis, but the alteration of the other elements may be involved in monocyte
receptor expression.
Although western blots showed no apparent difference in the expression ofHSP70 and HSC70
at 37°C and 44°C, X-ray microanalysis showed that there were differences in the way the
elemental concentrations were altered at 37°C and 44°C. However, it must be noted that the
cells were isolated and treated very differently and therefore direct comparisons are not valid.
In future studies the alterations in the elemental concentrations induced by the anti-malarial
drugs on the monocyte phagocytosis of latex beads, B-hematin, hemozoin and malaria infected
red blood cells could be investigated. The effects of anti-malarial drugs on the elemental
concentrations in heat shocked human or canine monocytes in the presence or absence of B-
hematin, hemozoin or malaria infected red blood cells could also be investigated. These results
could be compared to the phagocytic indices and the expression of heat shock proteins
previously mentioned. Other avenues to explore using X-ray microanalysis are the effects on
the elemental concentrations in the malaria parasite in the red blood cell, brought about by
therapeutic concentrations of anti-malarial drugs. Although other investigators have examined
the membrane transport in the red blood cell as well as in malaria infected red blood cells, no
one fully understands the implications for the cells of increases and decreases in the
concentrations of elements (Kirk, 2001). Other methods could be utilized, such as fluorescent
ion-sensitive indicators, which can be used to monitor the intracellular elemental
concentrations in time course studies (Kirk, 2001). At present fluorescent indicators are
available for Na, H, K, Ca, Mg and Cl. The elemental concentrations could also be measured
using atomic absorption spectroscopy or electron energy loss spectroscopy (EELS)
(Jeanguillaume et al., 1996). In order to utilize X-ray microanalysis to its fullest potential in a
study such as that presented here, it would be preferable to plunge freeze the grids in liquid
nitrogen or propane and then freeze dry the samples. This would give clearer ultrastructural
details within the cell and would enable the investigator to determine the elemental
concentrations in the different intracellular organelles. Unfortunately, the samples could not be
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Figure 6.1 Diagrammatic representation of the present study on the effects of anti-
malarial drugs, suramin, fever and phagocytosis on the concentrations of elements in
canine monocytes.
This study was a preliminary investigation into the effects of anti-malarial drugs and heat
shock on the elemental concentrations in canine monocytes, as well as the effects of heat
shock on the expression of HSPs. Although the results at present are inconclusive in light of
the current lack of knowledge with regard to elemental homeostasis in monocytes, each anti-
malarial drug and experimental condition induced a unique response in the monocytes. The
baseline elemental concentrations in canine monocytes have been conclusively determined in
this study and will aid in further work in this field. Monocytes are complex cells, and in this
unique study we have identified that various anti-malarial drugs, fever and hemozoin alter the
concentrations of elements in different ways (Figure 6.1). Further investigations will hopefully
increase understanding of the implications of these changes on monocytes.
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